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Abstract 
Artificial neural interfaces can connect the central nervous system with the outside world 
and hold great potential for rehabilitating patients that suffer from paralysis, other forms 
of motor dysfunction, or limb loss. Several types of brain neural interfaces, with varying 
levels of invasiveness and abilities to acquire neural signals, have been developed. For 
example, non-penetrating recording electrodes placed externally on the scalp or 
subdurally on the brain surface can gain functional information. However, many 
researchers believe that recording and stimulating devices that penetrate into specific 
regions of the brain (i.e. intracortical microelectrodes) will likely provide the most useful 
signals for neural interfacing. Despite the potential that intracortical microelectrodes have 
shown, widespread clinical implementation is impeded by the fact that it is difficult to 
consistently record high quality neural signals over clinically relevant time frames. This 
is in large part due to neuro-inflammation, which involves both neuron degeneration and 
foreign body encapsulation. Several factors have been implicated to contribute to neuro-
inflammation following device implantation, including the mechanical mismatch between 
the often highly rigid implant and the much softer brain tissue, and the oxidative stress 
state that forms around the implant as a result of inflammation. To enable long-term 
consistent neural recordings, new materials are needed for the next generation of 
intracortical microelectrodes, with an increased emphasis on reducing the neuro-
inflammatory response.  
 x 
 
This dissertation pursued the development of new physiologically responsive, 
mechanically adaptive polymeric materials for neural interfacing applications and the 
study of the structure-property relationships of these materials. Expanding a previously 
established design principle for chemo-responsive mechanically adaptive materials 
inspired by the architecture of the sea cucumber dermis, several families of 
nanocomposites were designed, prepared and studied. These materials consist of a matrix 
polymer that is reinforced with rigid cellulose nanocrystals (CNCs) and the interactions 
between the CNCs, and therewith the overall mechanical properties, can be influenced by 
exposure to water. The adaptive nature of these materials makes them useful as a basis 
for penetrating cortical microelectrodes that are sufficiently stiff to be easily implanted 
into the cortex, but upon exposure to physiological conditions soften to better match the 
stiffness of the brain. Several new rationally designed materials systems were 
investigated.  
Thus, nanocomposites based on poly(vinyl alcohol) and CNCs derived from tunicates and 
cotton were studied to explore how aspect ratio, surface charge density, and filler content 
influence the mechanical properties. The new materials offer an initial stiffness that is 
significantly higher than that of previous generations of such responsive materials, 
presumably on account of polymer-CNC interactions. It was also shown that the aqueous 
swelling characteristics of the nanocomposites could be controlled via the processing 
conditions. Using this tool, the switching “contrast” of the nanocomposites upon 
exposure to (emulated) physiological conditions could be varied. 
Physiologically responsive mechanically adaptive materials based on poly(vinyl alcohol) 
or poly(vinyl acetate) and CNCs isolated from tunicate or cotton were further bestowed 
with the capability to also locally administer the anti-oxidant drugs curcumin, resveratrol 
or superoxide dismutase mimetic with burst or sustained release profiles. These materials 
represent the first examples of materials for intracortical implants which combine two 
independently effective mechanisms – mechanical morphing and localized anti-oxidant 
release. They permit, for the first time, to explore if the combination leads to synergistic 
effects and will permit investigations of how the release kinetics of anti-oxidant therapies 
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at the intracortical implant-tissue interface influence neural integration. A first in vivo 
study of PVA/CNC/curcumin nanocomposites in rats revealed that over the first four 
weeks of the implantation, curcumin-releasing, mechanically adaptive implants were 
associated with higher neuron survival and a more stable blood-brain barrier at the 
implant-tissue interface than the neat poly(vinyl alcohol) controls.  
Finally, the ability to mechanically morph upon exposure to physiological conditions was 
imparted to optical fibers for optogenetics. This recently developed neural interfacing 
platform relies on the activation or muting of neurons using light and one must expect 
that mechanical mismatch of conventional optical fibers and the cortical tissue also 
contribute to the chronic neuroinflammatory response. Thus mechanically adaptive 
optical fibers made of PVA were developed, which may mitigate this problem. Produced 
by a one-step wet-spinning process, the fibers display an initial stiffness that is slightly 
higher than that of commercial optical fibers and permits facile insertion of small-
diameter implants into the cortex. Upon exposure to (emulated) physiological conditions, 
the fibers swell slightly with water and their stiffness is reduced significantly, while the 
concomitant changes to the fiber’s optical properties are small. The PVA optical fibers 
permit to deliver light of a range of wavelengths that is sufficiently intense to stimulate 
neurons in the brain and meet the optical demands of optogenetic applications. 
This dissertation derived fundamental insights into the structure-property relationships by 
governing the adaptive nature of these materials through composition (i.e. different 
polymer matrices, types and amount of nanofiller, and therapeutic agents) and also 
processing conditions. While in vivo studies using the new materials presented here have 
only begun, it is already clear that the materials made and studied in this dissertation will 
be useful to advance the understanding of how stimuli-responsive polymeric materials 
can help to decrease the neuroinflammation effects associated with intracortical implants. 
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Zusammenfassung 
Künstliche neurale Schnittstellen können verwendet werden, um das zentrale 
Nervensystem mit der äusseren Welt zu verbinden. Sie bieten deshalb grosses Potential 
für die Rehabilitierung von Patienten, die unter Lähmung, anderen Formen von 
motorischer Dysfunktion oder Amputationen leiden. Es wurden verschiedene Arten 
neuraler Gehirnschnittstellen entwickelt, mit unterschiedlichen Invasivitätsgraden sowie 
der Fähigkeit, neurale Signale aufzunehmen. Beispielsweise können nicht-eindringende 
aufzeichnende Elektroden, welche extern auf der Kopfhaut oder subdural auf der 
Hirnoberfläche angebracht werden, funktionale Informationen gewinnen. Allerdings ist 
unter Forschern die Annahme verbreitet, dass Aufzeichnungs- und Stimulationsgeräte, 
die in spezifische Regionen des Gehirns eindringen (z. B. intrakortikale 
Mikroelektroden), wahrscheinlich die nützlichsten Signale einer neuralen Schnittstelle 
liefern werden. Trotz des Potentials, welches intrakortikale Mikroelektroden gezeigt 
haben, ist die breite klinische Implementation durch die Tatsache behindert, dass es 
schwierig ist, beständig qualitativ hochwertige neurale Signale über einen klinisch 
relevanten Zeitrahmen aufzuzeichnen. Dies wird hauptsächlich durch Neuroinflammation 
verursacht, was sowohl Neuronendegeneration als auch Fremdkörperverkapselung 
beinhaltet. Viele Faktoren werden in Zusammenhang gebracht, einen Beitrag zur 
Entzündung der Gehirnareale in Folge von Geräteimplantationen zu leisten, darunter die 
mechanische Diskrepanz zwischen dem häufig sehr steifen Implantat und dem deutlich 
weicheren Hirngewebe, sowie dem oxidativen Stresszustand, der um das Implantat als 
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Resultat der Entzündung entsteht. Um langzeit-beständige neurale Aufzeichnungen zu 
ermöglichen, werden neue Materialien für die nächste Generation intrakortikaler 
Mikroelektroden benötigt, mit grösserer Betonung auf einer Reduktion der 
neuroinflammatorischen Antwort benötigt. 
Die vorliegende Dissertation verfolgt die Entwicklung physiologisch responsiver, 
mechanisch adaptiver Polymere für neurale Schnittstellenapplikationen sowie eine Studie 
zur Struktur-Eigenschaftsbeziehung dieser Materialien. Ausgehend von einem zuvor 
etablierten Designprinzip für chemisch-responsive mechanisch adaptive Materialien, 
inspiriert durch die Architektur der Dermis von Seegurken, wurden verschiedene 
Familien von Nanokompositen entworfen, präpariert und untersucht. Diese Materialien 
beinhalten ein Matrixpolymer, welches durch steife Cellulose Nanokristalle (cellulose 
nanocrystalls, CNCs) und die Wechselwirkungen zwischen den CNCs verstärkt wird, so 
dass auch die gesamten mechanischen Eigenschaften durch Kontakt mit Wasser 
beeinflusst werden können. Die adaptive Natur dieses Materials lässt es nützlich 
erscheinen als Basis für eindringende kortikale Mikroelektroden, die ausreichend steif 
sind, um einfach in den Kortex implantiert werden zu können, aber unter physiologischen 
Bedingungen erweichen und besser zur Steifigkeit des Gehirns passen. Mehrere neue, 
rational entworfene Materialien wurden untersucht.  
Nanokomposite basierend auf Polyvinylalkohol (PVA) und CNCs, gewonnen aus 
Manteltieren und Baumwolle, wurden hinsichtlich des Einflusses von Aspektverhältnis, 
Oberflächenladungsdichte und Füllstoffkonzentration auf die mechanischen 
Eigenschaften untersucht. Die neuen Materialien bieten eine anfängliche Steifigkeit, 
welche signifikant höher ist als bei vorangegangenen Generationen solcher responsiver 
Materialien, vermutlich wegen der Wechselwirkungen zwischen Polymer und CNCs. 
Ferner wurde gezeigt, dass die Quellcharakteristika der Nanokomposite im wässrigen 
Medium durch die Verarbeitungsbedingungen kontrolliert werden konnten. Unter 
Verwendung dieses Instruments konnte der „Schaltkontrast“ der Nanokomposite durch 
Kontakt mit (emulierten) physiologischen Bedingungen variiert werden.   
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Physiologisch responsive mechanisch adaptive Materialien basierend auf 
Polyvinylalkohol oder Polyvinylacetat und CNCs, die aus Manteltieren oder Baumwolle 
gewonnen wurden, wurden so konzipiert, auch lokal die antioxidativen Wirkstoffe 
Curcumin, Resveratrol oder Superoxiddismutase mimetisch mit plötzlichen („burst“) 
oder nachhaltigen Freisetzungsprofilen zu regulieren. Diese Materialien repräsentieren 
die ersten Beispiele für interkortikale Implantate, welche zwei voneinander unabhängig 
effektive Mechanismen kombinieren – mechanische Verformbarkeit und lokale 
Freisetzung von Antioxidantien. Sie erlauben erstmals Untersuchungen darüber, wie die 
Freisetzungskinetik bei Antioxidanstherapie an der intrakortikalen Implantat-Gewebe 
Grenzfläche die neurale Integration beeinflusst. Eine erste in-vivo Studie mit 
PVA/CNC/Curcumin Nanokompositen an Ratten zeigte, dass über die ersten vier 
Wochen der Implantation Curcumin-freisetzende, mechanisch adaptive Implantate mit 
einer höheren Neuronenüberlebensrate und einer stabileren Blut-Hirn-Schranke an der 
Grenzfläche zwischen Implantat und Gewebe assoziiert wurden als die reinen 
Polyvinylalkohol Kontrollproben. 
Abschliessend wurde die Fähigkeit der mechanischen Verformung durch Einfluss 
physiologischer Bedingungen für optische Fasern für die Optogenetik verwendet. Diese 
kürzlich entwickelte Plattform für neurale Schnittstellen beruht auf der Aktivierung oder 
Stummschaltung von Neuronen, die Licht verwenden. Es wird erwartet, dass die 
mechanische Diskrepanz zwischen konventionellen optischen Fasern und kortikalem 
Gewebe auch zur chronischen neuroinflammatorischen Antwort beiträgt. Daher wurden 
mechanisch adaptive optische Fasern aus PVA entwickelt, welche dieses Problem lindern 
könnten. Die Fasern wurden in einem einstufigen „dry-jet“ Nassspinnprozess produziert 
und sie zeigen eine anfängliche Steifigkeit, die geringfügig höher ist als die kommerziell 
erhältlicher optischer Fasern, und die müheloses Einführen von Implantaten mit geringem 
Durchmesser in den Kortex ermöglicht. Unter (emulierten) physiologischen Bedingungen 
quellen die Fasern mit Wasser geringfügig auf und ihre Steifigkeit wird signifikant 
reduziert, während die begleitenden Veränderungen der optischen Eigenschaften der 
Faser gering sind. Die optischen Fasern aus PVA erlauben es, Licht in einem 
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Wellenlängenbereich zu transportieren, der hinreichend intensiv ist, Neuronen im Gehirn 
zu stimulieren und optischen Anforderungen für optogenetische Anwendungen gerecht 
zu werden.  
Die vorliegende Dissertation leitet fundamentale Einblicke in Struktur-
Eigenschaftsbeziehungen her, indem sie die adaptive Natur dieser Materialien durch 
Zusammensetzung (z.B. unterschiedliche Polymermatrices, Art und Menge der 
Nanofüller und therapeutischer Substanzen) sowie die Verarbeitungsbedingungen 
vertieft. Während in-vivo Studien zum hier vorliegenden neuen Material gerade erst 
begonnen haben, ist es schon heute ersichtlich, dass die im Rahmen dieser Dissertation 
hergestellten und untersuchten Materialien zum Fortschritt des Verständnisses nützlich 
sind, wie stimuli-responsive Polymere helfen können, neuroinflammatorische Effekte in 
Zusammenhang mit Intrakortikalimplantaten zu verringern.  
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Chapter 1 – Introduction to Biocompatible Materials for Intracortical 
Microelectrodes1 
 
Neural interfaces bridge the central nervous system to the outside world. Originally, 
neural interfaces were developed as a basic science tool, and as such, have been used 
extensively to develop an understanding of how the nervous system works.1-3 
Additionally, neural interfaces hold great potential for rehabilitating persons with 
paralysis, other forms of motor dysfunction, or limb loss. Such rehabilitative applications 
require signal transducing systems that are commonly referred to as brain machine (or 
brain computer) interfaces.4 In brain machine interface (BMI) applications, a recording 
device is used to extract volitional intent in the form of consciously modulated neuronal 
signals from the nervous system. Using a variety of signal processing algorithms, 
extracted neural signals can then be used to drive external devices such as limb 
prostheses or computers.5-11 
A number of types of recording devices which rely on varying levels of invasiveness and 
access different forms of neural information have been developed. For example, non-
penetrating recording electrodes placed externally on the scalp or sub-durally on the brain 
surface can gain functional information.10, 11 However, many researchers believe that 
recording devices that penetrate into specific regions of the brain will likely provide the 
most useful control signals for brain machine interfacing.12 Despite the potential that 
penetrating intracortical microelectrodes have shown, widespread clinical implementation 
is impeded by the inability to consistently record high quality neural signals over 
clinically relevant time frames.13-16 As such, this thesis focuses on intracortical 
microelectrodes implanted within the cerebral cortex, which record from single or small 
populations of nearby neurons. 
                                                
1This chapter is adapted from Jorfi, M.; Skousen, J.L.; Weder, C.; Capadona, J.R. Journal of Neural 
Engineering, 2015, 12, 011001. DOI:10.1088/1741-2560/12/1/011001 
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In this introduction the evolution of traditional intracortical microelectrode systems is 
discussed from a materials science perspective. Particular emphasis is given to key 
material developments that have facilitated the longest and highest quality in vivo 
recordings. In addition, a number of primary failure modes are discussed that must be 
overcome to achieve the full potential of intracortical microelectrodes for in vivo 
recording applications. Lastly, the impressive progress that has been made in recent years 
to develop the next generation of materials for intracortical microelectrodes is reviewed. 
By framing recent advancements within the context of current successes, the most 
promising strategies are highlighted and the most critical challenges for improving 
intracortical electrode-based neural interfaces are discussed. 
1.1. TRADITIONAL INTRACORTICAL MICROELECTRODES FOR BRAIN 
MACHINE INTERFACING 
A number of intracortical microelectrodes have been designed to interface with cortical 
neurons, including insulated metal microwires and semiconductor-based devices such as 
the Michigan and Utah electrode arrays, which are discussed in more detail below. 
Regardless of the specific design or manufacturer, a similar compound circuit can be used 
to describe how microelectrodes extract electrical signals generated from single target 
neurons. Extensive descriptions of each of the primary portions of the compound circuit 
are available elsewhere,17, 18 and therefore only a brief description will be included here.  
The first portion of the circuit involves the complex set of presynaptic inputs that interact 
with the target neuron being recorded from. These inputs can be both excitatory and 
inhibitory. If a sufficient excitatory postsynaptic potential is created within the target 
neuron then a compound action potential is generated through depolarization of the axon 
hillock. The ion-based signal generated at the axon hillock then travels through the 
extracellular space to the electrode-recording site.  As transport is primarily diffusion 
based, the strength of the ionic signal that reaches the recording site is governed by the 
overall distance traveled and the impedance of the extracellular space.  
 3 
At the recording site, intracortical electrodes measure microvolt changes in neural 
activity (or action potentials), which reflect the above described changes in the flow of 
ions across the neuronal membrane.19 The electric potential produced by this ion-based 
neural activity is recorded by the electrode arrays as voltage change. Signals can be 
amplified and converted into an electrical current, which can be processed by signal 
acquisition and processing techniques.20 Signal processing can be classified into three 
stages: 1) pre-processing, 2) feature extraction, and 3) detection and classification. First, 
the signals will be processed to remove the unwanted components (i.e. noise) and extract 
specific signal features by filtering or source separation. Then, once the signals are 
classified, an algorithm can be applied to translate the signal into device 
commands/orders that carry out the user’s intent.20-22 The output device can vary from 
application to application and have ranged from overt command or control functions such 
as moving a cursor on a computer screen, to a facilitating a robot to walk on a treadmill, 
driving a wheelchair, or controlling a robotic arm.23 
Figure 1-1 shows a commonly used equivalent circuit model (Robinson Model) of metal 
microelectrode recoding in the brain.17 In particular, signals at the tip of the 
microelectrode (Vsig) generate currents (I) that flow to ground through the microelectrode 
and effective ampliﬁer circuit, creating the potential (Vin) at the input of the ampliﬁer 
before being recorded (Vrec); Rs is the resistance of the electrolyte; Re is the leakage 
resistance which models the flow of the charge carriers crossing the electric double layer; 
Ce is the capacitance of the microelectrode-electrolyte interface; Rm is the resistance of 
the microelectrode; Cs is all the shunt capacitance to ground; and Za is the input 
impedance of the amplifier. Thus, the effective impedance of the microelectrode is 
comprised of the resistance of the electrolyte (Rs), the resistance and capacitance of the 
double layer interface of the electrolyte (Re and Ce) and the (negligible) resistance of the 
microelectrode (Rm). The impedance of the microelectrode is frequency dependent. At 
low frequencies, the impedance is dominated by the series combination of Rs and Re, 
whereas at high frequencies Ce bypasses the effect of Re so that the impedance is now 
close to Rs. Thus, by measuring the impedance of an electrode at high and low 
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frequencies, it is possible to determine the component values for the equivalent circuit. It 
is worth noting that several physical properties of electrodes effect the electrical 
characteristics and thereby the electrode impedance.17, 18, 24  
 
Figure 1-1. Electrical circuit model of intracortical microelectrode in the brain. 
1.2. CHALLENGES TO OBTAINING CONSISTENT, HIGH-QUALITY NEURAL 
RECORDINGS 
Despite substantial success that has been achieved using intracortical microelectrode in 
neural interface applications, many studies have shown chronic cortical recording to be 
inconsistent in a variety of species and with multiple electrode types. As early as 1974, 
Burns et al. showed a progressive decline in unit recordings in cat cerebral cortex after 
implantation, with only 8% of the electrodes functioning after 5 months.25 Forty years 
later, recording instability is still a commonly documented problem. For example, Liu et 
al. reported that implanted electrodes have low recording stability during acute tissue 
remodeling, and thereafter experience a continual decrease in recording ability over the 
ensuing months.15, 16 Additionally, Ludwig et al. and Freire et al. have both described 
fluctuations in recording stability that agree well with previous findings.26, 27 
A number of failure modes likely influence chronic recording stability and quality 
including: 1) direct mechanical damage of the electrode; 2) corrosion of electrical 
contacts; 3) degradation of passivation layers and insulating coatings; and 4) the neuro-
inflammatory response that the brain mounts against chronically implanted devices.13, 28 
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Traditionally, microelectrode failure modes have largely been studied independently from 
one another. However, as recently suggested by Sanchez,29 there is likely considerable 
interplay among the various failure modes making it difficult isolate a single mechanism 
of failure.  
1.2.1. The Neuro-Inflammatory Response 
There is increasing consensus that the neuro-inflammatory response to intracortical 
microelectrodes is a primary hurdle preventing applications in brain machine interface 
from reaching their full potential. Therefore, improving the understanding of the neuro-
inflammatory response that develops following microelectrode implantation in the brain, 
and developing strategies to reduce its impact is critical to achieving the promise of brain 
machine interfaces and enable longer durations for basic science experiments. 
Over 100 studies have described stereotypic features of the brain’s response to 
microelectrodes that occur irrespective of the type of implant, method of sterilization, 
species studied, or implantation method. From this rich body of literature, it has become 
increasing clear that the brain’s response consists of an interconnected web of molecular 
and cellular components. The ultimate result of this interplay is the continuous 
perpetuation of response, and the prevention of microelectrode integration into the 
surrounding tissue. With respect to the molecular and cellular components, several 
theories have been presented that explain how individual components of the response 
might adversely impact recording quality. However, it is highly likely that multiple 
aspects of the response are at play simultaneously. Thus, further study into the details of 
the neuro-inflammatory response and the development of more comprehensive mitigation 
strategies are indicated. 
1.3. MATERIAL STRATEGIES FOR IMPROVING MICROELECTRODE 
BIOCOMPATIBILITY AND RECORDING PERFORMANCE 
In the last decade, various materials-based strategies have been investigated with the 
objective of minimizing the neuro-inflammatory response and enabling long-lasting 
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neural interfaces with high fidelity recording performance. In all cases, developers have 
sought to address one, or a set of limitations, of traditional intracortical microelectrodes. 
Throughout the following sections we will review the primary approaches to develop the 
next generation of intracortical microelectrodes including: 
§ Minimizing motion-induced trauma using compliant microelectrode substrates 
§ Limiting surgical trauma and/or inflammatory cell accumulation by manipulating 
microelectrode architecture 
§ Preventing protein and inflammatory cell adhesion through non-fouling surface 
coatings 
§ Manipulating inflammatory cell phenotype through use of surface topography 
§ Directing wound healing and tissue integration at the microelectrode-tissue interface 
using bioactive materials 
§ Reducing the concentration or impact of inflammatory soluble factors through the 
use of passive and active antagonists 
§ Improving the chronic performance of intracortical microelectrodes using conducting 
polymers or nanomaterials 
The following sections discuss the progression of each of the primary materials-based 
approaches to improve intracortical microelectrode performance. Each subsection is 
concluded with our interpretation on the strengths/limitations and questions that must be 
addressed to enable consistent, high-quality long-term neural recordings. 
There are a number of important facts to consider when comparing and analyzing the 
impact of material-based approaches for improving microelectrode function. First, 
isolating the impact of a given strategy to one variable that could influence the neuro-
inflammatory response is difficult at best. For example, as will be discussed in Section 
1.3.1, a major strategy in the field for reducing the neuro-inflammatory response is the 
creation of compliant, polymer-based microelectrodes that better match the mechanical 
properties of the surrounding tissue. It is believed that the improved mechanical matching 
between the implant and the surrounding tissue will limit repetitive, micromotion-
induced damage at the biotic/abiotic interface. However, many of the polymers used to 
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create compliant microelectrodes absorb a significant degree of water and are likely 
permeable to small molecules, adding the possibility that the findings in these studies 
have been influenced by improved clearance of macrophage secreted factors. Conversely, 
as will be discussed in Section 1.3.2, strategies that aim to reduce the neuro-inflammatory 
response by manipulating microelectrode architecture also unavoidably alter underlying 
mechanical properties such as microelectrode compliance. Therefore, further studies 
should be conducted to isolate the impact of individual design variables as well as 
possible interactions or emergent phenomena to elucidate the overall design space 
available for microelectrode designers.  
Equally as important when analyzing findings from studies that have examined new 
strategies for reducing the neuro-inflammatory response, one must critically assess the 
role that tissue processing and other employed techniques may have on reported results. 
For example, in almost all cases the implanted microelectrodes are removed from tissue 
prior to analysis. Microelectrode removal may disrupt the tissue interface by removing 
adherent tissue and may influence data interpretation,30-33 especially for coatings that 
improve cell attachment. Different groups also use a variety of markers to describe the 
same cellular and molecular features of the neuro-inflammatory response. An example of 
this is the use of pan-macrophage markers such as OX-42 and IBA-1 vs. markers for 
macrophage activation such as CD-68. There are also large to subtle differences in the 
methods used to image and quantify tissue that can lead to differences in interpretation. 
Common differences include the use of confocal vs. traditional microscopy as well as a 
large variety of boutique software packages. Therefore, efforts to improve consistency 
across studies and groups could be quite useful for improving comparisons between 
studies. 
1.3.1. Mechanically Compliant Intracortical Microelectrodes 
As discussed above, traditionally, microelectrodes have been composed of metals, silicon 
and/or ceramics. These materials have high stiffness (high modulus) relative to brain 
tissue. While the high stiffness has enabled current microelectrode geometries the ease of 
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implantation into the cortical tissue,34 the Young’s modulus difference between brain 
tissue (3-13 kPa)35 and typical electrode materials (~200 GPa) is believed to result in 
strain on the surrounding brain tissue.36, 37 Therefore, mechanically-compliant 
intracortical microelectrodes, which have a mechanical behaviour that more closely 
matches that of the brain tissue, offer exciting alternatives for intracortical microelectrode 
technology over the traditional stiffer devices. This is perhaps most readily accomplished 
with polymeric materials which permit access to a Young’s modulus range that stretches 
from ones of kPa (in the case of hydrogels) to the tens of GPa (in the case of naturally 
oriented fibers) regime. Initial approaches to relieve microelectrode-associated tissue 
strain relied on the implementation of “softer” materials in the development of 
mechanically compliant microelectrode. As discussed below, the selection of “off-the-
shelf” polymers with a reduced modulus allowed researchers to begin to investigate the 
role of tissue strain in microelectrode performance. However, the use of “softer” 
materials introduced additional hurdles, and interesting potential solutions. One important 
challenge of compliant materials is associated with the required physical characteristics. 
In particular, sufficient mechanical strength and toughness are needed for handling and 
each of the devices. “Softer” penetrating microelectrode must also be sufficiently strong 
and stiff to enable insertion into the brain without buckling,38, 39 and to permit eventual 
removal. Therefore, it is important to understand the basic mechanic characteristics of the 
neural interfacing devices and the neural tissue. A comprehensive discussion of the 
governing equations which drive microelectrodes mechanics is out of the scope of this 
review. However, the following section provides the essential aspects of the mechanical 
requirements for intracortical microelectrodes.  
1.3.1.1. Introduction to Microelectrodes Mechanics 
Intracortical microelectrodes experience different forces during penetration though the 
brain tissue. The three relevant forces acting on the electrode shank (see Figure 1-2) are: 
1) the tip force (TF), i.e., the reaction acting on the tip in the axial direction during 
penetration, whose value depends on the shape and dimension of the tip; 2) the friction 
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force (FF), which is exerted on the side walls of the electrode in the axial direction and 
can be determined by the normal force acting on the surface and the coefficient of 
friction; and 3) the clamping force (CF), which is exerted by the compressed tissue on the 
electrode’s walls – CF increases as the electrode penetrates deeper due to the continual 
increase in contact area.40  
 
Figure 1-2. Forces acting on the intracortical microelectrodes upon penetration. 
The microelectrode insertion force (IF) is equal to the total axial force acting on the 
probe during penetration (IF = TF + FF + CF). The maximum IF during microelectrode 
insertion for a rigid metal electrode into the rat brain was reported to be 500-1000 µN, 
depending on the electrode shapes, tip angle and dimensions.41, 42 In order to allow 
intracortical microelectrode insertion into the brain tissue without buckling of the 
implant, the IF must be lower than the critical loading force for a given electrode. 
Therefore, this range of insertion forces can serve as a reference for the buckling forces 
any new microelectrode design must overcome for successful insertion. Given similar 
dimensions as a planar silicon or microwire microelectrode, “softer” polymer-derived 
microelectrodes should exceed a force of 1000 µN for successful insertion into cortical 
brain tissue.43-46  
In order to quantitatively determine the strength of intracortical probes, at least two 
parameters have to be measured: the maximum load (force) required to buckle the probe 
shank, which determines the stiffness of the probe, and the maximum fracture stress, 
which determines the strength of the shank after it buckles. These two parameters can be 
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calculated from the following two equations:  
𝐹!"   = 2𝐸𝐼𝜋!𝐿!                                         (1− 1) 
 𝜎!"# = 6𝐸ℎ𝑢𝐿!                                         (1− 2) 
Equation (1-1) express the buckling load, 𝐹!"  , and is derived using mechanical Euler 
theory of columns. The Euler theory defines E as the Young’s modulus, I as the area 
moment of inertia, and L as the length of the column.47 Equation (1-2) defines the 
fracture stress of the shank, where h is the shank thickness, u is the maximum amount of 
lateral deflection of the buckled shank, and both E and L are consistent with the Euler’s 
equation.  
Several studies have characterized both the properties of the brain tissue surrounding an 
implanted microelectrode, and the forces required to insert or extract the devices.48 The 
known mechanical interactions between the microelectrode and the brain tissue have 
been used to identify and quantify the primary mechanical requirements for 
microelectrodes insertion.49 Future studies may also utilize this information to evaluate 
the efficacy of design strategies intended to modify the material properties or geometry of 
novel microelectrodes. Effective microelectrode design must be concerned with a trade-
off between the conflicting requirements of proper materials to minimize the tissue 
damage and chronic strain on the tissue, as well as potential buckling and damage to the 
microelectrode itself. 
1.3.1.2. Compliant Polymeric Materials for Intracortical Microelectrodes 
Several research groups have attempted to investigate the effects of mechanical mismatch 
between the microelectrodes and the cortical tissue. Many groups have developed 
microelectrode substrates and substrate coatings from materials such as poly(imides), 
benzocyclobutene (BCB), SU-8, polydimethylsiloxane (PDMS), and Parylene-C (Figure 
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1-3) that are more compliant than materials traditionally used to create electrodes.50-57 For 
example, Rousche et al. reported the fabrication of poly(imide)-based multichannel 
implantable intracortical electrodes and recorded the neural activity from the cortex of 
rat’s brain.58 Polyimide presents several attractive features such as inherent flexibility, 
and manufacturability using existing microfabrication technology. However, due to its 
low stiffness (in comparison to metal- or silicon-based microelectrodes), polyimide-based 
electrodes of typical dimensions cannot penetrate through the tissue during surgery (i.e., 
IF > 𝐹!"  ), resulting in device buckling. Another problem in the use of polyimide for 
neuroprosthetic devices is the high moisture uptake (4-6% w/w), which can lead to a 
rapid decrease of the electrode impedance after implantation. 
 
Figure 1-3. Chemical structures of compliant polymeric materials and monomers 
commonly used for neural interfaces. 
To address some of the challenges associated with the use of polyimides, Lee et al. 
reported a new design for polyimide-based intracortical microelectrodes, which provide 
adequate stiffness for insertion into neural tissue.59, 60 In their design, a 5-10 µm thick 
silicon layer was applied to the polymer to increase the composite stiffness to prevent 
buckling during insertion. The Young’s modulus of these electrodes increased 
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significantly from 2.8 GPa (neat polyimide without silicon backbone) to 31 GPa and 58 
GPa with 5 and 10 µm thick silicon layers, respectively. A penetration test into rat brains 
showed that the electrodes with silicon backbone layers could penetrate the rat pia 
without buckling. In vitro biocompatibility tests revealed no cytotoxic effects on cultured 
cells and supported cell adhesion and growth over the polyimide electrode surface. 
However, one of the initial goals for the design of polyimide-based microelectrodes was 
to facilitate a “softer” implant after insertion. The intent was to minimize strain field 
generations within the surrounding “soft” brain tissue. The use of a “stiff” silicon backing 
to increase the polyimide devices from 2.8 GPa to 31 or 58 GPa (defined above) prevents 
buckling failure during insertion, yet appears counterproductive towards minimizing 
chronic in vivo tissue strain.  
Alternative work on flexible polymer-based intracortical electrodes included the use of 
benzocyclobutene (BCB)-based polymers as a template for chronic neural applications.61-
63 BCB polymers offer a lower moisture uptake (0.2% w/w) than polyimide (4-6% w/w), 
good chemical resistance, and also a low dielectric constant (~2.6). BCB polymers 
display a stiffness which is comparable to that of polyimides, and therefore buckling 
during insertion is also an issue for this type of polymer. Thus, reinforcing strategies have 
been developed to increase the stiffness of BCB-based neural interfaces to enable 
insertion into neural tissue. For example, Lee et al. micro-machined a thin layer of silicon 
backing (5-10 µm) onto the electrode.63, 64 Clement et al.62 succeeded in recording neural 
signals in a rat cortex using BCB-based electrodes without the problem of water uptake 
that occurs with polyimide-based electrodes as mentioned above. However, the silicon-
backed BCB microelectrode possesses similar concerns for increase tissue strain 
described above for polyimide-based devices. Either tissue strain does not directly impact 
recording quality, or the reported study was not carried out long enough to realize the 
strain-induced detriments to the neuroinflammatory response. To this end, an alternative 
approach is the use of dissolvable materials such as glucose or sugar.65 Therefore, BCB-
based electrodes may have the potential for further development of long-term compliant 
neural implants.   
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Parylene-C is another compliant polymer with low water absorption and low dielectric 
constant. While both polyimide and parylene have comparable elastic moduli, Parylene-C 
has several advantages such as easy fabrication, and lower water absorption than 
polyimide. However, it has a low tensile strength, and is also suffering from buckling 
during insertion.46 Nevertheless, several studies have reported the development of 
Parylene-C based microelectrodes that can be inserted into the brain tissue without 
assistive aids. For example, the LaPlaca lab fabricated flexible Parylene-C based 
electrodes using photolithography techniques that were inserted into the rat barrel 
cortex.46 LaPlaca was interested in determining the extent and duration that a controlled 
cortical impact and device micromotion effects on both the integrity of the 
microelectrode, and the ability to obtain neural recordings. To facilitate insertion of the 
“flexible” Parylene-C devices, implants were designed larger, at 100 µm wide and 25 µm 
thick. LaPlaca and colleagues demonstrated that the “flexible” devices withstood the 
trauma and associated micromotion, and remained capable of obtaining neural recordings 
minutes after impact, suggesting future applicability of such devices. While promising, 
the histological effects of the larger implant size may negatively affect chronic recording 
abilities. In an attempt to better understand how modifications to traditional 
microelectrode geometries could facility insertion of flexible polymer microelectrodes, 
Egert et al. engineered parylene-based microelectrodes with a variety of shank 
footprints.44 In their brief conference proceedings, the team reported on the application of 
the addition of vertical stiffeners, alternative geometries, and insertion guides designed to 
remain attached throughout the life of the implant or be removed either directly after 
implantation of slowly through bio-degradation. Each of the novel devices tested 
remained electrically active after 3 months of a soak test. Unfortunately, design strategies 
that facilitate insertion and were capable of integration into array technology required 
permanent features that either increased the stiffness or footprint, both which have been 
linked to increased neuroinflammatory responses. Therefore, while Parylene-C 
microelectrodes have been developed for acute in vivo and chronic cell-free recording, 
long-term reliability of “flexible” non-reinforced devices has to our knowledge yet to be 
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achieved. The cross-linked epoxy resin SU-8 is another flexible polymer that has been 
investigated widely as alternative substrate to silicon-based microelectrodes. In 
comparison to polyimide, BCB-based substrates and Parylene-C, SU-8 offers several 
advantages. The most prominent advantages of SU-8 include: 1) the possibility of easily 
adjusting the probe thickness to overcome the buckling issues associated with flexible 
polymers, 2) high aspect-ratio lithography capability, 3) suitable dielectric properties, 4) 
thermochemical stability, 5) low-cost photolithographic processability, and 6) suitable for 
microfluidic applications.66, 67 Fully cross-linked SU-8 has a glass transition temperature 
of around ~200 °C, a degradation temperature of ~380 °C and a Young’s modulus of ~4-
5 GPa.66 In a series of contributions, Fernández and colleagues developed different SU-8-
based microelectrodes for neural applications using photolithography techniques (see 
Figure 1-4).67-71 Impedance spectroscopy studies showed that the electric behavior of 
these SU-8-based microelectrodes was very similar to that of silicon (Si) and silicon 
carbide (SiC)-based microelectrodes.69 Altuna et al. fabricated SU-8-based multisite 
microelectrodes with multiple fluidic channels (Figure 1-4c) and studied their electrical 
recording and drug delivery ability in the brain.71 Drug delivery was achieved in 
quantities in the range of tens of nanoliters to a few microliters at the CA1 cellular layer 
in order to stimulate neuronal firing. In vivo rat studies showed that the SU-8-based 
microelectrodes were able to record from identifiable isolated neurons together with 
muli-unit firing and local filed potentials similar to conventional silicon-based 
microelectrodes.  
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Figure 1-4. SEM pictures of microelectrode tips of SU-8-based electrodes. Figure (a) 
reprinted with permission from Ref. 68, copyright © 2009 IOPScience, Figure (b) 
reprinted with permission from Ref. 70, copyright © 2010 IOPScience, and Figure (c) 
reprinted with permission from Ref. 71, copyright © 2013 Royal Society of Chemistry. 
Despite the advantages of SU-8, the toxicity of this polymer limits its use in neural 
applications. The first characterization of SU-8 cytotoxicity to neuronal culture was 
reported by Vernekar et al. in 2008.72 Vernekar showed that thick untreated SU-8 
substrates are not compatible with primary neuronal culture.72 It was found that less than 
10% of primary neurons survived when cultured to or on top of a SU-8 substrate. The 
authors suggested that the poor cytocompatibility of SU-8 is due to leaching of toxic 
components such as residual solvents and (fragments of) the photo acid generator used 
for the polymer, as well as poorly sustained neural adhesion. Additionally, it was found 
that post-processing strategies play a key role on the cytocompatibility of SU-8 in vitro 
cell culture. For example, Vernekar et al. improved the neuronal cell viability to 45.8% 
and 86.4% following 3-day heat treatment (150 °C) under vacuum, and sonication (in 
isopropanol) of the SU-8 substrates, respectively. Since neuronal loss is well documented 
following the inflammatory response to implanted microelectrodes that do not 
demonstrate poor cytocompatibility, the benefits associated with SU-8 device fabrication 
may not outweigh the cytotoxic handicaps associated with current SU-8 derived 
microelelctrodes.Due to the biocompatibility of poly(dimethylsiloxane) PDMS for many 
device applications, several groups have also explored the suitability of PDMS as flexible 
material for intracortical interfacing applications. For example, in an in silico model, 
Subbaroyan and Kipke examined the strain effect induced by an intracortical 
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microelectrode using a flexible PDMS interconnect.51 A PDMS interconnect (E’ = 6 
MPa) resulted in two orders of magnitude smaller strain compare to commercial silicon 
(E’ = 200 GPa). The results suggest that reducing interconnect stiffness could reduce 
interfacial strain and eventually may reduce the shear induce damages around the 
implant. However, quantitative immunohistochemistry showed significant neuronal loss 
up to 60 µm from the implant interface. In another study, Guo and DeWeerth used 
multilayer wiring interconnect technology to implement PDMS-based conformable 
microelectrode arrays.73 In our own experience (unpublished), PDMS can also suffer 
from poor cytotoxicity, presumably due to leaching components. Similar results have 
been noted offline, and have dampened some of the initial enthusiasm for penetrating 
PDMS-based microelectrode devices. Despite the mixed results for the applicability of 
PDMS-based microelectrode technologies, if the difficulties associated with implanting 
“softer” microelectrodes are overcome, the breadth of knowledge in both 
microfabrication and the neuroinflammatory response to peripheral nervous system 
neural interfaces may propel PDMS to the forefront of materials selections for compliant 
intracortical microelectrodes.  
In summary, intracortical microelectrodes derived from polymeric substrates with a 
Young’s modulus of less than 3-5 GPa have had limited success in attenuating glial scar 
formation or improving neural recordings. One drawback of most of these materials is 
that their Young’s modulus is still 6 orders of magnitude larger than that of the brain.52, 53, 
64, 74, 75 Additionally, the slight decrease in the stiffness of these polymeric devices results 
in a critical buckling load that is smaller than the insertion forces, presenting difficulties 
in implanting the microelectrodes.52, 76-78 While insertion aides and shuttles have been 
explored, none have been identified that facilitates insertion without increasing the device 
footprint or stiffness. 
1.3.1.3. Insertion Aides and Biodegradable Materials 
As mentioned above, a key limitation of compliant polymer-based intracortical 
microelectrodes is their limited stiffness. It is important to note that a high-level of 
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compliance that is well suited for in vivo applications can also be fabricated from a 
thinner film of stiff materials or lattice structures.79-81 Nanomaterials and open 
architecture structures fall into this category, and will be addressed separately below in 
sections 4.8. In the case compliant polymeric microelectrodes, low material stiffness 
yields a low buckling force. Without increasing the cross-sectional area, it can become 
difficult to insert compliant polymer-based intracortical microelectrodes into the brain 
without damaging excess tissue or the microelectrode.38 Thus, methods and strategies 
have been developed to facilitate the implantation of “compliant” intracortical 
microelectrodes. Such methods include coating the microelectrode with biodegradable 
polymers,82-85 hydrogels,86-88 and gelatine,89 using a removable insertion shuttle to carry 
the polymer microelectrode into the cerebral cortex,90 or stiffening the microelectrode by 
incorporating a thin silicon backing.59, 60, 63, 64, 91, 92 In this section a few of the many 
examples of insertion aides for complaint microelectrodes based on “soft” polymers are 
discussed.  
As an alternative to the silicon-backed compliant polymer systems discussed above, 
Takeuchi et al. incorporated a microfluidic channel into a compliant Parylene-C based 
microelectrode.52 Takeuchi filled the channel with a reinforcing material designed to 
dissolve after implantation. In a first proof of concept study, the channel was filled with 
biocompatible poly(ethylene glycol) (PEG) to stiffen the compliant microelectrode for 
insertion into the rat’s brain. PEG is solid at room temperature, but dissolves when in 
contact with tissue. The authors were able to successfully record neural signals from the 
rat’s brain through the microelectrodes. In this early work, Takeuchi et al. developed a 
clever alternative to silicon-back reinforcements that only temporarily increased the 
device stiffness, yet permanently increased the device footprint.  
More recently, and perhaps inspired by Takeuchi’s dissolvable system, several groups 
began investigating the use of biodegradable polymers as a shuttle for compliant 
devices.243, 251, 252 Rapidly degrading polymers could be used as templates for neural 
electrodes if their incorporation increases the bucking force beyond the required insertion 
force, yet the stiffer degradable material quickly decomposes upon insertion, leaving 
 18 
behind a small compliant device. The appropriate biodegradable polymer should have the 
following criteria: (i) sufficient stiffness for insertion, (ii) faster degradation rate than the 
time frame of chronic inflammation, and degradation and formation of non-toxic 
products.93  
Perhaps one of the most promising examples of neural interfaces with degradable 
polymers has been explored by Shain and Kohn. In a series of investigations, Kohn and 
colleagues studied several different tyrosine-based polycarbonates as biodegradable 
carriers for intracortical microelectrodes with the objective to identify a material with the 
most suitable property.84, 93, 95 The tyrosine-derived polymers have attracted great interest 
in the context of soft neural interfaces due to their biocompatibility, biodegradability, and 
neutral pH of the hydrolysis products. A set of tyrosine-derived terpolymers was 
reported, in which the composition of the monomer constituents was varied (ethylene 
oxide; desaminotyrosyl-tyrosine; desaminotyrosyl-tyrosine alkyl ethyl ester,), with the 
objective to tune the mechanical and thermal properties, as well as the degradation rate. 
Polymers with appropriate composition had a sufficient stiffness (Young’s modulus of 
~393 MPa) in the dry state to facilitate implant insertion. Despite the relatively low 
modulus, Kohn’s materials possess an intrinsic strength of ~ 4 MPa (critical strength for 
insertion into cortical tissue is reported to be 0.3-1.3 MPa depending on the size and 
insertion speed of the microelectrode). Tyrosine-derived terpolymers become soft 
(modulus of ~85 MPa) within 30 minutes when immersed in artificial cerebrospinal fluid 
(ACSF).93 Interestingly, uncoated Kapton film is too flexible to implant into cortical 
brain tissue, while the tyrosine-coated Kapton film is able to penetrate the rat cortex. 
Additionally, by altering the degradation rates of the same tyrosine-based polymer, 
Lewitus et al.84 found that a rapid degrading and resorbing tyrosine-derived polymer 
significantly reduced the glial response at the implant site, while the slow resorbing 
implant resulted in continuous glia activation. The in vivo tissue response to the new 
tyrosine-based implants was compared to that of poly(lactic-co-glycolic acid) (PLGA)-
made implants as a commercially available and commonly used rapidly degrading 
polymer. It was found that the fate of surrounding neural tissue depended on the rate of 
 19 
microelectrode resorption, more so than the rate of degradation. For example, at one and 
four weeks post implantation the fast resorbing and degrading tyrosine-derived 
terpolymers displayed the most rapid and efficient tissue recovery. Alternatively, the 
ultrafast degrading but slow resorbing did not show any difference in tissue response 
compared to the slow degrading and slow resorbing polymer (i.e. PLGA) Additionally, 
immunohistochemistry evaluation of tyrosine-derived polymers showed minimal 
cytotoxicity and tissue inflammation over the course of 12 week test period in a rabbit 
calvaria model.94 Therefore, the authors of the study concluded that this class of 
biodegradable polymers offers a high potential for future design of long-term neural 
interfacing devices. 
In summary, several innovative approaches have been investigated to achieve temporary 
stiffening of soft polymer-based microelectrodes. Although, some of these approaches 
have been shown to be useful for insertion of single-shank electrodes, challenges still 
exist if they are to be applied to multi-shank electrodes. Therefore, current strategies must 
be refined, or new ones must be continually pursued. Parallel to the idea that it is difficult 
to determine one absolute mechanism for microelectrode failure, it is also unlikely that 
one device will serve the needs of the entire community. Therefore, insertion aided 
implants may provide promise to individual laboratories.  
1.3.1.4. In Situ Softening Materials 
An alternative approach to insertion aides and biodegradable materials is the use of in situ 
softening materials. Materials that can respond to external stimuli – referred as “stimuli-
responsive” or “smart” materials – are being considered for a broad range of biomedical 
applications, including the delivery of therapeutic molecules, as actuators, in tissue 
engineering and in the context of regenerative medicine.96-101 Recently, the idea to utilize 
physiologically responsive mechanically adaptive materials as substrates for intracortical 
microelectrodes has been proposed, with the objective to improve microelectrode 
biocompatibility by minimizing the microelectrode-induced mechanical strain on the 
surrounding tissue.102, 103 “Smart” softening neural interfaces are defined as sufficiently 
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stiff to be easily implanted into the brain, yet soft in vivo to better match the stiffness of 
the cortical tissue.  
The first realization of “smart” intracortical microelectrode materials was reported by 
Weder, Rowan, Capadona et al. in 2008.104 The team utilized the architecture of the sea 
cucumber dermis as their initial blueprint to develop a new class of biologically-inspired, 
stimuli-responsive, mechanically adaptive polymer nanocomposites whose mechanical 
properties can switched between stiff and soft states (Figure 1-5).104  
 
 
Figure 1-5. Top: Pictures of a sea cucumber, in the threatened (stiff) and relaxed (soft) 
and state. Bottom: Simplified schematic representation of the switching mechanism 
found in the sea cucumber dermis and used in physiologically responsive mechanically 
adaptive nanocomposites. A soft matrix is reinforced with rigid particles, whose 
interactions in are moderated by a chemical agent.  
The generation of mechanically adaptive nanocomposites currently under evaluation for 
intracortical microelectrodes was designed based on glassy a poly(vinyl acetate) (PVAc) 
matrix and rigid cellulose nanocrystals (CNCs) isolated from tunicates as reinforcing 
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filler.105, 106 These mechanically adaptive nanocomposites display a dual responsive 
behaviour. When dry, these nanocomposites are in the rigid state, because the matrix is 
glassy and the CNCs have a percolating rigid network, in which stress is effectively 
transferred. Attractive interactions among the CNCs are likely dominated by hydrogen 
bonds among the abundant hydroxyl groups of the CNC surface, but van der Waals' 
interactions may also contribute. Upon exposure to physiological conditions, the 
materials swell with the aqueous fluid and undergo a phase transition, water plasticized 
the matrix and lowers the glass transition temperature; in addition, the CNC network is 
disassembled on account of comprehensive hydrogen bonding with water molecules. 
PVAc nanocomposites with 16.5% v/v CNCs exhibited a mechanical contrast of three 
orders of magnitude upon exposure to physiological conditions and upon implantation 
into cortical tissue (E' = 5.1 GPa for a dry/pre-insertion and 12 MPa for artificial 
cerebrospinal fluid (ACSF)-swollen nanocomposite).38, 104, 105 It was shown that dry 
implants of this nanocomposite can readily be inserted through the pia mater into the 
cerebral cortex of a rat without the need for assistive devices. The insertion of the 
chronically compliant materials was a significant feat as reference implants consisting of 
the neat matrix polymer (PVAc) buckled under lower loads before they could be inserted 
into the cortical tissue.38 Ex vivo studies confirmed that the initially stiff microscale 
nanocomposites rapidly softened when implanted into the rodent brain.	  Figure 1-6 shows 
the stiffness of a 12.2% v/v PVAc/CNC nanocomposite upon introduction into ACSF at 
22 °C (Young’s modulus ~3400 MPa), and reveals that the softening occurs over the 
period of 15 min to reach a Young’s modulus of ~33 MPa. A comparison between the 
Young’s modulus of microprobes that had either been implanted in a living rat cortex 
showed no statistical difference immersed for 15 min in ACSF (Figure 1-6).38, 49 
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Figure 1-6. Plot showing the log of the Young’s modulus of mechanically adaptive 
PVAc/CNC nanocomposites as function of exposure time to ACSF or implantation time 
in the rat cortex. Data were acquired by either a dynamic mechanical analysis (DMA 
Data, open squares; bulk materials) using a submersion clamp and exposing the sample to 
ACSF preheated to 37 °C or mechanical tests of microprobes that had been implanted 
into the rat cortex for the time indicated and which were explanted for microtensile 
testing (Ex vivo Data, open circles). The x-axis indicates the time of exposure to either 
ACSF or implanted in the rat cortex, respectively. Reprinted with permission from Ref. 
38. Copyright © 2011 IOP Publishing. 
In preliminary investigations, Hess et al.107, 108 showed that laser micromachining 
followed by deposition of Parylene-C insulating layer, sputtering and patterning Ti/Au 
electrodes, and deposition and of Parylene-C layer is a suitable process for fabricate 
micro-scale multi-layered structure electrodes from the biologically-inspired 
nanocomposites. When patterned with titanium/gold, the nanocomposite-derived 
microelectrodes exhibited an impedance (95.0 ± 4.8 kΩ) that is comparable to that of Au 
electrodes (130 kΩ) on conventional substrates. Since the electrodes and insulation layers 
were thin in comparison to the nanocomposites substrate, the electrodes retained the 
dynamic mechanical properties. Swelling of the devices was highly anisotropic and much 
more pronounced in the direction orthogonal to the device, so that delamination did not 
pose a problem, at least in the laboratory conditions. While the significant swelling of the 
initially employed materials (70-90 % w/w for PVAc reinforced with 10.5% v/v CNCs 
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isolated from tunicates), this effect could be substantially lowered (~28% w/w swelling) 
by substation the filler with CNCs isolated from cotton, which are less hydrophilic 
(Figure 1-7).109  
The first in vivo evaluation of the neuro-inflammatory response to mechanically 
adaptable PVAc/CNC nanocomposites as substrate for penetrating microelectrodes was 
reported by Harris et al.39 Initial histological evaluations of these materials demonstrated 
that at four weeks post-implantation, compliant implants more rapidly stabilize neural 
cell populations within 200 µm of the implant than rigid, non-dynamic systems.39 
However, no significant difference between the mechanically-dynamic and the much 
stiffer control implants with respect to local neuron density was observed at 8 weeks. 
Thus, the results of Harris’s initial studies can be interpreted that, despite acute benefits 
after 4 weeks, the mechanical mismatch between microelectrodes and cortical tissue has 
appears to have little effect on the chronic neuro-inflammatory response. However, recent 
findings by Potter et al. demonstrate that the neuro-inflammatory response to intracortical 
microelectrodes is multi-phasic, and that a drop in neuronal density is observed at 16 
weeks with stiff electrodes.110 Therefore, it will be important to also study the response to 
the mechanically-dynamic, compliant materials after at least 16 weeks of implantation. 
More recently, Nguyen et al. have completed a more comprehensive histological 
evaluation of the neuroinflammatory response to PVAc/CNC nanocomposites implants. 
At 16 weeks post-implantation, Nguyen demonstrated the near complete attenuation of 
microglia activation and the absence of any appreciable neuron loss surrounding 
PVAc/CNC nanocomposites implants, compared to chemically-matched PVAc-coated 
Michigan-type microelectrodes (Figure 1-8).111  
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Figure 1-7. Photograph of a 2-electrode contact intracortical probe. The connection 
contact pads are at the larger end on the left, and the electrode contacts are near the tip of 
the shank on the right. Only the shank is intended to be inserted into tissue, as the 
connector end is only for making electrical connection to external electronics. For size 
comparison, the probe is sitting next to a United States penny. By layer, the structure of 
the probe is a 50 μm-thick PVAc/CNC film on the bottom (substrate layer), then a 1 um-
thick Parylene C layer to insulate the electrodes from moisture absorbed by the PVAc, 
then a 250 nm-thick sputtered gold conducting film on a 50 nm-thick titanium adhesion 
layer, and finally a second 1 μm-think Parylene C film to insulate the gold traces from the 
biological environment. The shank is 2 mm long and 230 μm-wide. Each electrode 
contact is 30 μm in diameter. Copyright: Allison Hess, Case Western Reserve University, 
United States. 
Interestingly, at earlier time points, few statistically significant differences we visualized 
between chemically-match compliant and stiff PVAc implants. Nguyen’s results 
demonstrate that the mechanical strain placed on cortical tissue by stiffer implants played 
a lesser role early after implantation than at more chronic time points. Our interpretation 
of these results is that subtle changes in the maturation of the glia cell populations around 
compliant versus stiff implants are initially dominated by wound healing. However, once 
the scar matures, it is more likely that differences in scar mechanics translates to 
differences in neuronal survival. Experiments to test this hypothesis are currently 
underway in collaboration between the Capadona and Muthswamy Laboratories. 
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Figure 1-8. PVAc/CNC nanocomposite implants (NC) reduce chronic 
neuroinflammation. IHC staining of CD68 for activated microglia showed increased 
expression surrounding PVAc-coated silicon control implants (PVAc-coated) compared 
to NC (A, C). Accordingly, staining of neuronal nuclei (NeuN) (B) and quantification of 
neuron counts indicated significant improvement in neuronal populations surrounding the 
NC implants from 0 to 50 µm as well (D). Scale bar = 100 µm. *p<0.05 Reprinted from 
Ref. 111. 
Softening intracortical implants have also been made from shape memory polymers 
(SMPs).92, 112 Shape memory polymers can both change their mechanical properties and 
also have the ability to recover from a programmed temporary shape. The original shape 
is regained upon application of external stimulus, such as temperature, humidity, light or 
a combination of these stimuli.113, 114 Sharp et al.92 developed SMP-based 
microelectrodes in an attempt to decrease initial tissue damage resulting from electrode 
implantation and enhance long-term biocompatibility. A micro-casting method was used 
to fabricate intracortical microelectrodes from an epoxy-based shape memory polymer 
(Figure 1-9). Pre-deformation was achieved by stretching the SMP horizontally on a 
hot/cold stage. Sharp et al. concluded that it is feasible to fabricate SMP electrodes that 
would self-implant at controlled rate, although this was not yet demonstrated. 
Histological analysis of implants that were inserted in the cortex of rats only investigated 
the role of reactive astrocytes, at one week post-implantations. Therefore, conclusions on 
the effects of implantation rate on initial damage or long-term biocompatibility will 
require additional time points and histological markers. 
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Figure 1-9. Schematic (top) and light micrographs of a prototype SMP neuronal probe. 
The first panel shows the as-fabricated probe. The middle panel shows the deformed 
probe after stretching horizontally. The final panel shows the recovered shape of the 
probe after deployment at 37 °C. Reprinted with permission from ref. 92 Copyright © 
2006 IOP Publishing. 
More recently, Ware et al.112 developed a thermally and water-responsive SMP system 
based on commercially available acrylate monomers. The fabricated neural electrodes are 
stiff before swelling (storage modulus of ~700 MPa at 37 °C) and soften in vivo (storage 
modulus of ~300 MPa at 37 °C) within 24 h. The SMP used in this study is sensitive to 
many of photolithography processing requirements (i.e., organic solvents, water, heat, 
vacuum, bases, acids and adhesion). Thus, to overcome these challenges, a transfer-by-
polymerization was used to fabricate reproducible and robust neural microelectrodes 
(Figure 1-10) with tunable moduli to improve biocompatibility of the microelectrodes 
with brain tissue. Acute in vivo studies demonstrated that acrylate–derived in situ 
softening SMP-based microelectrodes were capable of recording an excitatory neuron in 
a rat cortex. 
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Figure 1-10. Picture (left) and optical microscope image (right) of a mechanically 
adaptive cortical probe with 8 recording channels fabricated from a shape-memory 
polymer by transfer-by- polymerization process. Reprinted with permission from Ref. 112. 
Copyright © 2012 Wiley-VCH. 
Ware and co-workers also utilized thiol-ene/acrylate-based polymers to create second 
generation physiologically responsive neural interfaces.115, 116 The thiol-ene/acrylate-
based substrates soften from a Young’s modulus of >1 GPa (dry state at room 
temperature) to 18 MPa upon exposure to physiological conditions, as a result of 
plasticization by small water uptake (less than 3%). Ware et al. demonstrated that the 
modulus of the thiol-ene/acrylate polymers could be controlled through variation of the 
diacrylate content as a result of variable glass transition temperature. Although, 
intracortical electrode arrays derived from the thiol-ene/acrylate-based polymers were 
capable of recording neural activity in rats over 1 month post-implantation., long-term 
chronic recording studies compare with silicon electrode arrays as control are required.116 
Finally, immunohistochemical studies are required to quantify the potential beneﬁts of 
these thiol-ene/acrylate-based polymers as basis for thermally-responsive neural 
interfaces, following chronic (>16 week) implantation. 
Tien et al. used silk fibroin to fabricate mechanically adaptive neural electrodes, which 
are also capable of releasing therapeutic agents.117 The elastic modulus of silk is reduced 
upon hydration from 1.8 GPa in the dry state to 20 MPa in the wet state. In addition to 
dynamic mechanical properties, the effect of silk fibroin coatings on reactive gliosis was 
studied using an in vitro glia scarring model around the electrode array. While in vitro 
immunohistochemical staining after one week showed that silk-coated stainless steel 
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wires stimulated less “scar index” for both the microglia marker ionized calcium binding 
adapter molecule 1 (IBA1) and chondroitin sulphate (CS) proteoglycan, no significant 
difference was observed in case of the astrocyte marker glial fibrillary acid protein 
(GFAP) “scar index”, relative to the uncoated stainless steel microwires (Figure 1-11). 
Finally, Tien et al. investigated the capacity for silk to encapsulate and release scar-
inhibiting agents such as the enzyme chABC as a potential avenue to ameliorate axonal 
growth inhibition by CSs within the glial scar. . Reactive glia cells produce extracellular 
matrix molecules, such as CSs, that inhibit axonal growth, and prevent regeneration of 
damaged neurons near the electrode. It was found that the chABC releasing silk films 
exhibited an almost 50% reduction in CS staining in the glial scarring model over 1 week. 
In summary, the hypothesis that the mechanical mismatch between current metallic- or 
silicon-based intracortical microelectrodes and the brain tissue propagates 
neuroinflammatory events leading to microelectrode failure has led to the development of 
new class of in situ softening polymeric materials such as mechanically adaptive polymer 
nanocomposites and shape memory polymers for neural interfaces. While, initial 
histological studies of implants based on mechanically adaptive polymers suggest that 
adaptive materials can better stabilize neural cells populations at the neural 
tissue/electrode interface than rigid electrodes (up to eight weeks), there are still several 
challenges that need to be addressed. First, as stated above, Nguyen’s results demonstrate 
that the mechanical strain placed on cortical tissue by stiffer implants played a lesser role 
early after implantation than at more chronic time points. Therefore, histological studies 
for such adaptive materials must be conducted for long-term implantation times. Second, 
if such in vivo tissue response studies confirm that adaptive materials are indeed better 
than previously developed rigid electrodes, one must ask how soft do they need to be? 
Answers to these questions are important to the development of this field.  
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Figure 1-11. (A) SEM images of uncoated and silk-coated stainless steel microwires. (B) 
Representative images of brain sections labelled for GFAP, IBA1, and CS around 
uncoated and silk-coated microwires. (C) Quantification of staining for GFAP, IBA1, and 
CS around the microwires. Error bars show standard deviation. Horizontal bars denote a 
significant difference between staining around uncoated and silk-coated wires (∗p < 0.05, ∗∗p < 0.005). Reprinted with permission from ref. 117. Copyright © 2013 Wiley-VCH. 
Additionally, the work of the combined work of the laboratories presented within this 
section suggests the potential for synergistic effects of combinatorial approaches 
throughout the progressive inflammatory response. For example, one could envision the 
incorporation of bioactive molecules such as anti-inflammatory, anti-oxidant drugs and/or 
proteins on or within the mechanically-dynamic neural electrode devices to mitigate 
initial trauma, coupled with a chronically compliant device to dictate scar mechanics and 
mediate chronic tissue strain. Finally, it is important to note that since much of softening 
polymeric materials (e.g. shape-memory polymers) are synthesized in laboratories, 
leaking residues from any of these materials can be highly toxic and probably lead to cell 
death around the electrode (as described for SU-8 above). Therefore, development of 
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robust processes that allow repeatable control of properties (e.g. efficient polymerization 
reactions or non-solvent processes) is necessity.  
1.3.2. Incorporating Bioactive Materials 
Over the last decade, another promising approach to control cell phenotype at the 
biotic/abiotic interface has been developed, which involves the decoration of 
microelectrodes with bioactive surface coatings.118-129 A broad-spectrum of bioactive 
materials has been immobilized on the implant surface to control the neuro-inflammatory 
response (Table 1-1). Bioactive materials have been shown to be at least temporarily 
successful in attenuating the neuro-inflammatory response to intracortical 
microelectrodes within the brain tissue. However, it is not clear if the temporary effect of 
most bioactive strategies is a result of biomolecule consumption (exhausted supply or 
degradation), or an evolution of redundant biology overcoming the initial effect of the 
surface modification. 
Perhaps one of the simplest and most common biomaterials approaches is the passive 
adsorption or covalent immobilization of ECM components to promote “directed” cell 
attachment. As biomaterialists became interested in the device-mediated neuro-
inflammatory limitations to intracortical microelectrodes, the attachment of ECM 
proteins and peptides onto the microelectrode surface were among the first methods 
reported. Extracellular matrix-based materials for neural interfacing applications have 
been recently reviewed by Chen and Allen.130 Therefore, only select representative 
examples or new considerations will be discussed here. 
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Table 1-1. Non-Exhaustive List of Bioactive Surface Treatments for Intracortical 
Microelectrodes. 
Bioactive Agent Coating Material Electrode Type Reference 
Dexamethasone 
(DEX) 
Poly(pyrrole) (PPy) Gold-coated 
coverslip 
131 
PLGA nanoparticles embedded in 
alginate hydrogel Silicon 
132 
Nitrocellulose Silicon 
133 
PLGA nanofibers Silicon 
134 
Poly(propylene sulfide) 
nanoparticles embedded in 
poly(ethylene oxide) 
Platinum 
135 
Laminin (LN) 
Dextran Silicon, gold 
and polyimide 
136 
Poly(ethyleneimine) (PEI)             
or Chitosan (CH) Silicon 
126 
Poly(pyrrole) (PPy) Gold-coated 
coverslip 
137 
Poly(ethyleneimine) (PEI) Silicon 
138 
L1 
Poly(ethylene glycol) (PEG) Silicon 
139 
Silicon dioxide modified using 
silane chemistry Silicon 
121 
Parylene-C Tungsten 
140 
α-MSH 
Nitrocellulose Silicon 
129 
Silicon modified using silane 
chemistry Silicon 
120 
Nerve Growth 
Factor (NGF) 
Parylene-C Silicon 
82 
Poly(ethylene dioxythiophene) 
(PEDOT) Platinum 
141 
Poly(pyrrole) (PPy) Polystyrene 
142 
Superoxide 
Dismutase (SOD) 
Surface functionalization Silicon 
143 
 
Among the most important ECM proteins for neural applications is laminin (LN), an 
adhesive protein that plays crucial roles in cell migration, differentiation, and axonal 
pathfinding.144 The two main peptide sequences from LN that are often targeted for 
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biomaterial applications include Ile-Lys-Val-Ala-Val (IKVAV) and Tyr-Ile-Gly-Ser-Arg 
(YIGSR). In 1993, Massia and Hubble were among the first to report on receptor-specific 
cell spreading on surfaces covalently immobilized with YIGSR.145 Twenty years later, 
Massia developed a surface grafting method that allows for the covalent immobilization 
of IKVAV on the surface of silicon, silicon oxide, gold and insulating polymers such as 
polyimide, all common components of intracortical microelectrodes.136 This work 
highlights the specificity of LN peptides for supporting neuronal attachment, and 
reinvigorated the use of LN-derived strategies for intracortical microelectrode 
applications. 
Likely based on Massia’s work, the Bellamkona group reported a series of publications 
utilizing LN-based coatings as surface modifications for intracortical microelectrodes 
applications.126, 138 First, a layer-by-layer (LBL) assembly was used to build up a 
deposition of poly(ethyleneimine) (PEI) and LN on silicon wafers with an oxide layer. It 
was found that the PEI-LN layer was stable for at least 7 days under simulated 
physiological conditions, and significantly improved neuron adhesion and differentiation 
in vitro.126 The subsequent in vivo study revealed that PEI-LN coatings are able to reduce 
the counts of reactive microglia and astrocytic tissue response to Si-based electrodes after 
4 weeks post-implantation.138 However, LN coating elicited a more robust pro-
inflammatory response at one day post-implantation than uncoated devices, as indicated 
by increased CD-68 positive microglia, GFAP astrocytes, and pro-inflammatory cytokine 
expression. Interestingly, neuron densities were statistically similar at all of the time 
points investigated, suggesting no advantage to the LN coating for recording applications. 
In parallel to the LN work in the Bellamkonda lab, several laboratories have investigated 
the ability of doping conductive polymers, with LN-based peptides in order to increase 
neuronal attachment. For example, Stauffer and Cui investigated two different LN 
fragments, YIGSR and RNIAEIIKDI, as dopants in an electropolymerized poly(pyrrole) 
(PPy). The goal of the initial in vitro study was to combine the critical electrical 
properties of conducting polymers with the ability to promote specific-cell attachment 
(YIGSR) and neurite outgrowth (RNIAEIIKDI).137 Stuaffer and Cui’s results confirm the 
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cell-specific attachment and growth seen over the previous decades in many laboratories. 
The novelty of their work was that the combination of the two peptides on a conducting 
polymer scaffolding synergistically increased both neuronal attachment, and neurite 
outgrowth, while also demonstrating low impedance and increased charge capacity. 
Despite the promising in vitro results suggesting that LN-containing coatings may 
enhance the long-term recording stability of neural interfaces, the in vivo recording 
performance of these materials have not been reported to date. 
In a second example of LN-derived peptide incorporation into conducting polymers, 
Green et al. doped PEDOT with DEDEDYFQRYLI and DCDPGYIGSR.146 Interestingly, 
Green et al. demonstrated that large peptide dopants produced softer PEDOT films with a 
minimal decrease in electrochemical stability. However, despite the retained bioactivity 
of dopant peptides, the effects were largely dependent on initial cell attachment, and 
neither of the peptides investigated provided the bioactivity of the native LN protein. In a 
later study, Green et al. also examined the effect of entrapping nerve growth factor 
(NGF) within the PEDOT during electrodeposition.147 The incorporation of NGF was 
shown to remain biologically active within the PEDOT. However, Green et al. also found 
that the use of both a LN peptide dopant and NGF in the PEDOT resulted in polymers 
with decreased mechanical and electrical properties compared with controls containing 
only NGF.147 
Despite retained biological activity of the incorporated peptides, the combination of 
biological molecules within conducting polymers has thus far failed to provide the 
synergistic benefits that the field has anticipated. In fact, the most recent reported studies 
from the Poole-Warren group provided an interesting report of the performance of 
conducting polymer electrodes, without the incorporation of biological molecules.148 
Since isolated peptide sequences typically demonstrate enhanced activity of targeted 
functions compared to full protein controls,149 it is likely that the immobilization methods 
employed within conducting polymer requires further optimization, perhaps insulating 
spacer groups to isolate the biomolecules from the polymers. 
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While the use of LN surface modification alone has not successfully improved the 
biocompatibility or recording quality of microelectrodes, there is increasing evidence that 
the presentation of other specific ECM molecules or networks of ECM components that 
mimic the complexity of natural brain tissue may be useful. For example, the Cui group 
has demonstrated encouraging work with the cell adhesion molecule L1. L1 is a neuronal 
adhesion molecule that can specifically promote neurite outgrowth, neural migration, and 
neuronal survival. Azemi et al. demonstrated that neural electrode arrays coated with 
immobilized L1 showed enhanced levels of attachment of mouse cerebellum neurons in 
vitro.139 Azemi et al. directly compared the efficacy of L1 with LN. The study showed 
that while the LN-functionalized surfaces greatly promoted the growth of astrocytes, the 
L1-functionalized surfaces showed significantly reduced astrocyte attachment compared 
to both LN-coated and uncoated control surfaces.139 In a subsequent paper,121 Azemi et 
al. investigated the neuro-inflammatory response to L1-functionalized Michigan-type 
microelectrodes implanted in a rat cortex for up to 8 weeks. The study revealed that L1-
functionalized microelectrodes show significant reduction in reactive tissue gliosis when 
compared with uncoated electrodes. The most promising aspect of the L1 approach is the 
ability to maintain normal neuronal populations at the microelectrode interface, and the 
significant increased density of neuronal filament at the interface (Figure 1-12). 
Interestingly, the Cui laboratory has more recently begun to explore the utility of L1-
functionalized electrodes for peripheral nervous system applications. Unfortunately, to 
date, no description of the impact of L1 immobilization on recording quality for 
intracortical microelectrode applications has been reported, but deserves further attention 
due to the success of foundational studies. 
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Figure 1-12. (a, b) Representative images of NeuN+ cells (green) around the NM 
(unmodified) and L1 (L1-peptide grafted) probes after 8 weeks of implantation in rat 
cortex. Below the set off images, the corresponding normalized cell count differences 
between L1 and NM probes for the 0–100 μm region away from the interface (*p < 0.05). 
(c, d) Representative images of neuronal filament (green) stained tissue after 8 weeks of 
implantation in rat cortex. Below the set off images, the corresponding normalized 
neuronal filament intensity level differences between L1 and NM probes for the 0–
100 μm region away from the interface (*p < 0.05). Scale bar = 100 μm. Reprinted with 
permission form Ref.121 Copyright © 2011 Elsevier.  
While Azemi et al. showed the supremacy of L1 over LN,121 other studies have also 
shown that presentation of LN alone may not be sufficient to mitigate the neuro-
inflammatory response. For example, Tanaka et. al. showed that microglia cultured on 
fixed (dead) astrocyte monolayers, even in the presence of serum, display a resting 
phenotype. Tanaka’s results indicate that cues presented by the astrocyte ECM are 
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sufficient to regulate microglia activation. Interestingly, the impact of fixed astrocyte 
ECM was significantly more effective at reducing microglial activation than individual 
ECM components such as LN or fibronectin (FN). 
However, utilizing complete, tissue-specific ECM may provide additional benefits to 
single protein approaches. Although ECM throughout the body shares common protein 
and glycosoaminoglycan building blocks, subtle differences indicate that the precise 
make-up of a tissues-specific ECM is vital in regenerative applications.150 Several studies 
have shown that culturing cells on tissue-specific ECM improves infiltrating cell 
proliferation rates and increases the expression of desired phenotypic cell and tissue 
characteristics.151-155 In contrast, implantation of non-tissue specific ECM induces the 
formation of undesired, phenotypically irregular tissue at the implantation site.156, 157 
While bioactive approaches, based primarily on ECM proteins and peptides, have shown 
promise in improving the neuro-inflammatory response to intracortical microelectrodes, 
one limitation of these strategies is their short-lived nature. For example, inflammatory 
cells that unavoidably become activated in response to the initial iatrogenic trauma are 
known to phagocytize and remove adherent and even covalently immobilized proteins 
over time. Therefore, bioactive coatings should primarily be thought of and used as one 
component of a combinatorial strategy for improving microelectrode function and 
biocompatibility. Specifically, bioactive materials may serve as a key component to 
direct initial wound healing events and tissue integration following implantation. 
A further, and often overlooked, concern with protein-based coatings is their potential for 
immunogenicity. While the majority of proteins found in the ECM are well conserved 
between animals and humans, interspecies differences do exist. As a result the 
implantation of even decellularized, xenogenic ECM has been shown to elicit an adaptive 
immune response. Therefore the use of autologous or allogenic materials may prove key 
to maximizing the clinical success of ECM-based coatings. 
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1.3.3. Conducting Polymers 
The inherent conductive properties of intrinsically conductive polymers make them a 
useful class of materials for a wide range of biomedical applications, such as biosensors, 
tissue engineering, neuroprosthetic electrodes, drug delivery, and actuators.158, 159 
Conducting polymers are particularly attractive for intracortical microelectrode 
applications because they have mechanical properties that lie between those of 
conventional metallic microelectrodes and the brain tissue, can provide high surface area 
and therewith facilitate an efficient ion exchange between recoding sites and the brain 
tissue, and can at least in principle, be processed into a broad range of 
geometries/structures/architectures. Charge transfer is improved through reduced 
impedance and greater selectivity for both recording and stimulating neural interfacing 
applications; although their intrinsic conductivity is lower than that of gold, platinum, or 
stainless steel electrodes.  
The key feature of conducting polymers is conjugated double bonds along the backbone 
with a high degree of π-orbital overlap, results in electrically conductive materials. 
Conducting polymers with various morphologies can be directly deposited onto 
intracortical microelectrode surfaces. As a result, the conducting polymer coatings lower 
the impedance of the electrodes and can provide a mechanical buffer between the stiff 
intracortical microelectrode and the compliant brain tissue. Additionally, bioactive agents 
such as anti-inflammatory drugs and neurotrophic factors can be incorporated and 
delivered from these conducting polymer coatings. Several studies have shown that 
intracortical microelectrode functionality can be improved to some extent by coating the 
microelectrode surface with low-impedance conductive polymer with nanoscale 
roughness or porosity,85, 160, 161 or through addition of cell adhesion peptides,85 
proteins,126, 127, 162 or anti-inflammatory drugs.132, 163 Overall, in vivo studies have shown 
that these conducting coatings may enhance the chronic recording performance of 
intracortical microelectrodes.160  
Among the currently available conducting polymers, poly(pyrrole) (PPy) and poly-(3,4-
ethylene dioxythiophene) (PEDOT) (Figure 1-13) are the most studied conducting 
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polymers for intracortical microelectrode applications. Such conducting polymers have 
been doped with various dopants such as poly(styrene sulfonate) (PSS),161 perchlorate 
(ClO4-),164 para-toluene sulfonate (pTS),148 or sulphate (SO4)165 to modify the surface of 
metallic intracortical microelectrodes.166 In this section we discuss the development of 
conducting polymers used to modify the intracortical microelectrode surfaces with 
particular attention to the use of PPy and PEDOT. 
 
Figure 1-13. Chemical structures of poly(pyrrole) (PPy) and poly-(3,4-ethylene 
dioxythiophene) (PEDOT), examples of conducting polymers explored in neural 
interfaces. 
Much of the initial research on conducting polymers for neural interfacing focused on 
PPy due to the ease of preparation, high conductivity, controllable surface properties, and 
the possibility to electropolymerize this polymer from water. In 2001, Martin and co-
workers investigated the use of PPy as a surface coating for neural electrodes.85 In his 
report, PPy was combined with a genetically engineered protein, designed to incorporate 
GAGAGS sequences of silk alternated with the cell-binding sequence RGD. The 
polymers were deposited electrochemically onto the silicon microelectrodes. The study 
showed that the PPy-coated Michigan-style microelectrodes had a higher surface area and 
charge density compared with uncoated electrodes, which facilitates charge transport, and 
more efficient neural communication.85 In addition, it has been reported that a higher 
surface area significantly lowers the overall impedance of the intracortical 
microelectrodes.167 
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PSS has been used commonly as a dopant material for PPy due to its stability and in vitro 
compatibility with mammalian neuronal cells.161, 168-170 Cui and Martin electrochemically 
deposited PPy doped with PSS on the neural electrodes, and found that the coated 
electrodes had an increased surfaces area, which resulted in a 30-fold decrease in 
impedance.161 In 2005, George et al. reported on the biocompatibility of PPy-based 
cortical implants that had been doped with PSS or sodium dodecylbenzenesulfonate 
(NaDBS).169 Immunohistochemical studies showed that PPy-based intracortical implants-
doped either with PSS or NaDBS after 3 and 6 weeks implanted in a rat cerebral cortex 
had less gliosis than Teflon-coated microwire controls. However, the differences in 
gliosis at the 6-week time point had lessened compared to 3 weeks. George’s study also 
showed that incorporating neurotrophic molecules such as nerve growth factor (NGF) 
and brain-derived neurotrophic factor (BDNF) into the PPy matrix promoted the 
ingrowth of neural tissue into the lumen of the PPy-based implants, compared to implants 
without growth factors. As noted in earlier sections, analysis at limited intermediate time 
points can lead to incomplete conclusions. Therefore, further works need to be done to 
demonstrate whether the bioactive molecules can enhance neuronal adhesion and 
interaction with conducting polymer-based intracortical implants. 
The incorporation of conducting polymers within hydrogels that are used to coat 
conventional microelectrodes is another intriguing approach to better integrate 
intracortical microelectrodes with the neural tissue. Hydrogels are attractive due to their 
use in many biomedical device applications, their high water content which causes the 
mechanical properties to be similar to those of the brain tissue, and their porous network 
structure which can facilitate charge transport especially if conducting polymers are 
insulated. In one example, Michigan-style microelectrodes were first coated with cross-
linked alginate and then PPy/PSS was subsequently electrochemically polymerized on the 
device surface.168 PPy was observed to grow vertically form the electrode surface, and at 
the recording site recording site. It was found that the impedances of the porous hydrogel 
modified with conducting polymer films are around three orders of magnitude less than 
the impedance of the metal microelectrodes. The authors also found that the PPy/PSS-
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alginate-coated recording sites were capable to transporting charges as efficiently as 
conventional electrodes. Despite the growing number of studies being conducted with 
PPy for intracortical microelectrode applications, electrochemically made PPy has a 
poorly defined chemical structure in which there are a significant amount of α-β 
couplings. The presence of defective α-β couplings along the polymer backbone induce 
structural disorder, limits the electrochemical response, and is contributing significantly 
to polymer breakdown due to over-oxidation.171 With these limitations in mind, new and 
highly stable conducting materials must be found that can endure the long-term 
implantation lifetime as well as attack from biological agents present in the brain tissue. 
To overcome the drawbacks of PPy, poly(3,4-ethylene dioxythiophene) (PEDOT) has 
recently been explored as an alternative to PPy for neural interfacing electrodes. 
Specifically, PEDOT is more stable to oxidation and more conductive than PPy. Unlike 
PPy, undesired α-β couplings and structural disorder are eliminated in PEDOT by 
“blocking” the 3- and 4-positions of the monomer by the attachment of ethylenedioxy 
groups (Figure 1-14). Early studies by Cui and Martin172 explored the benefits of PEDOT 
as coating for neural microelectrodes. Cyclic voltammetry experiments demonstrated that 
PEDOT-coated electrodes were more stable than those coated with PPy. In addition, high 
quality acute neural signals were recorded with the PEDOT-coated Michigan-style 
microelectrodes in the cerebellum of guinea pig with higher signal amplitude than in 
reference experiments with un-coated microelectrodes with gold contacts. This is likely 
due to the deposition of conducting polymer (i.e. PEDOT), which decreases the 
impedance of the electrode (increase sensitivity). Cui and Martin’s findings are highly 
desirable for potential use of PEDOT as alternative conducting material for neural 
electrodes.  
After Cui and Martin initial report, several studies followed, which further explored the 
use of PEDOT as electrically conductive material in intracortical microelectrode 
applications. For example, Xiao et al. modified the surface of intracortical 
microelectrodes using PEDOT-MeOH that was electrochemically doped with 
poly(styrene sulfonate) (PSS).173 In this study, Xiao et al. improved the limited 
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processability (aqueous solubility) of PEDOT through the addition of an appropriate 
pendant side group onto the backbone. To this end, polar derivatives of EDOT, 
specifically EDOT-MeOH (the chemical structure of which has been shown in Figure 1-
14 was used. Xiao et al. found that the PEDOT-MeOH coating decreased the impedance 
by almost two orders of magnitude in comparison to the uncoated Michigan-style 
microelectrode. Decrease in electrode impedance leads to improved charge transfer from 
the surrounding brain tissue to the intracortical microelectrode, which is argued to lead to 
more effective recording and stimulating. In another investigation, Yang et al.174 
electrochemically deposited surfactant-induced ordered PEDOT onto gold-coated 
Michigan-style microelectrodes. Although, this ordered PEDOT polymer coated-
electrodes exhibited a lower impedance and a higher charge capacity than uncoated 
electrodes, it was found that the surfactant used in the preparation leached from the 
device when placed in a cell culture medium and killed all nearby cells in the culture.  
 
Figure 1-14. Chemical structures of monomers used to fabricate PEDOT and PEDOT-
MeOH. 
More recent studies by Martin and co-workers have shown that neural cells can be 
incorporated into PEDOT, while still maintaining cell viability and signal transduction 
capabilities. As a result, functional hybrid PEDOT-neural cell electrode coatings were 
created that can be used as highly biomimetic conductive substrates for intracortical 
microelectrodes. Polymerization of PEDOT around living cells has been reported in 
vitro175 as well as in vivo176 through living tissue. In one study, Richardson-Burns et al.175 
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reported the electrochemical polymerization of PEDOT in the presence of live neural 
cells that had been cultured on in-house fabricated Au/Pd sputter-coated electrodes and/or 
Applied Biophysics (Troy, NY) electrodes, as shown in Figure 1-15, resulting in the 
formation of PEDOT film around and onto adhered neural cells. Additionally, PEDOT, 
PEDOT/live neurons, and neuron-templated PEDOT coatings on the electrodes 
significantly enhanced the electrical properties and increased charge transfer capacity. 
While in vitro experiments show successful electropolymerization of conducting 
polymers around neural cells, it is critical to apply the concept in animal models to fully 
characterize the performance of the materials to more accurately understand the 
contribution of this strategy to the filed. 
         
Figure 1-15. (a) Schematic of the electrochemical deposition cell and the neural cell 
monolayer cultured on the surface of the metal electrode prior to polymerization. (b) 
PEDOT polymerized around living cells. Reprinted with permission from ref. 175 
Copyright © 2007 Elsevier. 
The first chronic, long-term neural recording studies of PEDOT-coated electrodes were 
conducted by Kipke and co-workers in 2006.160, 177 It was found that chronically 
implanted control microelectrodes were unable to record well-isolated unit activity due to 
a dramatically increased noise ﬂoor, while PEDOT-coated Michigan-style 
microelectrodes consistently recorded neural activity, and showed a much lower noise 
ﬂoor than un-coated gold-based controls over a six-week period following implantation 
in three male rats.177 
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More recently, Kozai et al. took a further step towards long-lasting conjugated-polymer-
based neural interfaces that elicit little tissue response in the brain, fabricating an 
integrated composite microelectrode consisting of electrically conductive carbon fiber 
core, a coating-based layer, and a PEDOT:PSS-based recording pad.178 Specifically, 
electrodes were fabricated by mounting carbon fiber, which serves as the conducting core 
and provides the mechanical backbone of the device, with a diameter of 7 µm onto a 
NeuroNexus microelectrode. The carbon fibers were then coated with a 800  nm thin 
poly(p-xylylene) layer (Figure 1-16a), and subsequently a 50 nm thick layer of poly((p-
xylylene-4-methyl-2-bromoisobutyrate)-co-(p-xylylene)), both with a chemical vapor 
deposition (CVD) process (Figure 1-16b). The later polymer provides initiator groups for 
a subsequent atom transfer radical polymerization (ATRP). This was used to apply a 
~200 nm thin layer of poly(ethylene glycol) methacrylate (PEGMA) (Figure 1-16c). 
Finally, a carbon recording site was exposed at the tip of the neural stainless-steel wire by 
cutting away the insulation, and the recording site was coated with a layer of 
PEDOT:PSS that was applied by electrochemical deposition (Figure 1-16d). Chronic 
neural recordings from the inserted implants into the motor cortex of rats showed that the 
resulting microelectrodes provided stable single-neuron recording over five weeks in the 
brain. Interestingly, the electrodes also showed reduced neuro-inflammation response 
compared with traditional silicon electrodes. Thus far, these electrodes with 
mechanically-compliant coatings are the smallest implantable neural electrodes that were 
able to record neuronal activity in animals. 
Conducting polymers aim to enhance the chronic performance of intracortical 
microelectrodes through providing a high surface area, and more conductive materials. 
Also, the charge transfer is likely improved through reduced impedance, thereby 
providing greater selectivity for both recording and stimulating neural applications. 
Despite the vast amount of research being produced in recent years on the conducting 
polymers for neural interfacing applications, the field is still growing and many 
challenges, limitations and questions remain to be answered. 
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Figure 1-16. (a–d) Schematic representation of the fabrication of microtherad electrodes, 
and (e) SEM images of a fully assembled, functional electrode. Reprinted with 
permission from Ref. 178. Copyright © 2012 Nature Publishing Group. 
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The key challenge of conducting polymers in neural interfacing applications is the 
preservation of the conductivity or electrochemical stability over long periods of time. 
For example, PPy and PEDOT films have been shown to lose up to 95% and 30% of their 
conductivity when subjected to 16 h of polarisation, respectively.179 Also, conducting 
polymers are often brittle and the addition of dopants to the system in many cases 
exacerbates this effect.166 Therefore, developing conducting polymers that are less brittle 
and more malleable while maintaining the conductivity and avoid delamination over time 
is required. Moreover, limited studies on the mechanical properties of conducting 
polymers for the duration of implant lifetime suggest that further research is needed to 
assess the durability of a coated intracortical microelectrode in animal models. This will 
provide an insight into possible delamination and/or mechanical erosion of conducting 
polymers. Another major drawback of conducting polymer systems is the diffusion of the 
employed dopants, unreacted monomers and typical process contaminations (e.g. 
solvents) into the medium, which all are slightly to moderately toxic. Unfortunately, most 
of the studies that have revealed a positive biological performance have been conducted 
in vitro. We believe that the cytotoxicity of released dopants is likely a limiting factor to 
the use of in-situ polymerization in vivo, despite the success in vitro – at least with the 
chemistries commonly explored. Thus, toxicity testing needs to be assessed using in vivo 
implantation studies to answer whether conducting polymers are useful for long-term 
neural implants. Today, most/all of the studies have relied on electropolymerization of 
conducting polymers on conductive electrodes (e.g. Au). In fact, the substrate to be 
coated needs to be conductive. So, the conducting polymer is really a mediator between 
the brain tissue and the conducting intracortical microelectrodes. Therefore, it is also of 
particular interest to look at printed polymer-based conductive microelectrodes for future 
neural interfacing applications. Finally, it is clear that long-term in vivo studies in this 
area of research is required for a better understanding of the impact of conducting 
polymers in improving long-term performance of intracortical microelectrodes include 
electrochemical stability, delamination, mechanical integrity and the maintenance of an 
intimate contact between the electrode and surrounding neural tissue.  
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1.3.4. Nanomaterials 
Nanomaterials have been explored in a variety of biomedical applications due to their 
unique properties arising from their nanoscale dimensions.180-182 Nanomaterials can be 
useful in cortical interfacing applications for several reasons. Perhaps most importantly, 
nanomaterials can interact with biological systems with a high degree of specificity, are 
able to stimulate and interact with target cells with minimizing undesirable effects, and 
the electronic properties of nanostructures can be tailored to match the needs associated 
with charge transport required for electrical/ionic level cellular interfacing. 
Charge transfer reactions involving the exchange of charge between various carriers 
occur at the electrode–polymer and polymer–tissue interfaces.183 In particular, it has been 
established that increasing the effective surface area of the interface will increase the 
ability for charge transfer to occur. Also, the electrical impedance of the microelectrode 
is inversely proportional to the surface area of the recording site.167 As a result, the 
intrinsically large surface area of nanomaterials results in high charge transfer as well as 
lower overall impedance of the intracortical microelectrode. 
Additionally, nanoscience approaches can present subcellular stimuli that can vary from 
one part of the neuron to another.184 For example, a combination of photolithography and 
layer-by-layer (LbL) self-assembly have been used to pattern secreted phospholipase A2 
(sPLA2), which promotes neuronal adhesion, on a non-fouling background of 
poly(diallyldimethylammoniumchloride) (PDDA).185 The approach used by Mohammed 
et al. facilitates nanoscale patterning with complex functional architectures that are 
tailored to the needs of a particular experiment. LbL self-assembly has also been used by 
Ai et al. on silicon rubber to pattern alternating laminin and poly-D-lysine or 
fibronectin/poly-D-lysine ultrathin layers, which are 3.5-4.4 nm thick, and encourage 
nerve cell adhesion, and support neurite outgrowth of cerebellar neurons.186 Taken 
together, the studies by Mohammad et al. and Ai et al. suggest that bioactive ultrathin 
coatings could be used to promote cell adhesion and limit immune responses, and may 
facilitate improved performance of intracortical microelectrodes.  
Additionally, several types of nanomaterials have been utilized in neural interface 
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devices, including carbon nanotubes, carbon nanofibers, and graphene. The use of 
nanomaterials and nanotools for neuroscience has been recently reviewed.187, 188 In this 
Section, we therefore limit the discussion to the current state of the most widely 
investigated nanomaterials in the content of neural interfacing applications. 
Carbon nanotubes (CNTs) are perhaps the most widely studied class of nanomaterials for 
intracortical microelectrodes,187, 189, 190 in view of their extraordinary strength, toughness, 
electrical conductivity, and surface area. As with the exploration of any new application 
for potential biomaterials, early work with CNTs towards intracortical microelectrodes 
began with in vitro applications. For example, Mattson et al. reported that multi-walled 
carbon nanotubes (MWCNTs) could be used as platform for neuronal growth.191 Since 
then, several studies have been devoted to evaluate neuronal growth on CNTs.192-196 
Wang et al. showed the first in vitro stimulation of primary neurons with CNT-based 
electrodes.197 The authors found that neurons can grow and differentiate on the 
microelectrode, and more importantly, that the neurons can be repeatedly stimulated with 
CNT electrodes. In parallel, several other groups confirmed the possibility to stimulate 
the neural cells via single-walled and/or multi-walled carbon nanotubes in cultured brain 
circuits.192, 198, 199 In 2008, Keefer et al. reported that CNT-coated metal microelectrodes 
improved both the recording and electrical stimulation of neurons in culture, and in vivo 
in rats and monkeys.200 In vivo recording studies of CNT-coated microelectrodes were 
conducted in the rat motor cortex and monkey visual cortex. It was found that CNTs-
coated microelectrodes had increased the neuronal recording sensitivity as well as 
decreased neuronal noise compared to un-coated tungsten microelectrode controls. It was 
possible to record local field potential (LFPs), multiple unit activity, as well as neuronal 
spiking simultaneously with one CNT-coated microelectrode in vivo. Additionally, 
Keefer et al. found that the combination of CNTs and the conducting polymer PPy 
increased the charge transfer beyond that seen with CNTs alone. Further, CNT/PPy-
coated microelectrodes had a significantly lower impedance (higher electrode neuronal 
sensitivity) than bare conventional tungsten and stainless steel microelectrodes. In a 
similar study, Luo et al. also reported that PEDOT/CNT-coated Pt microelectrodes 
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showed a much lower impedance than the bare Pt electrodes as characterized by 
electrochemical impedance spectrum (EIS) in PBS.201 Electrochemical impedance 
spectroscopy was used to show that the PEDOT/CNTs decreased the impedance of Pt 
microelectrodes with increasing coating thickness due to the increase of the electroactive 
surface area, which results in a bigger capacitance. The PEDOT/CNT-coated electrodes 
exhibited higher charge injection than traditional electrodes and in vitro tests with 
neurons showed that the neurons attached tightly to the PEDOT/CNT surface and 
exhibited long neurite extensions, suggesting that PEDOT/CNT-coatings are non-
neurotoxic and support the growth of neurons. Similar conducting polymer/CNT 
composite coatings were also studied by several other groups.202, 203 Lu et al. reported 
that co-deposited PPy/SWCNT coatings significantly reduce the impedance of 
platinum/tungsten microelectrodes. Additionally, the brain tissue response of 
PPy/SWCNT coated microelectrodes and un-coated Pt microelectrodes were studied with 
immunochemistry after a 6-week implantation in the cortex of rats. Quantitative analysis 
of glial ﬁbrillary acidic protein (GFAP) expression and neuronal nuclei (NeuN) showed 
signiﬁcantly lower GFAP and higher NeuN counts for the PPy/SWCNT coated 
microelectrodes within the first 100 µm from the implant/tissue interface (Figure 1-
17).203 
Despite the perspective advantages of CNTs for intracortical microelectrode applications, 
the studied devices are rigid (non-compliant) and may not be optimally suited for chronic 
neural in vivo applications. As a result, there is an increased attention towards the 
development of flexible CNTs-based intracortical microelectrodes by combination of 
flexible polymeric substrates and CNTs to overcome both the mechanical failure of more 
brittle CNTs-based devices, and device-mediated tissue strain. Flexible CNT-based 
neural electrodes were created by the combination of flexible polymeric substrates and 
CNT-based electrodes. Lin et al. were the first to fabricate a flexible CNT-based 
electrode array for neural recording applications.204 In this work, the CNT electrodes 
were partially embedded into a flexible Parylene-C film using a microfabrication process 
based on four steps: CNT growth, polymer binding, flexible film transfer, and partial 
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isolation. The flexible CNT electrodes produced were used to successfully record the 
spontaneous spikes from a crayfish nerve cord.  
 
Figure 1-17. GFAP immunostaining for the Pt implant control (A) and PPy/SWCNT 
coated Pt implant (C) after 6 weeks post-implantation. (E) Quantitative comparison of 
GFAP immunoreactivity between the control and coated electrodes as a function of 
distance from the electrode. The survival of neurons around the implanted electrode for 
the control (B) and coated implant (D) at 6 weeks post-implantation. (F) Quantification 
comparison of neuron survival between the control and coated electrodes as a function of 
distance from the electrode. Scale bar = 100 μm. Reprinted with permission from Ref. 203. 
Copyright © 2010 Elsevier. 
Alternatively, the direct growth of CNTs on flexible polyimide substrates has been 
reported by Hsu et al.205 Hsu et al. utilized UV-ozone exposure as a simple and low-cost 
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route to improve the interfacial properties between the CNT electrodes. UV-ozone 
exposure induces the formation of C-O, C=O, and O-C=O moieties on the surface of 
CNTs, increasing the hydrophilicity of the surface. UV-ozone treatment yielded a 50-fold 
impedance reduction and increased the interfacial capacitance by a factor of ten. In 
culture, UV-ozone treated CNTs electrodes promoted neuron and neurite growth in close 
contact with CNTs, suggesting the biocompatibility of modified CNTs for neuronal 
growth.205 In a subsequent study, spontaneous spikes were recorded from a crayfish with 
a signal-to-noise (SNR) ratio of 6.2. The flexible CNT electrodes were also used to 
record the electrocorticography (i.e. placing the electrode in the subdural region) of a rat 
motor cortex with a SNR of 8.7.206 More examples of CNT-based flexible electrodes for 
neural recording and simulating applications have been developed by Hanein et al.,190, 207, 
208 who transferred single-walled carbon nanotubes (SWCNTs) onto a flexible PDMS 
substrate. Recent evoked electrical activity recording studies with chick retinas 
demonstrated the device capability for high efficacy neuronal recording applications.190  
Carbon nanofibers (CNFs), which consist of multi-walled graphene structures stacked on 
top of each other, like a stack of ice cream cones, have also been explored as substrates 
for neural interfacing applications. Researchers at NASA Ames Research Center 
developed forest-like vertically aligned CNFs on a Si wafer by plasma enhanced 
chemical vapour deposition (PECVD).209 After the CNF film was submerged in a liquid 
and dried, the CNFs irreversibly stuck together to form microbundles (Figure 1-18). 
Stable 3D “fuzzy” films were created by electrochemically coating the CNFs with a thin 
layer of electrically conducting polypyrrole. It was found that the impedance of this kind 
of electrode decreased significantly compared to common metal electrodes due to the 
large surface area of 3D nanostructured CNFs, which results in high ion mobility. 
Furthermore, the PPy coating was shown to improve the biocompatibility of CNF-based 
electrodes compared to un-coated, and further reduces the electrode impedance by more 
than 20 times due to the redox potentials of the polymer. A subsequent study by the same 
group showed that an intimate neural-electrical interface can be formed between the 
vertically aligned CNFs and a neuronal network of PC12 cells.210 The addition of 
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neuronal growth factor (NGF) on the vertically aligned CNFs facilitated the formation of 
well-differentiated cells with mature neurites. Although, the freestanding CNFs coated 
with PPy and NGF were mechanically rigid to maintain their vertical alignment, they 
were found to be flexible enough to bend toward the cell body when driven by traction 
forces of the cells, thereby facilitating cell adhesion. Thus, it was suggested that the soft 
PPy coating not only improved the mechanical stability by forming a core-shell structure 
with the CNFs, but also promotes a better mechanical contact with neuronal cells due to a 
reduction of the local mechanical stresses.210  
 
Figure 1-18. Scanning electron microscopy images of (a) An as-grown CNF array. (b) 
An as-grown CNF array after being soaked in water and then dried in the air. (c, d) an as-
grown CNF arrays after electrodepositing a 40-nm-thick conformal polypyrrole film. (a, 
c) Perspective view images with scale bars = 500 nm. (b, d) Top view images with scale 
bars = 1.0 mm. Reprinted with permission from Ref. 209. Copyright © 2006 Wiley-VCH. 
Several studies suggest that graphene exhibits excellent biocompatibility, low 
cytotoxicity and supports neuronal growth.211-213 Therefore, graphene is another carbon 
nanomaterial that has been recently utilized in neural interface application. Chen et al.214 
reported the fabrication of graphene-based neural microelectrodes, while Luo et al.215 
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reported graphene oxide-based conducting polymer nanocomposites for potential neural 
interfacing applications. Chen’s study showed that graphene-based microelectrodes are 
capable of recording neural signals in a crayfish. These graphene electrodes showed 
biocompatibility and non-toxicity throughout the 16 day cell culture experiment with 
neuronal cells. In the second investigation, Luo et al. electrochemically doped PEDOT 
with graphene oxide (GO) and demonstrated that conducting PEDOT/GO 
nanocomposites supported the growth of neural cells with minimal toxicity along with 
low electrochemical impedance.215 To clearly demonstrate the potential of this class of 
graphene-based materials for neural microelectrodes, future studies need to investigate 
the chronic in vivo performance defined by both the ability to maintain a clinical viable 
signal quality and stimulation capabilities, as well as the biotic and abiotic failure modes 
(defined above). Alternatively, the Martin group134, 216 designed multifunctional 
nanobiomaterials that can be used for coating neural microelectrodes. These materials 
significantly decrease the electrode impedance and increase the charge density. Figure 1-
19 shows the fabrication process that includes electrospining of biodegradable nanofibers 
loaded with anti-inflammatory drug coating of the microelectrode/nanofiber assembly 
with a hydrogel layer, and subsequent electropolymerization of conducting polymer both 
around the nanofibers and within the hydrogel matrix. While in vivo data are in process 
and to our knowledge yet to be reported, the approach nicely demonstrates how several 
attractive concepts can be merged to create “smart nanobiomaterials” that are soft, have a 
low impedance, high charge density, and also can deliver anti-inflammatory drugs to 
alleviate the brain immune response to neural interfaces. 
Together with the Kipke group, Martin’s group also reported the use of conducting 
polymer nanotubes for chronic neural interfaces.217 This work showed that poly(3,4-
ethylene dioxythiophene) (PEDOT) nanotube-coated electrodes have a markedly lower 
impedance over a 7-week period than conventional Michigan-style microelectrodes. 
Figure 1-20 shows the fabrication process of such PEDOT nanotubes on the surface of 
Michigan-style microelectrodes. 
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Figure 1-19. Schematic represents fabrication of multifunctional biomaterial-based 
microelectrode. (A) Uncoated microelectrode. (B) Electrospining of drug-loaded 
nanofibers. (C) Hydrogel coating. (D) Electrochemical polymerization of a conducting 
polymer. Reprinted with permission from Ref. 134. Copyright © 2008 Elsevier. 
Martin and Kipke later investigated the effect of nanotube morphology on the properties 
of the electrodes in vitro.218 Their work demonstrated that the PEDOT nanotubes 
decreased the impedance of the electrode site by about two orders of magnitude, and 
increased the capacity of charge density by about three orders of magnitude compared to 
bare iridium microelectrodes.218 The team further showed that the mechanical properties 
of the conducting polymer can be tuned by their surface morphology. For instance, it was 
demonstrated that PPy and PEDOT nanotubes can adhere better to the surface of the 
neural electrodes than films of these polymers. For example, Figure 1-21 shows the 
delamination of conducting polymers films upon electrical stimulation, while nanotube 
mats made of the same materials did not show this undesirable effect, which would lead 
 54 
to electrode failure. Despite the many incredibly attractive materials properties that 
nanomaterials have demonstrated towards long-term neural interfaces, several of the 
devices created from these materials in their current form still suffer from limitation that 
have chronically plagued neural electrodes (degradation and delamination). Therefore, 
the combination approaches, such as thus being developed by Martin and colleagues, 
represent the starting point towards integrating nanomaterials into intracortical 
microelectrodes for neural interfacing applications. 
 
Figure 1-20. Schematic illustration of conducting polymer (PEDOT) nanotube 
fabrication on neural microelectrodes: (a, b) Electrospining of polylactic acid (PLLA) 
nanofibers. (c) Electrochemical deposition of PEDOT. (d) Dissolution of the PLLA core. 
(e, f) Optical microscopy images of the entire microelectrode (e) and single electrode site 
(f) before surface modification. (g, h) Optical microscopy images of the entire 
microelectrode (g) and single electrode site (h) after electrospining of PLLA nanofibers. 
(i, j) Optical microscopy images of the entire microelectrode (i) and single electrode site 
(j) after electrochemical deposition of PEDOT and remove of the PLLA core. Reprinted 
with permission from Ref. 218. Copyright © 2009 Wiley-VCH. 
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Figure 1-21. Scanning electron microscopy images of conducting polymers after CV 
measurements on a neural electrode: (a-d) PEDOT film, (e-f) PPy film. The images show 
delamination on the edge of polymer film. (g) PEDOT nanotubes. (h) PPy naotubes. In 
contrast to the films, PPy nanotubes and PEDOT nanotubes remained firmly attached to 
the neural electrode after CV measurement. Reprinted with permission from Ref. 218. 
Copyright © 2009 Wiley-VCH. 
In summary the recent research activities focused on use of nanomaterials in the domain 
of neural interfacing applications has contributed significantly to our understanding of the 
development of better biocompatible intracortical microelectrodes. The application of 
nanomaterials in chronic neural interfaces is still in its infancy despite an impressive 
body of research that is emerging, partly because of the complexities associated with 
interacting with neural cells and the mammalian nervous system. Moreover, there are still 
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fundamental gaps of knowledge regarding the potential toxicity of nanomaterials within 
the brain that need to be addressed. We believe that there are still tremendous 
opportunities for nanomaterials to contribute to neural interfacing devices to generate 
intracortical microelectrodes that can enhance, and improve the current technologies.  
Thus, herein, we present a brief outline of the most important future areas of 
nanomaterials in the chronic neural interfacing applications that need to be investigated: 
§ Integration of traditional approaches and nanomaterials to design new types of 
intracortical microelectrodes. 
§ Development of new types of nanostructured coatings offered by nanomaterials that 
could also increase the charge injection capacity and reduction of impedance. 
§ Incorporation of anti-inflammatory agents in the coatings using layer-by-layer self-
assembly technique. 
§ Miniaturization of the traditional intracortical microelectrodes using smaller and more 
compliant flexible nanomaterials, while maintaining efficient electrochemical 
function. 
§ Improvement of electrical and biological properties of the neural tissue-electrode 
interface. 
§ Design of easily manufacturable, highly conductive, and mechanically strong and 
flexible intracortical electrodes using nanomaterials, and conductive and adaptive 
polymers. 
§ Investigation the chronic long-term potential toxicity profiles as well as delamination 
and degradation of nanomaterials over the period of implantation. 
§ Comprehensive long-term recording and stimulation studies of nanomaterials in 
animal models. 
Finally, these exciting avenues must be tempered with the realization that the toxicity of 
nanomaterials is still a developing field, and that a better understanding of how nanoscale 
materials interact with the central nervous system is required before one can use 
nanomaterials widely in neural interfacing applications.  
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Chapter 2 – Scope and Objectives 
 
The overarching goal of this dissertation was to develop physiologically responsive 
mechanically adaptive materials that can be used to create adaptive implants for neural 
interfacing applications. Targeting materials with new property matrices that can 
contribute to developing an understanding for the causes of chronic neuroinflammatory 
responses of intracortical implants, the objectives of the present thesis were as follows: 
1. To ensure reliable insertion of mechanically morphing intracortical electrodes and 
to reduce their cross-sectional area, it is desirable to increase the initial stiffness of 
physiologically responsive mechanically adaptive nanocomposites above the 
maximum achievable with previously reported materials (tensile storage modulus > 
5 GPa). Thus, one aim of the present thesis was to explore mechanically adaptive 
biologically inspired nanocomposites based on poly(vinyl alcohol) as the matrix 
and cellulose nanocrystals derived from tunicates and cotton as the filler. This 
design was based on the hypothesis that the use of a polar glassy polymer that 
promotes significant matrix-nanocellulose interactions would result in stiffer 
nanocomposites than previously employed matrices. A systematic study of this 
system is reported in Chapter 3. 
2. Based on the previous findings that anti-oxidant treatment can prevent 
microelectrode-mediated neurodegeneration and blood-brain barrier breach, and the 
hypothesis that the mechanical mismatch plays a dominant role in reactive gliosis at 
the microelectrode tissue interface, another objective of the present dissertation was 
to develop in-situ softening antioxidant-releasing polymeric materials, which can 
serve to explore if the combination of two independently effective mechanisms – 
softening and anti-oxidant release – leads to synergistic effect in reducing the 
neuroinflammation at the intracortical microelectrode-tissue interface. Thus, in 
Chapter 4, curcumin-releasing mechanically adaptive implants based on poly(vinyl 
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alcohol) and optionally cellulose nanocrystals are reported. These materials were 
used to create implants for an in-vivo study in rats, in which the faith of the cortical 
tissue surrounding the implants was investigated. After 4 weeks, the new curcumin-
releasing, mechanically adaptive implants promoted a higher neuron survival and a 
more stable blood-brain barrier than the neat poly(vinyl alcohol) controls, but the 
benefits of the curcumin release were lost after 12 weeks, where both sets of 
compliant materials (with and without curcumin) had no statistically significant 
differences in neuronal density distribution profiles. To explore to what extent the 
poly(vinyl alcohol) matrix was responsible for this outcome, drug-releasing, 
mechanically adaptive materials based on poly(vinyl acetate), cellulose 
nanocrystals, and the anti-oxidants curcumin or resveratrol were made and studied. 
The related study is reported in Chapter 5.  
3. Finally, an objective of the present dissertation was to further extend the concept of 
adaptive neural interfacing materials, which were initially developed to create 
mechanically morphing intracortical electrodes, to optogenetic applications. Thus, 
Chapter 6 discusses the first examples of physiologically responsive mechanically 
adaptive optical fibers for this purpose. The hypothesis was that mechanically 
adaptive optical fibers, which could penetrate the cortical tissue and become soft in 
response to the brain fluid, may mitigate the neuroinflammatory response in 
chronic optogenetic applications. The mechanical and optical properties of this new 
class of materials were investigated in vitro and compared to those of conventional 
optical fibers used in optogenetic studies.  
In summary, several materials design approaches were pursued to create new materials 
for intracortical implants with built-in functions that are designed to reduce the glial scar 
formation around the implant. In Chapter 7 the most relevant results and insights gained 
from the experiments conducted are summarized and general conclusions are drawn in 
consideration of the in-vivo studies that are so far available. In addition, possible future 
directions are discussed. 
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Chapter 3 – Physiologically Responsive Mechanically Adaptive Bio-
Nanocomposites for Biomedical Applications2 
 
3.1. ABSTRACT 
We report mechanically adaptive bio-nanocomposites based on poly(vinyl alcohol) 
(PVA) and cellulose nanocrystals (CNCs), whose mechanical properties change 
significantly upon exposure to simulated physiological conditions. These nanocomposites 
were made using CNCs derived from tunicates (t-CNCs) and cotton (c-CNCs) to explore 
how aspect ratio, surface charge density, and filler content influence the mechanical 
properties. Dynamic mechanical analysis data reveal a significant enhancement of the 
tensile storage modulus (𝐸!) upon introduction of CNCs, which scaled with the CNC type 
and content. For example, in the dry, glassy state at 25 °C, 𝐸! increased up to 23% (for c-
CNCs) and 88% (for t-CNCs) compared to the neat polymer. Exposing the materials to 
simulated physiological conditions caused a drastic softening of the materials, from 9.0 
GPa to 1 MPa for c-CNCs and from 13.7 GPa to 160 MPa for t-CNCs. The data show 
that the swelling characteristics of the nanocomposites and the extent of mechanical 
switching could be influenced via the amount and type of CNCs and also the processing 
conditions. The high stiffness in the dry state and the ability to tailor the mechanical 
contrast via composition and processing makes the new materials particularly useful as 
basis for adaptive biomedical implants. 
  
                                                
2This chapter is adapted from Jorfi, M.; Robert, M.N.; Foster, E.J.; Weder, C. ACS Applied Materials & 
Interfaces 2013, 5, 1517−1526. Matthew Robert prepared and characterized c-CNCs based materials.  
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3.2. INTRODUCTION 
Materials that selectively respond to external stimuli are often referred to as “smart”, 
“intelligent”, or “adaptive” due to their intrinsic ability to change their physical or 
chemical properties on command.1, 2 Among many other uses, they have garnered 
significant attention due to their potential applications in biomedical and biotechnological 
fields,3-5 including their use as transient implants,6, 7 drug delivery carriers,8, 9 tissue-
engineering scaffolds,10, 11 thermoresponsive hydrogels,12 self-healing materials,13, 14 cell 
cultures,15 bioseparation membranes,16 sensors and actuators.17, 18 One intriguing feature 
exhibited by some of these materials is their ability to change mechanical properties “on 
command”.19 One recently demonstrated approach for the design of such materials relies 
on the preparation of polymer-based nanocomposites, which are comprised of a 
polymeric matrix and reinforcing nanofibers, whose interactions are stimuli-responsive 
and regulate the mechanical properties of the bulk material.19, 20 In a recent study Korley 
et al. extended this concept to polymer composites based on electrospun nanofibers as the 
filler, where mechanical morphing is achieved by changing the properties of the filler and 
not filler-filler or filler-matrix interactions.21 
Amongst many potential nanofillers, crystalline cellulose nanofibers, referred to as 
“nanowhiskers”, have been widely investigated.22-25 Cellulose nanocrystals (CNCs) can 
be isolated from a variety of sources, including plants (e.g. wood, cotton, or wheat straw), 
marine animals (tunicates), as well as bacterial sources, such as algae, fungi, and amoeba 
(protozoa).22 Using CNCs isolated from tunicates, Favier et al. reported the first CNC-
reinforced polymer nanocomposites in 1995. These materials displayed substantially 
enhanced mechanical properties, which were explained with the formation of a 
percolating, hydrogen-bonded network of CNCs within the polymer matrix.26, 27 This 
initial work was followed by a large number of studies that explored the reinforcement of 
a plethora of polymer matrices with CNC from a broad range of sources.19, 20, 22, 25 The 
widespread interest in CNC-based nanocomposites is explained by the low cost, 
outstanding mechanical properties, availability, sustainability, biodegradability, and low 
density of CNCs. 
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In a series of contributions, we demonstrated that the stiffness of CNC-based 
nanocomposites can be reversibly changed by controlling the degree of interactions 
between the rigid filler.20, 28-33 The CNCs form a percolating network within the matrix 
that is – amongst several contributing intermolecular forces – primarily held together by 
hydrogen-bonds among the surface hydroxyl groups, although CNC-polymer interactions 
also as important as other systems in which interactions between filler and polymer 
matrix play an important role.34-36 This causes a significant reinforcement of the polymer 
matrix. Upon exposure to chemicals that can competitively hydrogen-bond to the CNCs 
or interfere with intermolecular van der Waals forces, e.g. water, the interactions between 
individual CNCs are reduced and the nanocomposite softens considerably, as predicted 
by mechanical models. Our first generation of such mechanically adaptive 
nanocomposites was based on a rubbery ethylene oxide-epichlorohydrin copolymer (EO-
EPI) and t-CNCs.28, 37 Incorporation of 19% v/v t-CNCs into EO-EPI results in an 
increase of the storage modulus, 𝐸!, from 3.7 MPa (neat EO-EPI) to 800 MPa (EO-EPI/t-
CNC nanocomposite) at 25 °C. These materials undergo a pronounced and reversible 
modulus reduction from 800 to 20 MPa upon exposure to water. Plasticization of the 
polymer matrix upon aqueous swelling has been shown to reinforce the effect, for 
example in nanocomposites based on poly(vinyl acetate) (PVAc) and t-CNCs or c-
CNCs.29, 30 The PVAc/t-CNC nanocomposites showed an increase of the 𝐸! from 1.8 GPa 
(neat PVAc) to 5.2 GPa for a nanocomposite containing 16.5% v/v t-CNCs. Due to the 
glassy nature of the PVAc matrix, these materials exhibit a much higher initial stiffness 
than the EO-EPI based systems, but soften greatly (5.2 GPa to 12 MPa) upon exposure to 
water due to matrix plasticization and t-CNCs decoupling.  
We have shown that such biologically-inspired mechanically adaptive materials are 
potentially useful as substrates for medical devices, for example intracortical 
microelectrodes.38, 39 Such neural prosthetic devices, which connect the brain with the 
outside world, promise to be useful for many clinical applications, but it has proven 
difficult to achieve long-term connectivity, presumably on account of the mechanical-
mismatch between current electrode materials and the cortical tissue.40 Initial in-vivo 
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experiments with PVAc/t-CNC nanocomposites suggest that mechanically adaptive 
intracortical neural prosthetics can more rapidly stabilize neural cell populations at the 
interface than rigid systems, which bodes well for improving the functionality of 
intracortical devices.39, 41 The realization of such intracortical electrodes,38 and other 
medical devices would benefit significantly, if mechanically adaptive materials with a 
higher than currently available stiffness (𝐸! = 5.2 GPa)30 could be made available. Thus, 
we have explored mechanically adaptive stimuli-responsive nanocomposites based on 
PVA as the matrix and CNCs derived from tunicates (t-CNCs) and cotton (c-CNCs) as 
the filler. This design was based on the hypothesis that the use of a polar glassy polymer 
that promotes significant matrix-CNC interactions would result in stiffer nanocomposites 
than previously employed matrices. With this perspective, PVA was chosen for this 
purpose because it can be water-soluble (depending on the degree of hydrolysis and heat 
treatment),42 and has many hydroxyl groups that can interact with the surface hydroxyls 
of CNCs. Moreover, PVA is biocompatible, nontoxic and already used in a wide variety 
of biomedical applications such as contact lenses43-45 and FDA-approved nerve grafts.46 
Several studies have reported PVA-based nanocomposites with t-CNCs47 and c-CNCs,48-
50 as well as microfibrillated cellulose.51 While previous work has shown dynamic 
mechanical properties of such nanocomposites by exposing them to humid atmosphere, 
we herein investigate the dynamic mechanical properties by complete submersion into a 
simulated physiological fluid to explore the properties under more relevant conditions for 
use in biomedical applications. We demonstrate that by particular processing conditions, 
it is possible to control the aqueous swelling of the material and the degree of softening it 
experiences.   
3.3. EXPERIMENTAL SECTION 
Materials. Poly(vinyl alcohol) (PVA) 99% hydrolyzed (Mw = 85,000-124,000 g/mol; 𝛿 = 
1.26 g/mL) and all reagents were purchased from Sigma-Aldrich and used without further 
purification. Artificial cerebrospinal fluid (ACSF) was prepared by dissolving the 
following materials in 1 L of deionized water: NaCl = 7.25 g, KCl = 0.22 g, NaHCO3 = 
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2.18 g, CaCl2·2H2O = 0.29 g, KH2PO4 = 0.17 g, MgSO4·7H2O = 0.25 g, and D-glucose = 
1.80 g.52 A literature value of 1.46 g/mL was used for the density of the CNCs.53  
Isolation of Cellulose Nanocrystals from Tunicates. t-CNCs were isolated from 
tunicates (Styela clava) collected from floating docks in Point View Marina (Narra-
gansett, RI). The t-CNCs were prepared by sulfuric acid hydrolysis of the cellulose pulp. 
The protocol was based on the method described by Favier et al.,26 utilized modifications 
reported by Shanmuganathan et al.,30 and relied on minor changes that are detailed in the 
Appendix.  
Isolation of Cellulose Nanocrystals from Cotton. c-CNCs were isolated from Whatman 
filter paper with minor modifications to a previously published procedure.54 After sulfuric 
acid hydrolysis and dialysis treatment, the resulting dispersion was sonicated for 3 h and 
left to settle at room temperature for 18 h. The supernatant was then decanted off and the 
c-CNC dispersion was spray-dried using a Büchi Mini Spray Dryer (Model B-191) to 
yield dried c-CNCs as a white powder. The drying parameters were an inlet temperature 
of 110 °C, a flow rate of 4 mL/min, a nozzle airflow of 700 mL/min, an aspiration rate of 
70%, and an outlet temperature of 60 °C.  
Preparation of PVA/CNC Nanocomposites. Lyophilized t-CNCs or spray-dried c-
CNCs were dispersed in deionized water at a concentration of 5 mg/mL by sonicating for 
10 h and 7 h, respectively. PVA was dissolved in deionized water at a concentration of 50 
mg/mL by stirring for 2 h at 90 °C. Nanocomposites comprising 4-16% v/v CNCs were 
prepared by combining the appropriate amounts of the CNC dispersion and PVA solution 
to cast a film weighing 1 g. This mixture was stirred at room temperature for 30 min, 
followed by sonication for 30 min, and the resulting homogeneous mixtures were cast 
into Teflon Petri dishes of a diameter of 100 mm. The dishes were placed into an oven at 
35 °C for 5 days to evaporate the water, and the resulting films were then further dried in 
the oven at 70 °C for 24 h. The films were compression-molded between spacers in a 
Carver laboratory press (1000 psi for 2 min, followed by an increase of pressure to 2000 
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psi for 15 min). Unless otherwise stated, PVA/t-CNC films were compression-molded at 
150 °C, and PVA/c-CNC films were compression molded at 120 °C. Both types of films 
were allowed to cool to ~70 °C over the course of ca. 90 min under the applied pressure 
to yield 70-100 µm thin nanocomposite films. The thickness of the films was measured 
using an electronic digital caliper (Fowler) and micrometer (Millimess Inductive Digital 
Comparator Extramess 200, Mahr). For reference purposes, neat PVA films were 
prepared in a similar manner by solution-casting and subsequent compression-molding at 
120 °C and 150 °C. 
Atomic Force Microscopy (AFM). Atomic force microscopy was carried out on a 
NanoWizard II (JPK Instruments) microscope. 10 µL of dilute aqueous CNC dispersions 
(0.1 mg/mL) were deposited onto freshly cleaved mica (SPI Supplies Division of 
Structure Probe, Inc.) and allowed to dry at 70 °C for 2 h. The scans were performed in 
tapping mode in air using silicon cantilevers (NANO WORLD, TESPA-50) with a scan 
rate of 1 line/sec. 
Transmission Electron Microscopy (TEM). The dimensions of the CNCs and the 
homogeneity of the CNC dispersion in the PVA/CNC nanocomposites were examined by 
transmission electron microscopy (TEM) using a Hitachi H-1700 microscope operating at 
an accelerating voltage of 75 kV. To assess the CNCs dimensions, lyophilized CNCs 
were dispersed in deionized water at a concentration of 0.1 mg/mL by sonication. 
Subsequently, 3 µL of the aqueous CNC dispersions were deposited on carbon-coated 
grids (Electron Microscopy Sciences) and allowed to dry at 70 °C for 2 h. CNC 
dimensions were determined by analyzing 10 TEM images of CNCs with a total of more 
than 100 individual CNCs of which length and width were measured. The dimensions 
thus determined are reported as average values ± standard error.  
Conductometric Titration. Conductometric titrations were performed to quantify the 
surface charges of CNCs. 50 mg of the CNCs were suspended into 10-15 mL of aqueous 
0.01 M hydrochloric acid. After 5 min of stirring and 30 min of sonication, the 
 75 
suspensions were titrated with 0.01 M NaOH. The titration curves were evaluated by 
considering the following three regions: the titration of the excess of HCl, a weak acid 
corresponding to the sulfate-ester surface groups, a finally the excess NaOH present after 
titration of all of the acid (see Figure A3-1 in the Appendix). The three regions were 
separately fit to lines, and the volume of NaOH used to titrate the sulfate-ester groups 
was determined by the volume comprised within the points at which the linear fits 
intersect one another (shown graphically in Figure A3-1). To assess the accuracy of this 
titration volume with regard to other weakly acidic species being in solution, such as 
dissolved CO2, a blank titration was performed without CNCs present in solution. This 
volume was calculated to be 0.08 mL of NaOH and was subtracted from the volumes 
determined for titrations containing CNCs to further calculate the sulfate charge density. 
The concentration of sulfate groups was calculated following the equation: 𝑚𝑚𝑜𝑙  𝑆𝑂!!𝑘𝑔  𝑐𝑒𝑙𝑙𝑢𝑙𝑜𝑠𝑒 = 𝐶!"#$ ∗ 𝑉!"#$𝑊!"! ∗ 10!                                        (3− 1) 
where, CNaOH is the concentration of the base (0.01 M), VNaOH is the volume (L) of NaOH 
used to titrate the weak acid, and WCNC is the weight of S-CNCs employed for the 
measurement (g). 
Swelling Behavior. The swelling behavior of the PVA/CNC nanocomposites was 
investigated by immersing the materials in artificial cerebrospinal fluid (ACSF) at human 
body temperature (37 °C) over the course of 2 months. The degree of swelling was 
determined by measuring the weight of the samples pre- and post-swelling:  
Degree of swelling  (%)  =Mass of wet sample -  Mass of dry sample
Mass of dry sample
 ×  100          (3− 2) 
To minimize the error in measuring the degree of swelling, once the wet samples were 
taken out of the ACSF, they were placed on paper tissue to wick any excess ACSF from 
the surface; the samples were then immediately weighed.  
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Dynamic Mechanical Analysis (DMA). The mechanical properties of the PVA/CNC 
nanocomposites were characterized by dynamic mechanical analysis (DMA) using a TA 
Instruments Model Q800. Tests were conducted in tensile mode using a temperature 
sweep method (0-140 °C) at a fixed frequency of 1 Hz, a strain amplitude of 30 µm, a 
heating rate of 5 °C/min and a gap distance between the jaws of ~10 mm. The samples 
were prepared by cutting strips from the films with a width of ~6 mm. To determine the 
mechanical properties of the films in the wet state, the samples were swelled in ACSF at 
37 °C for periods of 1 week and 1 month. DMA experiments were conducted in tensile 
mode with a submersion clamp, which allowed measurements while the samples were 
immersed in ACSF. In this case, the temperature sweeps were done in the range of 23-75 
°C with a heating rate of 1 °C/min, a constant frequency of 1 Hz, a strain amplitude of 30 
µm and a fixed gap distance between jaws of 15 mm. 
Stress-Strain Measurements. Stress-strain measurements of PVA/CNCs 
nanocomposites were performed using a TA Instruments Model Q800 dynamic 
mechanical analyzer. Tests were carried out at 25 °C with a strain rate of 0.5%/min, a 
preload force of 0.01N, a gap distance between the jaws of ~10 mm, and using dog-bone 
shaped films having a width of 2.1 mm. Tensile moduli were calculated from the slopes 
of the linear region between 0 and 0.3% strain. 
Differential Scanning Calorimetry (DSC). Differential scanning calorimetry 
experiments were carried out with a Mettler Toledo STAR instrument under N2 
atmosphere. The typical procedure included heating and cooling cycles of approximately 
10 mg sample in a DSC pan from -50 to 250 °C using a heating rate of 10 °C/min. The 
glass transition temperature (Tg) was determined from the midpoint of the specific heat 
increment at the glass-rubber transition, while the melting temperature (Tm) was taken by 
the highest temperature point of the melting endotherm. 
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3.4. RESULTS AND DISCUSSION 
3.4.1. Isolation and Physical Properties of Cellulose Nanocrystals  
The CNCs used in this study were isolated from tunicates (t-CNCs) and cotton (c-CNCs) 
by sulfuric acid hydrolysis, using protocols that represent modified versions of well-
established methods. In the case of c-CNCs, spray-drying was used to isolate the dry 
CNCs (see Experimental Section). Polymer nanocomposites with t-CNCs have 
consistently been shown to exhibit superior mechanical properties than those with c-
CNCs, a fact that is mainly credited to their higher aspect ratio (~70 vs. ~10),23, 24 and on-
axis stiffness (tensile modulus ~143 vs. ~105 GPa).55, 56 c-CNCs, on the other hand, are 
more viable for commercial exploitation, because they are isolated from an abundant and 
sustainable bio-source. Due to their high density of strongly interacting surface hydroxyl 
groups, CNCs have a strong tendency for self-association.37, 54, 57 Transmission electron 
microscopy (TEM) and atomic force microscopy (AFM) images of the CNCs confirm 
that re-dispersion of the dried materials in water is readily possible (Figure 3-1, and 
Figures A3-2, A3-3, and A3-4). The dimensions of the t-CNCs, determined from TEM 
micrographs, were an average length and width of 2500 ± 1000 nm and 30 ± 5 nm, 
respectively. The average aspect ratio (A, defined as length to width ratio, l/w) of the t-
CNCs is therefore 83. The charge density of negatively charged sulfate esters on the CNC 
surface that are introduced during hydrolysis has been suggested to modulate CNC-CNC 
interactions and to affect their dispersability. By conductometric titration, the density of 
sulfate groups of the present t-CNCs was determined to be ~75 mmol/kg (Figure A3-1a 
in the Appendix). 
The c-CNCs used here were measured to have an average length and width of 220 ± 70 
nm and 22 ± 6 nm, respectively, resulting in an aspect ratio of 10. In addition to 
exhibiting a lower aspect ratio than the t-CNCs, the charge density on the surface of c-
CNCs (~25 mmol/kg, Figures A3-1b and A3-1c in the Appendix), is significantly lower 
than that of t-CNCs. While t-CNCs were dried and isolated by lyophilization, spray-
drying was used for c-CNCs. In order to assess any influence of the drying process on the 
physical properties of the c-CNCs, one batch of as-prepared c-CNCs was, after dialysis 
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and sonication, split into two portions, which were dried by lyophilization and spray 
drying, respectively. TEM and conductometric titration data suggest that the drying 
method has no influence on the physical dimensions of the c-CNCs or on their surface 
charge density and morphology (Figures A3-1, A3-2, and A3-3). 
 
Figure 3-1. AFM amplitude images for (a) lyophilized t-CNCs, and (b) spray-dried c-
CNCs deposited from aqueous dispersions (0.1 mg/mL) onto freshly cleaved mica 
surfaces. 
3.4.2. Nanocomposite Processing 
PVA solutions and CNC dispersions were combined, and after solution-casting and 
evaporation of solvent, the resulting films were re-shaped by compression-molding to 
result films of the nanocomposite with 4-16% v/v CNCs and a thickness of 70-100 µm. 
Due to the limited thermal stability of the nanocomposites above the melting temperature 
(Tm) of PVA (~220 °C), the films were compressed at a temperature much below Tm. 
PVA/t-CNC nanocomposites were compression-molded at 150 °C without any visible 
color changes, while PVA/c-CNC nanocomposites yellowed, when processed at this 
temperature (Figure A5 in the Appendix). As a consequence, PVA/c-CNC nanocompo-
sites were processed at 120 °C, unless otherwise noted. Several explanations have been 
proposed in the literature regarding the degradation of CNCs,58-60 and we speculate the 
differences in thermal degradation arise from differences related to the source of CNCs.  
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3.4.3. Thermal Properties  
The thermal properties of PVA/CNC nanocomposites were determined using differential 
scanning calorimetry (DSC, Table 3-1). The DSC curves (Figure A3-6 in the Appendix) 
show that the Tg (68 and 71°C) and Tm (216 and 217 °C) of the neat PVA only slightly 
depends on the temperature at which the films were compression-molded. In both cases, 
the incorporation of CNCs led to an increase of Tg by approximately 10 °C, which 
interestingly was independent of the CNC content. The Tg of the polymer 
nanocomposites is strongly influenced by the extent of interactions between nanoparticles 
and polymer chains.61 In the present work, both the polymer matrix and reinforcing phase 
are rather hydrophilic. Hence, strong molecular interactions (hydrogen bonding and/or 
van der Waals forces) between the polymer and CNCs can be expected, which can 
restrict the segmental mobility of the macromolecules and thereby increase Tg. A similar 
trend was found in PVA-based nanocomposites, comprising CNCs,50 bacterial cellulose 
nanocrystals,62 or nanoclay particles.63 In addition, upon introduction of CNCs the width 
of the melting peak increases, and the degree of crystallinity (𝜒!) increases slightly. This 
shows that the CNCs perhaps act as small nucleation sites for the crystallization of PVA. 
Also this effect was largely independent of the CNC content. 
3.4.4. Mechanical Properties of Dry PVA/CNC Nanocomposites 
The mechanical properties of the nanocomposites were established using dynamic 
mechanical analysis (DMA, Table 3-2). Figure 3-3a shows the tensile storage moduli (𝐸!)  of the PVA/t-CNC nanocomposites and a neat PVA reference film in the dry state as 
a function of temperature. At room temperature (25 °C), the neat PVA matrix, processed 
at 150 °C exhibits an 𝐸! of 7.3 GPa. Upon increasing the temperature, 𝐸! drastically 
decreases to 840 MPa at 100 °C (~Tg + 30 °C) due to a transition from the glassy to the 
rubbery regime at ~70 °C, which is seen as a maximum in the tan δ curves (Figure 3-2b). 
PVA/t-CNC nanocomposites containing 4 to 16% v/v t-CNCs showed a significant in-
crease in 𝐸! compared to the neat matrix below and above the Tg. At 25 °C, 𝐸! increased 
from 7.3 GPa (neat PVA) to 13.7 GPa for the nanocomposite containing 16% v/v t-CNCs 
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(Figure 3-2a, and Table 3-2). A more significant reinforcement was observed above Tg. 
At 100 °C, the nanocomposite containing 16% v/v t-CNCs shows an 𝐸!of 5.4 GPa, which 
represents a seven-fold increase over the stiffness of the neat PVA (840 MPa) at this 
temperature. At temperatures well above Tg where the softening of the material is 
attributed to higher polymer chain mobility, the significantly higher stiffness of the 
nanocomposites at these temperatures supports the notion that a percolating network of 
stiff CNCs reinforces the surrounding soft polymer matrix. Theoretically, further 
reinforcement is possible with higher loadings, although practical limitations regarding 
the brittleness of the material make 16% v/v loading a reasonable upper limit. 
Table 3-1. Thermal properties of neat PVA and PVA/CNC nanocomposites as a function 
of CNC type and content. 
Sample 
CNC Content 
(% v/v) 
Tg (°C)a Tm (°C)a ∆Hm (J/g) χc (%)b 
Neat PVAc  71 217 43.9 27 
PVA/t-CNC 4 81 218 50.2 33 
 8 83 214 49.7 34 
 12 82 220 48.8 35 
 16 82 215 44.1 34 
Neat PVAd  68 216 49.6 31 
PVA/c-CNC 4 79 216 58.5 38 
 8 80 213 52.4 36 
 12 81 212 47.3 34 
 16 82 210 40.9 31 
aThe data obtained from the second heating scan of DSC measurements. bχc= 
∆Hm
w∆H! , where w is the weight 
fraction of polymer matrix in the nanocomposites, ∆Hm is the measured melting enthalpy and ∆Ho is the 
enthalpy of 100% crystalline PVA (161 J/g).64 cFilms were compression-molded at 150 °C. dFilms were 
compression-molded at 120 °C. 
The 𝐸! of nanocomposites prepared with c-CNCs exhibits a similar trend as observed for 
the t-CNC nanocomposites, although the stiffness increase was more modest. As 
discussed above, PVA/c-CNC nanocomposite films yellowed upon compression molding 
at 150 °C and were thus processed at 120 °C. At all temperatures, the 𝐸! of dry PVA 
reference films, processed at 120 °C, was found to be slightly lower than that of the neat 
 81 
PVA processed at 150 °C (Figures 3-2a, 3-2c, Table 3-2). For example, at 25 °C 𝐸! 
values of 7.3 and 7.0 GPa were measured. PVA/c-CNC nanocomposite with 16% v/v c-
CNCs exhibited a 𝐸! of 9.0 GPa at 25 °C, which is higher than that of the neat PVA (7.0 
GPa), but lower than the 𝐸! of 13.7 GPa of the t-CNC nanocomposite with the same CNC 
content. Above Tg (at 100 °C) 𝐸! of this nanocomposite was 1.4 GPa, which represent a 
two-fold enhancement over the stiffness of the neat polymer (Figure 3-2c and Table 3-2). 
The lower reinforcement displayed by the c-CNCs compared to the t-CNCs is consistent 
with previous findings and can be attributed to lower aspect ratio and stiffness of c-
CNCs.20 
Table 3-2. Tensile storage moduli (𝐸!) of dry and ACSF-swollen films of neat PVA and 
PVA/CNC nanocomposites determined by DMA. Data represent averages (N = 4-7). 
  Dry Nanocomposites Swollen Nanocomposites 
Sample 
CNC 
Content 
(% v/v) 
E! at 25 °C 
(GPa) 
E! at 100 °C 
(GPa) 
E! at 37 °C 
after 1 week 
in ACSF 
(MPa) 
E! at 37 °C 
after 1 month 
in ACSF 
(MPa) 
Neat PVAa  7.3 0.84 11.1 6.9 
PVA/t-CNC 4 10.5 2.1 45.4 46.8 
 8 11.1 3.7 78.3 85.2 
 12 11.7 4.7 124 108 
 16 13.7 5.4 164 173 
 16b 12.3 3.0 60c  n.m. 
Neat PVAb  7.0 0.7 1.4c n.m. 
PVA/c-CNC 4 6.8 0.5 1.5c n.m. 
 8 7.7 0.8 3.6c n.m. 
 12 8.3 1.0 1.6c n.m. 
 16 9.0 1.4 1.9c n.m. 
 16a 8.4 2.1 13c n.m. 
aFilms were compression-molded at 150 °C. bFilms were compression-molded at 120 °C. cSamples were 
measured after 1 day immersed in ACSF. n.m. = not measured. 
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Figure 3-2. Dynamic mechanical analysis (DMA) data of dry PVA and dry PVA/CNC 
nanocomposites as a function of temperature and CNC content. (a) Tensile storage 
moduli (𝐸!) and (b) loss tangent (tan 𝛿) of PVA/t-CNC nanocomposites. (c) Tensile 
storage moduli (𝐸!) and (d) loss tangent (tan 𝛿) of PVA/c-CNC nanocomposites.  
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Figures 3-2b and 3-2d display the loss factor (tan 𝛿) curves of neat PVA and the two 
series of nanocomposites as a function of temperature. Tan 𝛿 is the ratio of loss modulus 
to storage modulus 𝐸!! 𝐸!  of the material and is indicative of its damping behavior. All 
curves show a single relaxation peak centered at Tα, which corresponds to the Tg 
determined by DSC. The introduction of CNCs led to a reduction in peak intensity (Iα) 
and a shift of Tα to higher temperature compared to the neat PVA films.  The peak 
intensity of the curve is indicative of the magnitude of energy loss due to relaxation 
processes in the material, which in this case reflect polymer chain relaxation due to the 
onset of the glass transition. The trend of decreasing Iα and increasing Tα is attributed to 
the reduced mobility of PVA chains in the amorphous phase due to the presence of the 
CNCs, but it is, unfortunately, not possible to deduce to what extent CNC-CNC or CNC-
PVA interactions contribute to this effect. Above a CNC content of 8% v/v, i.e., in a 
regime where the CNC concentration is above the percolation threshold, the changes in Iα 
and Tα seem to level off.  
Table 3 shows a comparison of the 𝐸! values of the dry PVA/CNC nanocomposites 
studied here with previously reported mechanically adaptive nanocomposites based on a 
range of polymer matrices. The data are quoted for a filler content of ~16% v/v. The 
comparison shows that the stiffness of the present PVA/t-CNC nanocomposites at 25 °C 
is more than three times higher than that of the stiffest mechanically adaptive 
nanocomposites reported to date. This implies that a good dispersion of the CNCs has 
been achieved in the PVA matrix and supports the conclusion that strong molecular 
interactions such as H-bonding50 and/or van der Waals forces65 between the CNCs and 
the polymer matrix indeed increase the reinforcing effect of the cellulose. Similar 
observations have been reported for other PVA-based nanocomposites with strong 
polymer-filler interactions.50, 66, 67  
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Table 3-3. Comparison of tensile storage moduli (𝐸!) of current materials 
with previous mechanically adaptive nanocomposites comprising ~16% v/v 
of CNCs.  
CNC Type 
Polymer 
Matrix 
E! of Neat 
Polymer 
at 25 °C (GPa) 
E! of 
Nanocomposite 
at 25 °C (GPa) 
Reference 
Tunicate EO-EPI 0.004 0.8 28 
Tunicate PBMA 0.6 3.8 20 
Tunicate PVAc 2.0 5.2 20 
Cotton PVAc 2.0 4.0 29 
Tunicate PVA 7.3a 13.7 this work 
Cotton PVA 7.0b 9.0 this work 
aPVA film was compression-molded at 150 °C. bPVA film was compression-molded at 
120 °C. 
In order to further evaluate the reinforcing effect of the CNCs on the mechanical 
properties of the nanocomposites, the Young’s moduli of the nanocomposites with 8 and 
16% v/v CNC content were determined by way of tensile testing (Figure A3-7). The 
Young’s modulus changed in a similar manner as E′ (i.e, from 12.2 GPa for the neat PVA 
to 15.3 and 17.1 GPa for nanocomposites with 8 and 16% v/v t-CNC and to 13.8 and 15.5 
GPa for nanocomposites with 8 and 16% v/v c-CNC). The maximum stress increased 
from 104 MPa for the neat PVA to 130 and 140 MPa for nanocomposites with 8 and 16% 
v/v t-CNC and to 126 and 110 MPa for nanocomposites with 8 and 16% v/v c-CNC. 
3.4.5. Analysis of Mechanical Data in the Framework of the Percolation Model  
The mechanical reinforcement in optimally assembled CNC nanocomposites is caused by 
the formation of a percolating CNC network, in which stress transfer is facilitated by 
intermolecular interactions between the CNCs.26 The stiffness of these materials can be 
described by a percolation model that has been successfully used to predict the 
mechanical behavior of heterogeneous materials, such as polymer blends68 and 
nanocomposites.28-30, 37, 69 Detailed information about the percolation model and its use 
for modeling CNCs-based nanocomposites can be found elsewhere.25 Within the 
framework of this model, 𝐸! of the nanocomposite can be expressed by: 
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E'= 
1 -2ψ +  ψXr Es' Er'  +(1 - Xr)ψEr' 2
1 - Xr Er'  +(Xr -ψ)Es'
             (3− 3)   
 
The subscripts s and r refer to the soft phase (polymer matrix) and rigid phase (CNCs), 
respectively. 𝜓 is the volume fraction of the percolating rigid phase (CNCs) that 
participates in the load transfer, which can be written as:  
                                              ψ = Xr Xr - Xc1 - Xc 0.4                                                         (3− 4)   
Where  𝑋!   ≥   𝑋!; 𝑋! is the volume fraction of CNCs and 𝑋! is the critical CNC volume 
fraction (percolation threshold) which was calculated by 0.7/A. Figures 3-3a and 3-3b 
show the predictions for the two series of nanocomposites studied here, along with 
experimentally determined 𝐸! values of dry PVA/CNC nanocomposites at 100 °C, i.e., at 
~Tg + 30 °C. For the calculations, aspect ratios (A) of 83 and 10 (as determined by TEM) 
were used for t-CNCs and c-CNCs, respectively, and storage moduli 𝐸!! of 840 MPa (for 
the PVA processed at 150 °C) and 700 MPa (for the PVA processed at 120 °C) were 
employed for the neat polymer matrix at 100 °C (as determined by DMA). The tensile 
storage modulus of the CNC phase, 𝐸!! , was in previous studies derived by either 
measuring the stiffness of a neat t-CNC or c-CNC film or by fitting the model against the 
experimentally determined properties of the nanocomposites and using 𝐸!!  as a fit 
parameter. While the morphology (and therewith the stiffness) of a neat CNCs film 
depends strongly on the processing conditions and has little resemblance to that of a CNC 
network within a polymer matrix, the 𝐸!!  values of 5-24 GPa for t-CNC-based,28, 30, 70 and 
0.6 - 5 GPa for c-CNC-based29, 37, 70 nanocomposites determined by these approaches 
appeared to roughly match. Interestingly, 𝐸!!  values of 80 GPa and 10 GPa are required to 
fit the model to the data for the t-CNC-based and c-CNC-based nanocomposites with 
PVA studied here (Figures 3-3a, and 3-3b). A comparison of the data for several other t-
CNC-based nanocomposites shows that for a given CNC content, 𝐸! increases with the 
polarity of the polymer matrix (PS37<PVAc30<Epoxy70), suggesting that systems with 
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pronounced CNC-polymer interactions may exhibit larger reinforcement due to factors 
that are not explicitly accounted for in the percolation model.70 This conclusion is 
consistent with the results of Dufresne and co-workers, who also reported difficulty in 
fitting data for PVA/c-CNC nanocomposites according to the methods used for similar 
materials.50  
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Figure 3-3. (a) Tensile storage moduli (𝐸!) of neat PVA and PVA/t-CNC 
nanocomposites as a function of CNC content in the dry state at 100 °C ( ), re-dried after 
swelling with ACSF for 1 week ( ), ACSF-swollen after immersion in ACSF at 37 °C 
for 1 week ( ) and 1 month (Δ). The solid line shows values predicted by the percolation 
model for the dry state (𝐸!!  = 80 GPa). The dotted line shows values predicted by the 
Halpin-Kardos model for samples conditioned in ACSF at 37 °C (𝐸!"!  = 130 GPa,  𝐸!"!  = 5 
GPa,  𝐸!! = 11 MPa,  𝐺!! = 1.77 GPa,  𝐺!!   =   3.9  MPa, vr = 0.3, vs = 0.44).71 (b) Tensile 
storage moduli (𝐸!) of neat PVA and PVA/c-CNC nanocomposites as a function of CNC 
content in the dry state at 100 °C ( ), and ACSF-swollen after immersion in ACSF at 37 
°C for 1 week ( ). The solid line shows values predicted by the percolation model (𝐸!!  = 
10 GPa). The dotted line shows the prediction by the Halpin-Kardos model for samples 
conditioned in ACSF at 37 °C (𝐸!"!  = 130 GPa,  𝐸!"!  = 5 GPa,  𝐸!! = 1.44 MPa,  𝐺!! = 1.77 
GPa,  𝐺!! = 0.5 MPa, vr = 0.3, vs = 0.44).71 Because of solvent uptake the volume fraction 
of CNCs in ACSF-swollen samples is lower than in the dry state. Data points represent 
averages of N = 3-6 measurements ± s.d.   
3.4.6. Swelling Behavior 
The swelling behavior of the nanocomposites in physiological conditions was 
investigated by immersing the materials into artificial cerebrospinal fluid (ACSF) at 37 
°C to mimic physiological conditions. It is known that heat-treated, PVA is no longer 
water soluble,42 and that the processing temperature of PVA affects the permeability of 
the material and thereby the potential for water uptake.72 Indeed, the swelling 
characteristics of the materials studied here were found to be strongly dependent on the 
temperature used for compression-molding, but not the type or content of CNCs. Neat 
PVA and PVA/t-CNC nanocomposite films processed at 150 °C exhibit ~40% w/w 
swelling, whereas neat PVA films and PVA/c-CNC nanocomposites processed at 120 °C 
exhibit approximately ~120% w/w swelling (Figure 3-4), regardless of the CNC content. 
The results indicate that the water uptake of the PVA/CNC nanocomposites is reduced by 
heat-treatment, likely on account of heat-induced cross-linking.73 The conclusion that the 
processing temperature is the primary factor for the swelling behavior was further 
supported by swelling PVA/c-CNC nanocomposites, which were processed at 150 °C, 
and PVA/t-CNC nanocomposites, which were processed at 120 °C (Figure 3-4). 
Compared to the other nanocomposites, these samples exhibited swelling that was 
consistent with their processing temperature rather than the type of CNC. Swelling 
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experiments in ACSF were extended over the course of two months to investigate the 
possible changes that might occur during prolonged biological implantation of the 
material (Table 3-4). The data show that for the PVA/t-CNC nanocomposites processed 
at 150 °C equilibrium swelling is reached within 24 hours and that these materials do not 
degrade over the course of two months. Similarly, PVA/c-CNC nanocomposite films 
reached an equilibrated swelling within 24 hours and maintained their integrity for at 
least one week. A comparison of the swelling data of the present PVA/t-CNC and the 
previously investigated PVAc/t-CNC nanocomposites30 shows that the PVA-based 
nanocomposites swell much less than their PVAc-based counterparts. For instance, the 
PVAc/t-CNC nanocomposites comprising 16.5% v/v t-CNCs displayed a degree of 
swelling of ~80%, while the PVA/t-CNC nanocomposites shows ~40% w/w of swelling 
with 16% v/v CNCs.  
 
Figure 3-4. Swelling of PVA/t-CNC nanocomposites compression-molded at 150 °C ( ), 
PVA/c-CNC nanocomposites compression-molded at 120 °C ( ), a PVA/t-CNC 
nanocomposite compression-molded at 120 °C ( ), and a PVA/c-CNC nanocomposite 
compression-molded at 150 °C ( ) as a function of CNC content, after the samples were 
immersed in ACSF at 37 °C for 1 day. Data represent averages of N = 3 measurements ± 
s.d. 
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Table 3-4. Swelling data of neat PVA and PVA/t-CNC nanocomposites at 37 °C in 
ACSF as a function of t-CNC content. Data represent averages (N = 3) ± s.d. 
Sample 
t-CNC 
Content 
(% v/v) 
After 1 
Day        
(% w/w) 
After 3 
Days     
(% w/w) 
After 1 
Week     
(% w/w) 
After 1 
Month      
(% w/w) 
After 2 
Months     
(% w/w) 
Neat PVA  35 ± 5 43 ± 4 38 ± 2 43 ± 4 45 ± 6 
PVA/t-CNC 4 41 ± 8 40 ± 6 48 ± 2 37 ± 8 50 ± 3 
 8 45 ± 3 44 ± 7 42 ± 5 47 ± 9 48 ± 6 
 12 39 ± 5 46 ± 9 37 ± 5 36 ± 5 46 ± 8 
 16 34 ± 1 42 ± 3 40 ± 8 42 ± 5 41 ± 2 
3.4.7. Mechanical Properties of ACSF-Swollen Nanocomposites  
The mechanical properties of ACSF-swollen PVA/CNC nanocomposites were 
determined by DMA using a submersion clamp set-up, which allowed the samples to be 
immersed in ACSF during the measurements. Neat PVA films softened substantially 
upon submersion in ACSF for one week and exhibited mechanical properties that appear 
to be correlated with their swelling behavior. Neat PVA films processed at 150 °C 
displayed a change in 𝐸! from ~7.3 GPa (dry) to ~11 MPa (ACSF-swollen), whereas 𝐸! 
for neat PVA films processed at 120 °C changed from 7.0 GPa to ~1 MPa. The ACSF-
swollen PVA/t-CNC nanocomposites display an 𝐸! that is higher than of the neat PVA 
films (Figure 3-5a and Figure A3-8 in the Appendix), but considerably lower than that of 
the corresponding materials in the dry state. For example, 𝐸! of the material comprising 
16% v/v t-CNCs dropped from 13.7 GPa (dry, RT) to ~160 MPa (ACSF-swollen at 37 
°C). The data in Figure 3-3 and Table 3-2 show that the switching is reversible and that 
ACSF exposure for 1 week and 1 month has the same effect. Moreover, the data in Figure 
3-3a show that the relation between 𝐸! of the ACSF-swollen PVA/t-CNC 
nanocomposites and the t-CNC content is fairly well described by the Halpin-Kardos 
model, whose application to the modeling of CNCs-based nanocomposites has been 
reported elsewhere.29, 30 Parameters used for the modeling (see caption to Figure 3-3) 
were taken from Ref. 71, except 𝐸!! of 11 MPa and 1.44 MPa for materials processed at 
150 and 120 °C, respectively, which were measured by DMA. The fact that the model 
underestimates 𝐸! suggests that the CNC-CNC and perhaps also CNC-matrix interactions 
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are reduced upon swelling with ACSF, but – perhaps on account to the abundance of 
hydroxyl groups on the matrix polymer and the CNCs that can interact with water – not 
entirely switched off. All of the ACSF-swollen samples show a significant drop of 𝐸! at 
~60 °C. Since this temperature is below the Tg of the plasticized PVA and far below the 
Tm of the matrix (~220 °C), we speculate that this transition is related to the dissolution of 
the matrix.  
The ACSF-swollen PVA and PVA/c-CNC films, which were processed at 120 °C and 
display considerably more swelling than the above discussed t-CNC-based materials, 
exhibit an 𝐸! of 1 - 4 MPa at 37 °C (Figures 3-3b and 3-5b, Table 3-2). Due to the rather 
low modulus, these measurements feature a significant error, and it is therefore not 
possible to draw a firm conclusion about how the nanocomposite composition affects the 
modulus of the ACSF-swollen materials. The fact that the ACSF-induced mechanical 
switching was very significant and the finding that similar values were observed for both 
the neat PVA and the nanocomposites suggest that the mechanical properties of these 
materials were largely governed by the swollen polymer matrix, supporting the notion 
that the water effectively reduced interactions between the CNCs and interrupted their 
continuous reinforcing network.  
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Figure 3-5. Dynamic mechanical analysis (DMA) data of ACSF-swollen films of (a) neat 
PVA and PVA/t-CNC nanocomposites and (b) PVA/c-CNC nanocomposites as a 
function of temperature and CNC content after immersion in ACSF at 37 °C for 1 week. 
In order to further probe the influence of the processing temperature on the mechanical 
switching, the tensile storage moduli (𝐸!)  of nanocomposites with 16% v/v t-CNCs that 
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had been compression-molded at 120 °C and 150 °C were compared (Table 3-2). It was 
found that the 𝐸! of PVA/t-CNC films processed at 150 °C, switched from 13.7 GPa (dry, 
RT) to 164 MPa (ACSF-swollen at 37 °C), whereas the material processed at 120 °C 
switched from 12.3 GPa to 60 MPa (Figure A3-9 in the Appendix). A similar result, was 
observed for the ACSF-swollen PVA/c-CNC films, which if processed at 150 °C 
exhibited an 𝐸!  of 13 MPa at 37 °C, while the same composition processed at 120 °C, 
showed an 𝐸! of 2 MPa at 37 °C (Figure A3-10 in the Appendix). A lower processing 
temperature therefore not only influences the mechanical properties of the materials in 
the dry state, but also reduces 𝐸! of the ACSF-swollen state considerably. While the 
PVA/c-CNC films processed at 150 °C show some yellowing, their dry-state mechanical 
properties are largely comparable to those of the material processed at 120 °C, and (on 
account of less swelling) a higher modulus in the soft state is achieved, suggesting that 
whatever effect is responsible for the yellowing, it is not negatively impacting the 
material’s mechanical characteristics. Thus, it appears that if PVA is used as a matrix, not 
only the CNC type and content but also the processing temperature can be used to tailor 
the mechanical contrast of CNCs-based, water-responsive, mechanically adaptive 
nanocomposites.  
3.5. CONCLUSIONS 
In summary, water-responsive, mechanically adaptive nanocomposites based on PVA 
and t-CNCs or c-CNCs offer an initial stiffness that is significantly higher than that of 
previous generations of such responsive materials. The use of PVA as a matrix polymer 
into which CNCs are incorporated proved useful for several reasons. The tensile storage 
moduli of PVA/CNC nanocomposites were - in both the glassy and rubbery regime - 
significantly higher than those of comparable nanocomposites. It appears that in addition 
to CNC-CNC interactions, polymer-CNC interactions, which could be promoted by the 
strong propensity of PVA to form hydrogen bonds and provide a compatible polymer-
filler interface, are a significant factor in this context. Another significant factor is the 
possibility of controlling the swelling characteristics of the PVA matrix, and therewith 
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the properties of water- or ACSF-swollen nanocomposites, via the processing conditions. 
Using this tool, the switching “contrast” of the t-CNC-based nanocomposites upon 
exposure to ACSF could be varied between a 90-fold to a 200-fold modulus reduction. 
The results suggest that other ranges can be dialed in via the processing temperature, 
which (in relative terms) affects mainly the soft state. Although not as stiff initially in the 
dry state, PVA/c-CNC nanocomposites exhibit a larger mechanical contrast (up to 900-
fold), as they soften much more than the t-CNC-based materials. This effect is related to 
the lower reinforcing power of c-CNCs. Despite the fact that decomposition of the c-
CNC-containing materials starts around 150 °C, the nanocomposites maintain useful 
mechanical properties. Therefore, one could envision employing a higher processing 
temperature for PVA/c-CNC nanocomposites to further increase the stiffness of the 
water-swollen state. Overall, we have demonstrated that varying the CNC type and 
concentration and the processing temperature allows one to tailor the mechanical 
properties of “hard” and “soft” state over a broad range. The hitherto unavailable 
contrasts accessible by the new materials make them potentially useful as substrates for 
neural prosthetic devices. Ongoing work in vivo studies seek to quantify the potential 
benefits of these mechanically-switchable materials as basis for adaptive neural 
interfaces.  
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3.7. APPENDIX 
 
 
Isolation of Cellulose Nanocrystals from Tunicates. The bleached tunicate mantles 
were blended at high speed, yielding a fine cellulose pulp. Sulfuric acid (95-97%, 600 
mL) was slowly (over the course of 2 h) added under vigorous mechanical stirring to an 
ice-cooled suspension of tunicate cellulose pulp in deionized water (6 g in 600 mL, 20 
°C). After 500 mL of the acid had been added, the dispersion was removed from the ice 
bath and was heated to 40 °C during the addition of the final 100 mL of acid. After the 
acid addition was complete, the dispersion was heated to 60 °C and was kept at this 
temperature for 1 h under continuous stirring. The mixture was then cooled to room 
temperature, centrifuged (30 min at 3300 rpm), and the supernatant solution was 
decanted. Deionized water was added and the centrifugation step was repeated until the 
pH of the dispersion reached about 5. After the last centrifugation the resulting CNCs 
were dialyzed in three successive 24 h treatments against deionized water to remove the 
last residues of the sulfuric acid. The suspension was diluted with deionized water (total 
volume 1 L) and sonicated for 18 h, before it was filtered through a No. 1 glass filter in 
order to remove any remaining aggregates. The concentration of the CNCs in the final 
dispersion was determined gravimetrically to be ~3 mg/mL. This dispersion was freeze-
dried using a VirTis BenchTop 2K XL lyophilizer with an initial temperature of 25 °C 
and a condenser temperature of -78 °C. The t-CNCs aerogel those produced was stored 
and used as needed. 
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Figure A3-1. Conductometric titration curves of CNCs. (a) Lyophilized t-CNCs, (b) 
spray-dried c-CNCs, (c) lyophilized c-CNCs, and (d) a blank titration without CNCs. 
                
Figure A3-2. Representative transition electron microscopy (TEM) images of CNCs. (a) 
lyophilized t-CNCs, and (b) spray-dried c-CNCs deposited from aqueous dispersions (0.1 
mg/mL). 
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Figure A3-3. Transition electron microscopy (TEM) images lyophilized c-CNCs 
deposited from aqueous dispersions (0.1 mg/mL). 
 
 
 
Figure A3-4. Three-dimensional AFM topographic (height) images for (a) lyophilized t-
CNCs, and (b) spray-dried c-CNCs deposited from aqueous dispersions (0.1 mg/mL) 
onto freshly cleaved mica surfaces.  
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Figure A3-5. Photographs of solution-cast and compression-molded PVA/c-CNC 
nanocomposite films (16% v/v c-CNCs) processed at 120 (left) and 150 °C (right), 
respectively. 
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Figure A3-6. DSC thermograms (second heating) of (a) PVA/t-CNC and (b) PVA/c-
CNC nanocomposites and neat PVA films compression-molded at (a) 150 °C and (b) 120 
°C, respectively. 
 
Figure A3-7. Chart showing the stress-strain curves of neat PVA and PVA/CNC 
nanocomposites as a function of CNC content (all data acquired at 25 °C). 
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Figure A3-8. DMA data of ACSF-swollen films of neat PVA and PVA/t-CNC 
nanocomposites after immersion in ACSF at 37 °C for 1 month.  
 
 
Figure A3-9. DMA data of ACSF-swollen films of 16% v/v PVA/t-CNC 
nanocomposites after immersion in ACSF at 37 °C for 1 day. The processing temperature 
is indicated in the Figure. 
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Figure A3-10. DMA data of ACSF-swollen films of 16% v/v PVA/c-CNC 
nanocomposites after immersion in ACSF at 37 °C for 1 day. The processing temperature 
is indicated in the Figure.
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Chapter 4 – Curcumin-Releasing Mechanically Adaptive Intracortical 
Implants Improve Proximal Neuronal Density and Blood-Brain Barrier 
Stability3 
 
4.1. ABSTRACT 
The cellular and molecular mechanism by which neuroinflammatory pathways respond to 
and propagate the reactive tissue response to intracortical microelectrodes remains an 
active area of research. We previously demonstrated that both, the mechanical mismatch 
between rigid implants and the much softer brain tissue, as well as oxidative stress 
contribute to the neurodegenerative reactive tissue response to intracortical implants. In 
this study, we utilize physiologically-responsive, mechanically adaptive polymer 
implants based on poly(vinyl alcohol), with the capability to also locally administer the 
anti-oxidant curcumin. The goal of this study is to investigate if the combination of two 
independently effective mechanisms – softening of the implant and anti-oxidant release – 
leads to synergistic effects in vivo. Over the first four weeks of the implantation, 
curcumin-releasing, mechanically–adaptive implants were associated with higher neuron 
survival and a more stable blood-brain barrier at the implant-tissue interface than the neat 
poly(vinyl alcohol) controls. Twelve weeks post implantation, the benefits of the 
curcumin release were lost, and both sets of compliant materials (with and without 
curcumin) had no statistically significant differences in neuronal density distribution 
profiles. Overall, however, the curcumin-releasing softening polymer implants cause 
minimal implant-mediated neuroinflammation, and embody the new concept of localized 
drug delivery from mechanically adaptive intracortical implants.  
                                                
3This chapter is adopted from Potter, K.A.*; Jorfi, M.*; Householder, K.T.; Foster, E.J.; Weder, C.; 
Capadona, J.R. Acta Biomaterialia, 2014, 10, 2209–2222 (*Co-first authors). Kelsey Potter and Kyle 
Householder carried out all in vivo studies.  
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4.2. INTRODUCTION 
Chronic intracortical microelectrode arrays allow neural firing patterns of many single 
neurons to be monitored over time from specific structures within the brain. In paralyzed 
individuals, chronic microelectrode recordings provide a way for their neural signals to 
directly control various assistive devices.1, 2 Chronic recordings in animals can advance 
our fundamental understanding of the brain function in both normal and diseased states.3, 
4 However, despite the ability of intracortical microelectrodes to record the activity of 
single- and/or multi-unit neuron activity early after implantation, a common issue 
surfaces. Eventually, neurodegenerative processes critically impair signal quality to the 
point that single neurons can no longer be detected across most electrodes. 
One widely accepted theory concerning microelectrode failure centers on changes in the 
viability and function of neuronal targets at the microelectrode recording sites. It has been 
shown by several groups that a reduction of viable neurons proximal to the implant 
occurs weeks to months after implantation.5-8 Further, neuronal processes that remain 
near the electrodes have been shown to be degenerative, with decreases in myelin and 
dendrite density.9, 10 The ability of intracortical microelectrodes to record activity from 
single neurons is directly related to the proximity of viable neurons, and thus the 
neurodegenerative process has significant ramifications for device performance.11 To 
fully realize the potential of brain-machine interface technology, the deterioration of local 
proximal neurons must be overcome. 
Significant efforts have been made to minimize the reactive tissue response to 
intracortical microelectrodes. Both materials-based and therapeutic strategies have been 
employed, with various degrees of success.12, 13 Additionally, Each of these approaches, 
as well as others, has demonstrated a clear short-term improvement in the 
neuroinflammatory response to implanted intracortical microelectrodes. However, the 
dominant mechanism leading to functional loss following intracortical implantation is 
unresolved.  
We have recently observed that the long-term neuroinflammatory response to traditional, 
rigid silicon microelectrodes is multiphasic.7 Additionally, we have also recently 
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proposed that the long-term neuroinflammatory response is self-perpetuating through the 
continual breach of the blood-brain barrier.10 The potential significance of our hypothesis 
is supported by recent results of Saxena et al., who demonstrated that the chronic blood-
brain barrier breach impacts microelectrode function.14 Many factors can contribute to the 
perpetual disruption of the blood-brain barrier, including (i) reactive microglia released 
pro-inflammatory molecules and reactive oxygen species in response to implanted 
microelectrodes6, 10, 15, 16 and (ii) the mechanical contrast between ‘stiff’ microelectrodes 
and ‘soft’ brain tissue resulting in micromotion-mediated tissue strain.17-19 
To further investigate these leading hypotheses, we have previously explored each aspect 
individually. For example, Potter et al. demonstrated that anti-oxidant treatment can 
prevent microelectrode-mediated neurodegeneration and blood-brain barrier breach.10 In 
addition, we developed a new class of physiologically-responsive, mechanically adaptive 
polymer nanocomposites. The nanocomposite implants are sufficiently rigid to allow 
insertion into the cortex, but soften considerably after implantation, to investigate the role 
of microelectrode-tissue mechanical mismatch.20-26 The polymer alone softens 
considerably upon exposure to physiological conditions due to plasticization upon 
absorption of water. The introduction of physiologically benign rigid, rod-like CNCs 
further increases the stiffness of the dry material. This is particularly important for 
polymers that are not stiff enough to penetrate the brain as small implant dimensions. 
Additionally, the high stiffness in the dry state and the ability to tailor the mechanical 
contrast via composition and processing renders nanocomposites particularly useful as 
basis for adaptive biomedical implants. Our previous nanocomposite work is in 
agreement with both in silico and in vivo studies proposing the hypothesis that the 
mechanical mismatch plays a dominant role in reactive gliosis at the microelectrode 
tissue interface.18, 27 
Together, our previous studies with nanocomposite-derived microelectrodes and anti-
oxidant therapeutics have shown a significant contribution of both oxidative stress and 
mechanical mismatch to the reactive tissue response to implanted intracortical implants. 
However, the interplay between the two mechanisms and possible synergies that may 
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arise from implanting mechanically adaptive implants with a drug-releasing feature has 
yet to be explored. Here, we employ our latest generation of mechanically adaptive 
polymer implants based on poly(vinyl alcohol) (PVA), and optionally cellulose 
nanocrystals (CNCs),24 to investigate the efficacy of the local delivery of anti-oxidant 
therapies at the intracortical implant-tissue interface.  
4.3. EXPERIMENTAL SECTION 
Materials. Poly(vinyl alcohol) (PVA) 99% hydrolyzed (Mw = 85,000–124,000 g/mol; δ = 
1.26 g/mL), curcumin (Figure 4-1), 2,2-diphenyl-1-picrylhydrazyl (DPPH), Tween 80, 
sucrose, Triton-X 100, and all other reagents used for material processing were purchased 
from Sigma Aldrich and used without further purification. 1X Phosphate buffered saline 
(PBS Buffer) was purchased from CellGro. 
 
Figure 4-1. Chemical structure of poly(vinyl alcohol) (PVA) and curcumin. 
 
Isolation of Cellulose Nanocrystals from Tunicates. Cellulose nanocrystals (CNCs) 
were isolated from tunicates (Styela clava) collected from floating docks in Point View 
Marina (Narragansett, RI). The CNCs were prepared by sulfuric acid hydrolysis of the 
cellulose pulp, according to established protocols,28 with slight modifications, as 
previously reported.24 Transmission electron microscopy (TEM), atomic force 
microscopy (AFM) and conductometric titration were used to characterize the physical 
dimensions, surface charge density, and morphology of the isolated CNCs (Figures A4-1 
and A4-2). 
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Preparation of Curcumin/Polymer Films. A PVA stock solution was prepared by 
dissolving PVA in dimethyl sulfoxide (DMSO) at a concentration of 50 mg/mL by 
stirring for 3 hours at 90 ºC. Similarly, a curcumin stock solution was made by dissolving 
curcumin in DMSO (10 mg/mL) by stirring for 1 hour at room temperature (RT). Films 
containing either 1% or 3% w/w curcumin were made by combining appropriate amounts 
of the above stock solutions, stirring the mixture for 30 minutes at RT and then sonicating 
for 30 minutes. The solutions were next cast into a Teflon® Petri dish, dried at 60 ºC for 5 
days and further dried at 120 ºC under high vacuum oven for an additional 24 hours to 
evaporate all of the solvent. After drying, films were compression-molded between 
spacers in a Carver® laboratory press (1000 psi for 2 minutes, followed by an increase of 
pressure to 2000 psi for 15 minutes) at 150 ºC, and then allowed to cool to ~70 ºC for a 
minimum of 90 minutes under the applied pressure to yield 70-110 µm thin films. The 
thickness of the films was measured using an electronic digital caliper (Fowler) and a 
micrometer (Millimess Inductive Digital Comparator Extramess 200, Mahr). For 
reference purposes, neat PVA control films were prepared in a similar manner by 
solution-casting and subsequent compression-molding. The curcumin/PVA films thus 
produced were stored in a desiccator at ambient temperature. 
Preparation of Curcumin/Polymer/CNCs Films. Films containing CNCs were 
prepared in a manner that mirrored the fabrication of curcumin/polymer films described 
above. However, in the case of CNC-containing films, CNC dispersions were combined 
with the appropriate amounts of the PVA and curcumin stock solutions, so that the CNC 
content in the final material was 8% v/v. Of note, lyophilized CNCs were dispersed in 
DMSO at a concentration of 3 mg/mL by sonicating for 10 hours.  
Swelling Behavior. Prior to in vivo evaluation, the physical and mechanical properties of 
the prepared films were characterized in the dry state and under simulated physiological 
conditions. To simulate the ionic composition of endogenous brain fluid, artificial 
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cerebrospinal fluid (ACSF) was used. ACSF was prepared following established 
protocols29 by dissolving the following materials in 1 liter of deionized water: sodium 
chloride (NaCl) = 7.25 g, potassium chloride (KCl) = 0.22 g, sodium bicarbonate 
(NaHCO3) = 2.18 g, calcium chloride dihydrate (CaCl2.2H2O) = 0.29 g, monopotassium 
phosphate (KH2PO4) = 0.17 g, magnesium sulfate heptahydrate (MgSO4.7H2O) = 0.25 g, 
and D-glucose = 1.80 g.  
The swelling behavior of the neat PVA control and the curcumin-loaded films was 
investigated by cutting the films into ~30 mm × ~6 mm × 70-110 µm rectangular strips 
and immersing the samples in ACSF at the physiological temperature of 37 ºC for one 
week. After one week incubation in ACSF, the degree of film swelling was calculated by 
comparing the weight of the films pre- and post-swelling: 
Degree of swelling (%) =
(Ws - Wd)
Wd
 × 100                    (4− 1)   
 
where Wd is the weight of the dry film prior to swelling and Ws is the weight of the 
swollen film. After swollen films were removed from ACSF, the samples were briefly 
placed on a small piece of tissue paper to wick any excess ACSF from the surface, and 
the samples were immediately weighed (Table 4-1). This experiment was repeated four 
times, and the results are expressed as mean ± standard deviation. 
Mechanical Characterization. The mechanical properties of the films were 
characterized by dynamic mechanical analysis (DMA, TA Instruments, Model Q800). 
Tests were conducted in tensile mode, sweeping the temperature between 0-140 °C at a 
fixed frequency of 1 Hz, and using a strain amplitude of 30 µm, a heating rate of 5 
°C/min, and a gap of ~10 mm between the jaws. Samples for mechanical testing were 
prepared by cutting strips (~30 mm × ~6 mm × 70-110 µm) from the films. To determine 
the mechanical properties of the films in the wet state, samples were first swelled in 
ACSF at 37 °C for one week. After the degree of swelling had been measured, DMA 
experiments were conducted in tensile mode with a submersion clamp, which allowed 
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measurements while the samples were immersed in ACSF. For wet samples, the 
temperature sweeps were carried out in the range of 25-55 °C with a heating rate of 1 
°C/min, a constant frequency of 1 Hz, strain amplitude of 30 µm, and a gap of ~15 mm 
between the jaws. These experiments were repeated three to five times, and the result was 
expressed as mean ± standard deviation (Table A4-2). 
In vitro Curcumin Release. To determine the release rates of curcumin from anti-
oxidant loaded films, samples (~30 mm × ~6 mm × 70-110 µm) were incubated at 37 °C 
in a mixture of 20 mL of 99.5% v/v ACSF and 0.5% v/v Tween-80 , which was added to 
increase the solubility of the curcumin in water. Here, polymer sample sizes were chosen 
to ensure that released curcumin could be detected spectrophotometrically. In set time 
intervals (t=1, 2, 4, 6, 8, 10, 24, 29, 33, and 48 h), 1 mL aliquots of the solution were 
withdrawn, diluted with 1.5 mL of the neat solvent (99.5% v/v ACSF and 0.5% v/v 
Tween-80), and the amount of curcumin released was detected spectrophotometrically 
(UV 2401-PC spectrophotometer, Shimadzu). The concentration of released curcumin 
was calculated using a calibration curve established by measuring the absorbance at 425 
nm of a series of solutions of the drug (5-30 µg/mL) in ACSF/Tween 80. The amount of 
curcumin released (relative to the amount of curcumin originally present in the material) 
was calculated using Equation 4-2, Where [Cur]UV is the concentration of curcumin 
measured by UV (mg/mL), VSample the volume of the sample in mL, WFilm the weight of 
the film in mg, and [Cur]Film is the nominal concentration of the curcumin in the film 
(mg/mg). This experiment was repeated four times, and the result was expressed as mean 
± standard deviation. 
Release   %   =    [𝐶𝑢𝑟]!"×  𝑉!"#$%!𝑊!"#$  ×[𝐶𝑢𝑟]!"#$     ×100                                         4− 2  
Measurement of Anti-oxidative Activity of Curcumin. The anti-oxidative activity of 
curcumin-releasing films was assessed using 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
following a previously reported method,30 with slight modifications. Here, the absorbance 
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of DPPH, a stable free radical, at 516 nm was monitored to quantify the anti-oxidant 
activity of curcumin, which is known to reduce DPPH, and thereby decreases its 
absorbance at 516 nm. Briefly, the films were cut into rectangular pieces (~30 mm × ~6 
mm) and placed into a methanolic solution of DPPH (100 µM). Samples were incubated 
at 37 ºC in the dark. The absorbance of the solution was measured spectrophotometrically 
at 516 nm in regular time intervals (t = 0, 1, 3, 5, 7, 9, 24, 30, and 48 h). The radical 
scavenging activity of curcumin-loaded films was expressed using Equation 4-3, where A 
and B are the absorbance values at time t, of the neat DPPH solution (A) and the DPPH 
solution in the presence of the anti-oxidant loaded film (B), respectively. All samples 
were tested three times to ensure repeatability of measurements. 
DPPH  Scavenging  Activity = 𝐴 − 𝐵𝐴                                            (4− 3) 
Animals and Surgical Implantation. Forty male Sprague Dawley rats (225–300 g) 
(Charles River) were used in this study and sacrificed either 2, 4 or 12 weeks after 
implantation. A minimum of five animals were used for each implanted condition and 
end point. In addition to surgically implanted animals, a minimum of two non-implanted, 
age-matched sham animals were used for each end point, as controls to assess 
background histological information. All procedures and animal care practices were 
performed in accordance with the Louis Stokes Department of Veterans Affairs 
Institutional Animal Care and Use Committee. 
Surgical procedures closely followed our established protocols.7, 10, 31 Briefly, animals 
were initially anesthetized using a mixture of ketamine (Butler Schein) (80 mg/kg) and 
xylazine (Butler Schein) (10 mg/kg) given intraperitoneally (IP). Depth of anesthesia was 
monitored using a pulse oxometer and toe-pinch reflex, and if required, isoflurane (Butler 
Schein) (0.5-2%) was used to maintain anesthesia for the duration of the procedure. 
Animal temperature was maintained using a circulating water heating pad, placed below 
the stereotaxic frame. Ophthalmic ointment (Butler Schein) was used throughout the 
procedure to prevent retinal drying. Prior to surgery, each animal received cefazolin 
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(Butler Schein) (16 mg/kg) and meloxicam (Butler Schein) (1 mg/kg) subcutaneously 
(SQ) to prevent infection and manage pain, respectively. Following initial anesthesia, the 
surgical area was thoroughly shaved and the animal was mounted onto a stereotaxic 
frame. Local anesthesia was provided using a SQ injection of Marcaine (Butler Schein) 
(0.5%) at the incision site. Prior to incision, a sterile surgical field was obtained by three 
alternating passes of betadine solution and 70% isopropanol over the surgical site. 
To perform the craniotomy, the skull was exposed by using a one-inch incision down 
midline and retracting surrounding tissue. Next, a 3-mm biopsy punch (PSS Select) was 
used to manually create a hole in the skull approximately 3 mm lateral to midline and 4 
mm caudal to bregma. The dura matter was gently reflected using a 45º dura pick and 
visible vasculature was avoided. Here, animals each received either a single sterile shank 
PVA implant (2 mm × ~100 µm × ~100 µm) or 3% Cur/PVA Curcumin implant (2 mm × 
~100 µm × ~100 µm). All samples were prepared to uniform dimensions by laser 
micromachining, and confirmed under a microscope. All implants used in this study were 
sterilized using ethylene oxide gas (14 hour cycle; University Hospitals Cleveland, OH) 
and were allowed to out gas a minimum of 72 hours prior to implantation. Implants were 
inserted carefully by hand until approximately 100 µm of the polymer shank remained 
above the cortical tissue. Prior to sample tethering, a silicone gel (Kwik-Sil, World 
Precision Instruments) was applied over each craniotomy to prevent cortical tissue 
dehydration. Polymer implants were then securely anchored to the skull using ultra-violet 
(UV) curing dental acrylic (Fusio/Flow-it ALC, Pentron Dental). The surgical site was 
closed using 5-0 monofilament polypropylene suture and triple antibiotic ointment was 
applied over the incision to prevent drying and localized infection around the surgical 
site. After recovery, animals received SQ injections of cefazolin (16 mg/kg) twice the day 
after surgery and meloxicam (1 mg/kg) daily for two days to prevent infection and 
manage pain, respectively. To minimize variability, the same surgeon performed all 
craniotomies.  
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Histological Tissue Processing. The inflammatory response to implanted devices was 
assessed by allowing animals to survive to controlled time points that correlated with 
different stages of inflammation.7 Prior to perfusion, animals were deeply anesthetized 
using a mixture of ketamine (80 mg/kg) and xylazine (10 mg/kg) administered IP. Each 
animal was then perfused transcardially with 1X phosphate buffer saline (PBS) at a rate 
of 50 mL per minute until the exudate was clear and then fixed with 4% 
paraformaldehyde at the same flow rate. The brain was then carefully extracted, placed in 
fresh 4% paraformaldehyde, stored at 4 ºC and allowed to post-fix for 24 hours. 
Following fixation and prior to sectioning, the tissue was cryoprotected by equilibrating 
in a step-wise gradient of sucrose (10%-20%-30%) in 1X PBS at 4 ºC. Tissue was 
equilibrated in sucrose until it ‘sunk’ to the bottom of the vial. Typically, tissue was 
equilibrated in 10% and 20% sucrose solution for 24 hours. In the case of 30% sucrose, 
tissue was equilibrated twice, initially for 48 hours, then the solution was replaced with 
fresh 30% sucrose and equilibrated for an additional 24 hours. The brain tissue was then 
frozen at -80 ºC in optimal cutting temperature compound (OCT) (Tissue-Tek), sliced 
axially in 20 µm sections in a cryostat, and mounted directly onto slides to be stored at -
80 ºC until immunohistochemical labeling. 
Immunohistochemistry. Immunohistochemical analysis of common central nervous 
system inflammatory markers was used to evaluate the extent of inflammation and 
necrosis around the implants. The primary antibodies utilized in this study included: 
mouse anti-glial fibrillary acidic protein (GFAP) (1:500, #A-21282, Invitrogen), rabbit 
anti-IBA-1 (1:250, #019-1974, Wako), mouse anti-CD68 (1:100, #MAB1435, Millipore), 
mouse anti-neuronal nuclei (NeuN) (1:250, #MAB377, Millipore), rabbit anti-
immunoglobulin G (IgG) (1:100, #618601, AbD Serotec) and rabbit anti-high mobility 
group box 1 (HMGB1) (1:250, #ab18256, Abcam). 
Immunohistochemical labeling of microglia/macrophages (IBA-1, CD68), astrocytes 
(GFAP), neuronal nuclei (NeuN), blood brain barrier stability (IgG), and TLR4-mediated 
mechanisms of inflammation and damage (HMGB1) was done using a previously 
 115 
reported methodology.7, 10, 31, 32 Brieﬂy, brain slices were allowed to equilibrate to RT to 
promote adhesion to microscope slides. Sections were then washed quickly three times 
with 1X PBS to remove remaining OCT, and permeated with 1X PBS containing 0.1% 
Triton-X 100 (Sigma) (1X PBS-T) for 15 minutes. All slides were then blocked for an 
hour at RT in blocking buffer (4% v/v goat serum (Invitrogen), 0.3% v/v Triton-X 100, 
0.1% w/v sodium azide (Sigma). Following blocking, primary antibodies were applied 
directly to samples and allowed to incubate overnight at 4 °C. Unbound primary 
antibodies were then removed using six subsequent 5 minutes washes with 1X PBS-T. 
Next, species-speciﬁc secondary antibodies (goat anti-rabbit or mouse Alexa-Fluor 488 
and goat anti-rabbit or mouse Alexa-Fluor 594, Molecular Probes) were diluted 1:1000 in 
blocking buffer and applied to the tissue sections for 2 hours at RT. In addition to 
secondary antibodies, 4,6-diamidino-2-phenylindole (DAPI, 1:36,000) (Invitrogen) was 
used to co-label total cell nuclei. Unbound secondary antibodies were removed with six 
subsequent 5 minutes washes with 1X PBS-T. Following washing, tissue 
autoﬂuorescence was removed with a 10 minutes treatment with 0.5 mM copper sulfate 
buffer (50 mM ammonium acetate, pH 5.0).31 Slides were finally thoroughly rinsed with 
deionized water, mounted with Fluoromount-G (Southern Biotech), allowed to dry at RT 
and then stored at 4 °C in the dark until imaged. 
Imaging and Quantitative Analysis. All immunohistological images in this study were 
acquired fluorescently using a 10X objective on an AxioObserver Z1 (Zeiss Inc.) and an 
AxioCam MRm (Zeiss Inc.). To allow for a wider field of view, without sacrificing 
image resolution, MosaiX software (Zeiss Inc.) was used to stitch together 16 individual 
10X images for each analyzed region of interest. Prior to analysis, stitched images were 
exported as unmodified 16-bit tagged image files (TIFs). Images were analyzed in the 
raw acquired form, with no further modifications. 
The quantification of inflammatory markers was done with two different methods. For all 
markers except neuronal nuclei, intensities were quantified using an in-house, freely 
available, written MATLAB program, MINUTE.31 Within the graphic user interface 
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(GUI), the implant region was defined and the surrounding image intensity quantified 
using expanding 2 µm rings from the defined region of interest. Intensities were 
quantified up to 1500 µm away from the implant interface. Quantified intensities were 
then normalized to a background region to obtain a normalized intensity profile for each 
analyzed marker. Here, background was defined as approximately 1200-1400 µm from 
the defined interface and held constant for any given stain, for all time points and 
analyzed conditions. To allow for statistical evaluation, the area under the curve of the 
normalized intensity plots was then obtained using MATLAB for all tested conditions. 
For clarity, data is presented as normalized intensity profiles as a function of distance 
from the implant. The area under the curve values were only used to find significance 
between conditions, and not otherwise reported. The following bins were used to 
determine significance: 0 to 50 µm, 50 to 75 µm, 75 to 100 µm, 100 to 125 µm, 125 to 
150 µm, 150 to 175 µm, 175 to 200 µm and then 100 µm bins out to 1000 µm from the 
implant. Binning intervals were defined based on those reported by multiple groups in the 
field5, 33, 34 and modeling studies by Busaki et al which outlined critical distance to 
maintain functional neural recordings.11  
In addition to the area under the curve, exponential curve fitting was applied to each 
normalized intensity plot to quantify the cellular and molecular distribution of labeled 
antigens. Using previously reported methods,7 curve fitting was done using the Nelder-
Mead method and the sum of the squared residuals was normalized to the variables λ and 
a. Lambda (λ) values, denoting the distance at which 63.2% of the total observed 
fluorescent intensity had returned to background levels, were obtained for each analyzed 
image (see Equation 4-4). Lambda values were only used if a R2 value of 0.9 was 
achieved after curve fitting. 𝑦 𝑥 = 𝑎   ∙   𝑒 !!!                                                   (4− 4) 
 
Neuronal nuclei (NeuN) densities around implanted materials were quantified using 
Adobe Photoshop. Similar to above, the implant region was defined and expanding 
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concentric rings at fixed radii were drawn up to 600 µm from the region of interest. Then, 
the area within each region and total number of neuronal nuclei were determined, 
manually. For all conditions and analyzed end points, neuronal nuclei density was 
normalized to age-matched, non-surgical control animals. Neurons in the sham tissue 
were counted using the same quantification as implanted animals and the densities were 
defined as 2757 ± 275, 2042 ± 156, and 1432 ± 184 cells per mm2 for 2 weeks, 4 weeks, 
and 12 weeks, respectively. All neuronal nuclei densities were reported relative to the 
sham values for a given end point. 
Statistical Analysis. For each analyzed marker, a minimum of 15 tissue sections from a 
minimum of five rats were used for statistical comparison. Each image was treated as an 
independent measurement and then averaged within a given cohort. For all comparisons 
between time of implant and material type, statistical analyses using a general linearized 
model two-way analysis of variance (ANOVA) were run using Minitab 16 (Minitab Inc.). 
Pair-wise comparisons were conducted using a Tukey’s post-hoc test. Significance was 
defined as a p-value less than 0.05. 
4.4. RESULTS 
4.4.1. Characterization of Curcumin-Loaded Materials 
The swelling behavior of the curcumin-loaded materials (with and without CNCs) and the 
neat PVA control in emulated physiological conditions was investigated by immersing 
the materials into ACSF at 37 °C (Table 4-1). The water uptake was found to be ~30 - 
40% w/w for all compositions, and no dependence of the drug or CNC content is 
apparent. The thermal properties of anti-oxidant loaded materials were determined using 
differential scanning calorimetry (DSC, Table A4-1). The DSC data show that the 
incorporation of CNCs and/or anti-oxidant led to an increase of the glass transition 
temperature (Tg) by approximately 10 °C in comparison to the neat PVA (~68 °C). A 
melting temperature (Tm) of ~220 °C was observed, independent of the presence of CNCs 
and/or anti-oxidant. However, the degree of crystallinity (χc) increased slightly (Table 
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A4-1), suggesting that the CNCs and the curcumin act as nucleation sites for the 
crystallization of PVA.  
Table 4-1. Swelling properties of neat PVA and curcumin-loaded films. 
Polymer Film Swelling (% w/w) 
Neat PVA Control   40 ± 6.0 
1% Curcumin/PVA 30 ± 10 
3% Curcumin/PVA 35 ± 2.0 
PVA/CNCs Control 40 ± 5.0 
1% Curcumin/PVA/CNCs 30 ± 5.0 
3% Curcumin/PVA/CNCs 27 ± 8.0 
4.4.2. Mechanically Adaptive Properties of Curcumin-Loaded Materials 
The mechanical properties of both curcumin-loaded PVA and PVA/CNC films were 
investigated using dynamic mechanical analysis (DMA). Figures 4-2 and A4-3 show the 
tensile storage moduli (E’) of the curcumin-loaded PVA (Cur/PVA) and the curcumin-
loaded PVA/CNC nanocomposites (Cur/PVA/CNCs) as well as a neat PVA reference 
film in the dry and ACSF-swollen state as a function of temperature. The curves reveal a 
nearly temperature-independent tensile storage modulus E’ of ~10 GPa at temperatures 
below ~20 °C. E’ is reduced as the temperature is increased towards the Tg (~68 °C), and 
reaches a rubbery plateau above ~100 °C. The incorporation of CNCs led to an increase 
of the E’, in particular above Tg.  
All curcumin-loaded materials softened substantially upon submersion in ACSF. For 
example, 3% Cur/PVA films display a reduction of E’ from ~9 GPa (dry, RT) to ~12 
MPa (ACSF-swollen, 37 °C) (Figure 4-2). The ACSF-swollen Cur/PVA/CNC 
nanocomposite films display an E’ that is higher than that of the Cur/PVA films (Figures 
4-2 and A4-3), but considerably lower than that of the corresponding materials before 
swelling. For example, E’ of the 1% Cur/PVA/CNC dropped from ~11 GPa (dry, RT) to 
~130 MPa (ACSF-swollen, 37 °C). Thus, mechanical tests confirm that all materials 
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studied here are rigid when dry, but soften considerably upon swelling in (emulated) 
physiological conditions, as targeted for the intended intracortical microelectrode 
applications. 
 
 
Figure 4-2. Representative dynamic mechanical analysis (DMA) traces showing the 
tensile storage moduli of (A) dry and (B) ACSF-swollen curcumin-loaded poly(vinyl 
alcohol) (PVA) samples as a function of temperature and curcumin content (1 or 3% 
w/w). Neat PVA was also studied for reference purposes. Average data of multiple 
experiments are compiled in Table A4-2. 
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4.4.3. Curcumin Release Profiles 
In vitro curcumin release studies were carried out by submersing curcumin-loaded films 
in ACSF at 37 °C and monitoring the absorbance of curcumin in the solution as a 
function of time. The release, relative to the total amount of curcumin nominally included 
in the composition, is shown in Figure 4-3 and Figure A4-4. The data reveal a burst 
release, where most of the drug elution occurs within a timeframe of ~10 hours. 
Interestingly, only about ~15-25% w/w of the curcumin comprised in the PVA was 
released into the ACSF medium, with no clear correlation to the curcumin content in the 
material (1 or 3% w/w) or the presence or absence of CNCs. The absolute amount 
released from the samples scaled with the curcumin content; the 3% curcumin-loaded 
PVA films released ca. 3.1 times more curcumin than the 1% curcumin-loaded PVA 
films and the 3% curcumin-loaded PVA/CNC nanocomposite films released ca. 2.2 times 
more curcumin than the 1% curcumin-loaded PVA/CNC nanocomposites.  
  
Figure 4-3. Cumulative in vitro release profile of curcumin-loaded polymers in ACSF at 
37 °C. Values represent mean ± S.D. (n = 4), and relative to the original nominal amount 
of curcumin in the materials. 
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4.4.4. Anti-oxidative Activity of Curcumin-Loaded Materials 
The antioxidant activity of the curcumin-loaded materials was investigated utilizing the 
ability of curcumin to scavenge DPPH radicals. The corresponding reaction changes the 
absorption of the DPPH and can be readily monitored. The neat DPPH solution shows 
slow discoloration over time (Figures A4-5 and A4-6), which is due to slow reaction with 
the hydrogen-donating solvent (i.e. methanol), and requires that the spectroscopic 
scavenging data are referenced to this baseline. The function did not change when films 
of the neat PVA or the PVA/CNC nanocomposites were placed into the DPPH solution 
(Figures 4-4A and A4-7A). By contrast, the decrease was accelerated in the case of PVA 
or PVA/CNC loaded with 1% w/w curcumin, and even more so in the case of samples 
comprising 3% w/w curcumin (Figures 4-4A and A4-7A). The relative antioxidant 
activity of the curcumin-loaded PVA films containing 1 and 3% curcumin after 48 h 
incubation was ~0.23 and ~0.68, respectively, while that of the curcumin-loaded 
PVA/CNC films containing 1 and 3% curcumin was ~0.11 and ~0.65, respectively 
(Figures 4-4B and A4-7B).  
4.4.5. In vivo Studies 
Following material validation in vitro, initial in vivo characterization of the curcumin-
loaded PVA materials was performed. Here, based on the performance in the DPPH anti-
oxidative activity assay, 3% curcumin-loaded PVA (3% Cur/PVA) was chosen for in vivo 
testing. Neat PVA was used as a control for histological assessment. Forty male Sprague 
Dawley rats (225–300 g) (Charles River) were used in this study and sacrificed either 2, 4 
or 12 weeks after implantation. 
4.4.6. Neuronal Nuclei Density (NeuN) 
Theoretical modeling has suggested that neuronal cell bodies must be within 50 µm of 
the intracortical microelectrode, in order to enable recordings of action potentials from 
individual neurons.11 To quantify the number of neurons around the implants used here, 
we utilized the NeuN antibody, which selectively stains for neuronal nuclei.35 All neuron 
 122 
counts are presented as a percentage to condition and age-matched no surgery control 
animals. 
 
 
Figure 4-4. (A) Plot showing the absorbance at 516 nm of a methanolic solution of 
DPPH (100 µM) as a function of time, and of the same solution in the presence of films 
consisting of neat PVA, or PVA with 1 or 3% w/w curcumin, respectively, incubated at 
37 °C in the dark for up to 48 hours. (B) DPPH scavenging activity calculated from the 
results shown in (A) according to equation 3. The results shown are means ± standard 
deviation of three independent experiments.  
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At 2 weeks after implantation, we observed that animals implanted with 3% Cur/PVA 
implants presented higher densities of NeuN+ neurons up to 200 µm from the implant 
surface (p < 0.04) than animals in which neat PVA control was implanted (Figure 4-5A, 
B). The asterisks in Figure 4-5 indicate conditions in which the binning intervals were 
statistically reduced from native sham tissue backgrounds (p<0.05). Note, neat PVA 
control implants demonstrated significantly lower NeuN+ neuron densities in comparison 
to background from 0 to 600 µm from the implant surface, except for from 400 – 500 µm 
from the implant surface at 2 weeks post implantation (Figure 4-5B). However, by 100 
µm from the implant surface, at the same time point, 3% Cur/PVA implants had returned 
to background levels of neuron densities, except for from 400 – 500 µm from the implant 
surface (Figure 4-5B). Reduction in neuronal densities at extended distances from the 
implant are most likely due to the craniotomy.36 
At 4 weeks after implantation, 3% Cur/PVA implants presented higher densities of 
NeuN+ neurons from 0 to 100 µm and 200 to 400 µm from the implant surface in 
comparison to neat PVA controls (p<0.04; Figure 4-5C). Additionally, only neat PVA 
control implants from 0 to 50 µm from the implant surface demonstrated significantly 
lower NeuN+ neuron densities in comparison the background. Animals implanted with 
curcumin-releasing implants showed densities insignificant from background for all 
binning intervals at 4 weeks after implantation (Figure 4-5C). However, at 12 weeks 
post-implantation, similar neuronal densities were noted between both polymer implants, 
with 3% Cur/PVA implants only presenting higher densities of NeuN+ neurons from 100 
to 200 µm from the implant surface (Figure 4-5D). In addition, both the neat PVA and the 
3% Cur/PVA implants demonstrated significantly lower NeuN+ neuron densities in 
comparison to background from 0 to 50 µm from the implant surface, while neither 
material set was statistically different from background beyond 50 µm. 
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Figure 4-5. Neuronal nuclei populations surrounding neat PVA control and curcumin-
releasing PVA implants. Neuronal (NeuN) density was investigated at 2, 4 and 12 weeks 
after polymer implantation up to 600 μm from the implant interface. At 2 weeks, neat 
PVA implants demonstrated significantly lower neuronal densities than non-surgery 
sham controls at all binning intervals investigated, except from 400 to 500 µm from the 
implant (*p<0.05) (A, B). Animals implanted with curcumin-releasing PVA, however, 
only demonstrated densities significant from background up to 100 µm from the implant 
interface (B). In addition, significant differences in neuronal populations were noted 
between the two types of polymer implants up to 200 µm at 2 weeks ( p<0.04) (B). By 4 
weeks post implantation, similar background densities of neurons, in comparison to non-
surgery sham controls, were noted at all binning intervals, except from 0 to 50 µm in neat 
PVA implanted animals (A, C). In addition, significant differences between polymer 
types were noted from 0 to 100 µm and 200 to 400 µm ( p<0.04) (C). At 12 weeks post-
surgical implantation, neat PVA and curcumin-releasing PVA demonstrated similar 
neuronal densities, with significant differences between the two samples only noted from 
100 to 200 µm from the interface (D). In addition, neuronal densities lower than sham 
backgrounds were only noted from 0 to 50 µm at this time point in both conditions (D). 
Scale = 100 µm. Data is represented as an average ± s.e.m.  
 
4.4.7. Blood Brain Barrier Permeability (IgG) 
Saxena et al. recently demonstrated a correlation between chronic blood-brain barrier 
(BBB) breach and microelectrode function.14 Therefore, we sought to explore the 
stability of the BBB after implanting the new mechanically adaptive, curcumin-releasing 
materials. The ability of the BBB to repair itself over time can be correlated to the 
amount of immunoglobulin G (IgG) present within the surrounding tissue.5, 16 If a 
microelectrode is implanted into the cortex and quickly removed, the BBB heals, as 
measured through the lack of IgG present in the tissue.7 Therefore, in order to investigate 
BBB integrity, the amount of IgG present at the implant site was examined.  
Representative images and quantitative analysis from immunohistological staining of IgG 
indicated that the blood-brain barrier surrounding the neat PVA control implants was 
significantly more compromised than the blood-brain barrier surrounding 3% Cur/PVA 
implants at both 2 and 4 weeks post-implantation, but not at 12 weeks post-implantation 
(Figure 4-6). At 2 weeks post-implantation (Figure 6A), higher levels of IgG infiltration 
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within the cortical tissue surrounding neat PVA implants was seen across all binning 
intervals from the implant-tissue interface extending to 1 mm from the implant surface 
(p<0.03 vs. curcumin-loaded implants). Further, the molecular distribution of IgG 
infiltration (lambda) was significantly higher (p<0.003) in animals receiving neat PVA 
control implants, indicating a much wider diffusion of accumulated serum proteins (Table 
4-2). No significant differences in lambda were noted at 4 or 12 weeks for IgG reactive 
tissue. Additionally, at 4 weeks post-implantation in the neat PVA control implants 
(Figure 6B), higher levels of IgG infiltration within the cortical tissue were seen from 200 
µm to 400 µm from the implant surface (p<0.03). By 12 weeks post-implantation, 
comparisons between both material sets failed to demonstrate significant differences in 
IgG infiltration within cortical tissue surrounding the implants (Figure 4-6C). 
 
Two Weeks Four Weeks Twelve Weeks 
IgG PVA 434.94 ± 64.59* 188.95 ± 38.06 135.97 ± 36.52 
3% Cur/PVA 108.23 ± 38.37* 113.24 ± 20.41 117.03 ± 15.86 
GFAP PVA 188.18 ± 20.21 81.55 ± 24.59 53.67 ± 6.70 
3% Cur/PVA 154.19 ± 19.37 88.92 ± 13.70 77.25 ± 9.36 
IBA-1 PVA 86.59 ± 20.20 49.57 ± 4.98 49.02 ± 5.23 
3% Cur/PVA 92.46 ± 13.42 45.16 ± 6.78 37.90 ± 5.97 
CD68 PVA 50.36 ± 19.20 46.48 ± 5.73 38.06 ± 3.91 
3% Cur/PVA 60.17 ± 8.84 44.06 ± 5.17 49.52 ± 7.77 
Table 2.  Lambda Values of Inflammatory Markers   
*denotes significance between polymer types 
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Figure 4-6. Infiltration of immunoglobulin-g (IgG) around neat PVA controls and 
curcumin-releasing PVA implants. The extent of blood brain barrier permeability around 
the implanted polymers was examined using labeling of immunoglobulin-g (IgG). At 2 
weeks, poly(vinyl alcohol) (PVA) (light grey-dashed line) implants demonstrated 
significantly higher IgG infiltration in comparison to curcumin-releasing samples (solid 
dark grey line) up to 1000 μm away from the implant (*p<0.03) (A). By 4 weeks, similar 
IgG profiles were noted between implanted conditions, with only significant differences 
noted from 200 to 400 μm away from the implant (*p<0.03) (B). No significant 
differences between conditions were noted between the two materials at 12 weeks after 
implantation (C). Scale = 100 μm. Data is represented as an average ± s.e.m. 
 
4.4.8. Astrocytic Scar Formation: Astrogliosis (GFAP) 
Immunostaining for GFAP+ cells allows for the monitoring of both immature/mature 
resting or activated astrocytes,37 both of which play a dominant role in repair following 
CNS injury. Further, many researchers hypothesize that the astrocytic diffusion barrier 
may play a beneficial role in restricting the impact of macrophage-secreted factors on the 
surrounding tissue, as well as mechanically shielding the surrounding tissue from 
micromotion-induced strains surrounding the historically stiff microelectrodes.8, 38, 39 
However, astrogliosis may also increase the tissue’s impedance to small ion transport, 
potentially limiting recording function as first suggested by Schmidt and co-workers.40, 41  
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Here, immunostaining for GFAP+ astrocytes showed that at 2 weeks post-implantation, 
3% Cur/PVA implants demonstrated significantly more GFAP+ cells within the first 100 
µm from the implant surface (Figure 4-7A, p < 0.01) than the neat PVA control implants. 
Interestingly, at 4 weeks post-implantation, the trend reversed, and the neat PVA control 
implants presented with more GFAP+ cells than the 3% Cur/PVA implants from 0 to 200 
µm from the implant surface (Figure 4-7B, p < 0.01). However, by 12 weeks post-
implantation, the distribution of GFAP+ cells encompassing both the neat and curcumin-
loaded PVA implants were statistically similar (Figure 4-7C). No significant effect on 
lambda was noted between polymer types for any investigated time point (Table 4-2). 
 
Figure 4-7. Astrogliosis surrounding neat PVA control and curcumin-loaded PVA 
implants in the cortex. The extent of astrocytic scarring around the implanted polymers 
was investigated using labeling of glial fibrillar acidic protein (GFAP). At 2 weeks post 
implantation, neat PVA control implants (light grey dashed line) had significantly less 
astrocytic scarring up to 100 μm away from the implant interface in comparison to 
curcumin-loaded implants (dark solid grey line) (*p<0.01) (A). In contrast, by 4 weeks, 
curcumin-releasing implants had significantly lower intensities of GFAP+ cells at the 
implant interface up to 200 μm away from the implant than the neat PVA controls 
(*p<0.01) (B). No significant differences were noted between the two materials at 12 
weeks post implantation (C). Scale = 100 μm. Data is represented as an average ± s.e.m. 
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4.4.9. Microglia and Macrophage Density (total – IBA-1; activated – CD-68) 
Microglia/macrophages mediate the inflammatory and immune response to minimize 
bacterial/viral invaders,42 as well as infiltrating serum proteins within the CNS 
(microglia).43 When activated, microglia and macrophages release several inflammatory 
factors that can become neurotoxic, and have been implicated to propagate the 
neuroinflammatory response to implanted intracortical microelectrodes.10, 15, 16 Therefore, 
many studies of the tissue response to intracortical electrodes have focused on 
microglia/macrophage activation in response to indwelling implants.  
The ionized calcium binding adapter molecule (IBA-1), which is involved in aspects of 
motility-associated rearrangement of the actin cytoskeleton, is a selective marker for both 
resting and activated microglia/macrophages.44 Immunostaining for IBA-1 provides 
information for total microglial and macrophage density and distribution around cortical 
implants. Here, immunohistological assessment demonstrated a significant increased 
density of IBA-1+ cells at the implant surface in comparison to background IBA-1+ 
expression (Figure 4-8; p<0.001). The increased density of IBA-1+ cells declined over the 
first 150-250 µm, back to background levels at all time points investigated post-
implantation. No statistically significant difference between the neat PVA control and 3% 
Cur/PVA implants were identified for any of the three time points examined. Further, no 
significant effect on lambda was noted between polymer types for any investigated time 
point (Table 4-2). 
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Figure 4-8. Total microglia and macrophage accumulation (IBA-1+ cells) around neat 
PVA controls and curcumin-releasing polymer implants. The total population of 
microglia and macrophages around implanted polymers was investigated by labeling 
IBA-1+ cells. Here, similar microglia/macrophage infiltration was noted and there were 
no significant differences between the two polymer materials for all assessed time points. 
Dark grey solid line denotes 3% Cur/PVA and dashed light grey line denotes neat PVA 
control. Scale = 100 μm. Data is represented as an average ± s.e.m. 
CD68 is a cytoplasmic antigen found only in activated microglia and macrophages.45 
Therefore, CD68 is more regularly used to identify activated microglia/macrophages, 
which are likely to be secreting pro-inflammatory molecules. As with IBA-1, 
immunohistological assessment of CD68 expression demonstrated a significant increased 
density at the implant surface in comparison to background CD68 expression (Figure 4-9; 
p<0.001). At 2 weeks post-implantation, the increased intensity of CD68+ cells declined 
over the first ~150 µm, back to background levels (Figure 4-9A). Additionally, no 
statistically significant differences between neat PVA controls and 3% Cur/PVA implants 
were identified. However, at 4 weeks post-implantation, CD68 reactive tissue expanded 
to ~450 µm for the neat PVA control and ~250 µm for the 3% Cur/PVA implants (Figure 
4-11B). Additionally, expression levels of CD68 were statistically higher for the neat 
PVA implants from 0 to 300 µm from the implant surface (p < 0.04). At 12 weeks post-
implantation, peak intensities of CD68 expression for both the neat PVA control and the 
3% Cur/PVA more than doubled the expression levels at 2 or 4 weeks post-implantation 
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(Figure 4-9C). Nevertheless, no statistically significant difference between neat PVA 
control and 3% Cur/PVA implants were identified. In addition, no significant effect on 
lambda was noted between polymer types for any investigated time point (Table 4-2). 
 
Figure 4-9. Accumulation of activated microglia and macrophages (CD68+) around neat 
PVA controls and curcumin-releasing implants. The presence of activated microglia and 
macrophages (CD68+) around implanted polymers at 2, 4 and 12 weeks post implantation 
was investigated. At 2 weeks, no notable differences between the two materials were 
demonstrated (A). However, by 4 weeks post implantation, significantly higher amounts 
of CD68+ cells were accumulated around neat PVA controls (light grey dashed line) than 
in the case of curcumin-releasing implants (dark grey solid line) up to 300 μm away from 
the implant interface (*p<0.04) (B). Similar to 2 weeks post implantation, no statistical 
differences between the two materials was noted at 12 weeks post implantation (C). Scale 
= 100 μm. Data is represented as an average ± s.e.m.  
4.4.10. Wound Healing (HMGB-1) 
Wound healing is a critical component following device implantation in the central 
nervous system. Recently, we demonstrated that acute suppression of wound healing 
events by anti-oxidant therapy was correlated with higher populations of viable neurons 
around implanted devices in the cortex.10 To investigate if curcumin-releasing implants 
support similar molecular mechanisms, the expression of high mobility group box-1 
 132 
(HMGB-1), a cytokine that has been shown to inhibit wound healing46, 47 was quantified 
at 2, 4 and 12 weeks post implantation.  
Notably, we found that curcumin-releasing implants had higher amounts of HMGB-1 at 
both 2 and 4 weeks in comparison to neat PVA control, with the highest amounts noted at 
2 weeks after implantation (Figure 4-10). By 12 weeks, however, the reverse trend was 
noted, where neat PVA implants had higher levels of HMGB-1 at the implant interface in 
comparison to curcumin-loaded implants. 
 
Figure 4-10. Expression of High Mobility Group Box-1 (HMGB-1) around neat PVA 
controls and curcumin-releasing PVA implants. A qualitative assessment of intra- and 
extracellular high mobility group box-1 (HMGB-1) expression was investigated around 
both polymers at 2, 4 and 12 weeks after implantation. At 2 weeks, animals with 
curcumin-releasing implants had slightly higher amounts of HMGB-1 at the device 
interface. Notably, high amounts (intra- and extracellular) of HMGB-1 were noted in 
both polymers at 4 weeks after implantation, with higher levels noted in animals 
receiving a 3% Cur/PVA implant. In contrast, by 12 weeks after implantation, neat PVA 
implants demonstrated larger amounts of HMGB-1 expression around the implant. 
Arrows denote extracellular accumulations of soluble HMGB-1 around implanted 
polymer samples. Scale = 100 μm. 
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4.5. DISCUSSION 
Intracortical microelectrodes have been developed from all classes of materials. 
Regardless of the combination of materials that have been employed, all suffer a similar 
fate. Early in the implant periods, activity of many neurons can be recorded. However, 
while such early results are encouraging, devices are often plagued by inconsistent long-
term recording stability and performance. Unfortunately, there has been much debate in 
the literature and conference circle over the mechanism of device failure.48-50 The debate 
has perpetuated primarily due to the believed inconsistency between the time course of 
the inflammatory response to the implant,5, 51-53 and the longest reported functional 
devices in animal and human models.54-56 57 58 In part due to the recent flux of funding by 
the Defense Advanced Research Projects Agency (DARPA), under the Histology for 
Interface Stability over Time program,14, 49, 59 several studies have been reported on the 
relative contribution of both the biotic and abiotic failure modes (not DARPA funded48). 
A number of failure modes likely influence chronic recording stability and quality, 
including 1) direct mechanical damage, 2) corrosion of electrical contacts, 3) degradation 
of passivation layers and insulating coatings, and 4) the neuro-inflammatory response that 
the brain mounts against chronically implanted devices.48-50 Utilizing 16-channel 50 µm 
tungsten microwire arrays, the Sanchez group assessed the biotic and abiotic failure 
modes of for up to 9 months in 25 rats.49 Their study concluded that mechanisms of 
failure were multi-faceted. Further, Sanchez felt that failure modes occur concurrently, 
and are incapable of isolation. Of note, Sanchez also reported a high level of ferritinin 
expression, intraparechymal bleeding and microglia degeneration; factors were attributed 
to oxidative stress.  
The Bellamkonda group has also linked oxidative stress to late-onset neurodegeneration 
at the microelectrode tissue interface.5 More recently, the Bellamkonda group has 
expended on their initial findings, and was among the first to demonstrate a direct 
correlation between electrode performance and the histological response.14 In agreement 
with the Sanchez group, Bellamkonda and team suggested that the blood-brain barrier 
status is the most critical physiological determinant of the performance of the 
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microelectrode.14 Further, Bellamkonda has demonstrated that increased expression of 
inflammatory signaling molecules, specifically cytokines and chemokines, directly 
correlate with histology and device performance.59 Findings from both Sanchez and 
Bellamkonda supported the seminal work by Biran et al. from 2005.52 In Biran’s study, 
the Tresco group demonstrated that microglia and macrophages cultured from explanted 
intracortical microelectrodes secreted increased levels of MCP-1 and TNF-α, both known 
to increase blood-brain barrier permeability in high levels. Most recently, the Donoghue 
group reported a 17 year retrospective of Utah electrode arrays in non-human primates.48 
In their extensive analysis, the Donoghue group reported that nearly half of the failed 
devices were acute mechanical failures. Mechanical failures can be largely due to the 
brittleness of the materials, and are a significant contributor to the recent exploration of 
polymeric alternatives to silicon and ceramic. Of the remaining failed devices, 46% of 
those were due to the biological response, 25% were reported as materials failure, and the 
remaining 28% were unknown. Degradation of insulating materials resulting in device 
failure can be catalyzed by the oxidative inflammatory response, further supporting 
finding by Sanchez stating that failure modes occur concurrently, and are incapable of 
isolation. The combined work of Sanchez, Bellamkonda, Tresco, Donoghue, and many 
more has directed the field to the significant interconnected role that both the blood-brain 
barrier and oxidative stress play on the performance of intracortical microelectrodes. 
Therefore, we have explored several mechanisms that have been suggested to either 
promote a decline in the stability of the blood-brain barrier or the inflammatory-mediated 
oxidative environment around intracortical microelectrodes. Specifically, we have 
previously shown that both anti-oxidative treatment and the use of mechanically adaptive 
materials are effective strategies to temporally mitigate the neuroinflammatory response 
to intracortical microelectrodes.8, 10 However, as discussed above, both mechanisms are 
interconnected, and synergistic approaches are yet to be reported. Here we investigated 
the use of anti-oxidant-releasing, mechanically adaptive polymers to begin to elucidate 
the potential use of a synergistic approach to address the variable neuronal viability and 
inflammatory processes.  
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Our group has developed physiologically-responsive, mechanically adaptive materials for 
use as “smart” substrates for intracortical microelectrodes,22, 26, 60 Our hypothesis is that 
mechanically adaptive materials are useful for intracortical microelectrodes that initially 
require a stiff material for easy insertion, but are chronically compliant to minimize strain 
on the surrounding brain tissue. Most of our reported materials are nanocomposites that 
are comprised of a polymeric matrix and reinforcing nanofibers. Our nanocomposite 
materials are engineered to be stimuli-responsive and regulate the mechanical properties 
of the bulk material. Among several materials series based on this architecture,25, 61, 62 we 
recently reported nanocomposites based on poly(vinyl alcohol) (PVA) and cellulose 
nanocrystals (CNCs) derived from tunicates.24 Unlike several of the polymer systems we 
have used previously, PVA has been FDA-approved for applications in nerve grafts.63 
Most processing conditions result in PVA that is water-soluble. However, the specific 
melt-processing protocol we employed renders the PVA materials water-insoluble. 
Additionally, curcumin is a natural polyphenol derived from the rhizome of the herb 
Curcuma longa having a wide range of therapeutic activities such as anti-cancer, anti-
inflammatory, anti-oxidant, wound healing, and neuroprotective effects.64, 65 Further, 
phase I clinical trials showed that curcumin is safe at very high doses (12 g/day) in 
humans.66, 67 Therefore, the system developed here utilized PVA and PVA/CNC 
nanocomposites capable of releasing curcumin short term.  
Prior to in vivo testing, the physiochemical characteristics (mechanical and thermal 
properties, swelling behavior), drug release, and anti-oxidant activity of a subset of four 
antioxidant-loaded PVA compositions with either 1% and 3% w/w curcumin and either 
no CNCs or 8% v/v CNCs were tested in vitro (ACSF, 37 °C). Swelling experiments in 
such emulated physiological conditions showed that the present materials swell by about 
30-40% w/w independent of the composition (Table 4-1). Further, all of the materials 
studied here undergo a pronounced and reversible modulus reduction from ~8-11 GPa to 
~1-130 MPa upon exposure to emulated physiological conditions (Figures 4-2 and A4-3). 
We have previously described that the reversible modulus change is due to matrix 
plasticization and/or decoupling of hydrogen bonding between CNCs. As expected based 
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on previous data, the CNC-containing nanocomposites show a higher tensile storage 
modulus in the ACSF-swollen state (~130 and ~40 MPa for materials containing 1% and 
3% w/w curcumin, respectively) than the CNC-free PVA loaded with the drug (~1 and 
~13 MPa). The higher modulus of PVA/CNC nanocomposites in emulated physiological 
conditions is consistent with demonstrated examples of modest reinforcement, even when 
the CNCs are decoupled.22 In vitro drug release studies were performed to establish the 
timeframe in which the curcumin is released under physiological conditions. Curcumin 
showed burst release kinetics from PVA films followed by a slower sustained release into 
the medium after 2 days (Figures 4-3 and A4-4). Qualitatively, the data match swelling-
induced release profiles.68 The fact that in all cases only a fraction of the incorporated 
drug is released from annealed PVA-matrices has been observed before,69 and was 
attributed to the semicrystalline nature of the matrix polymer, which hinders the diffusion 
of the drug molecules.70 The rate of curcumin release from these materials enables 
localized delivery of curcumin directly at the trauma site. Specifically, the size of cortical 
implants was capable of facilitating a localized release of 1.5 µM (1% curcumin 
containing polymers), 2.5 µM (3% curcumin loaded PVA/CNC) and 4.5 µM (3% 
curcumin loaded PVA) after 48 hours respectively. Since curcumin has previously shown 
to be effective in vitro from 0.1 µM to 5 µM,71, 72 all engineered polymer systems 
investigated here were capable of maintaining a therapeutic dose of curcumin for at least 
48 hours. Of the four anti-oxidant loaded samples studied, the two compositions loaded 
with 3% curcumin had higher DPPH scavenging activity than the materials with 1% 
curcumin. Since the 3% curcumin-loaded PVA demonstrated the largest mechanical 
contrast with the lowest stiffness after exposure to the physiological conditions (Figures 
4-2 and A4-3), is compositionally simpler than the nanocomposites, and displays a high 
absolute curcumin release, this composition was chosen for the in vivo studies. 
Specifically, 3% Cur/PVA and neat PVA intracortical probes were implanted into the 
motor cortex of rats and investigated the neuroinflammatory response surrounding the 
implant. Loss of viable neurons within 50 µm of the microelectrode could result in the 
inability to properly record individual neural activity 11. Therefore, we investigated the 
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effect our polymer system would have on the neuronal populations surrounding the 
intracortical implant. Notably, we found that the short-term release of curcumin from the 
implant directly impacted neuronal populations surrounding the device. Curcumin-loaded 
implants provided significant neuronal protection at both 2 and 4 weeks after 
implantation (Figure 4-5). In addition, we found that at 2 weeks post-implantation, neat 
PVA control implants were unable to return to sham background densities for all 
investigated binning intervals, except 400 to 500 µm from the implant. The incorporation 
of curcumin into the chronically compliant polymer implants resulted in neuronal 
recovery by 100 µm at 2 weeks post implantation, with only the binning interval of 400 
to 500 µm being significant from background densities. Similar trends were noted at 4 
weeks, where background neuronal densities were noted in all binning intervals for 
curcumin-loaded implants. In contrast, neat PVA control implants had significantly lower 
densities than background from 0 to 50 µm from the interface. Together, these results 
suggest that a mechanically compliant implant based on PVA was alone insufficient to 
maintain background densities of neurons around the implant, especially at 2 and 4 weeks 
following implantation. However, the incorporation of localized anti-oxidant, curcumin, 
aided in maintaining higher neuronal densities locally and globally around the implant.  
Fluctuations in neuronal populations around cortical implants have been shown to be 
time-dependent and directly correlated to the inflammatory response and vasculature 
stability following surgical implantation.5, 7, 73 Further, the use of anti-oxidants or 
mechanically compliant materials has shown variable effects on the neuroinflammatory 
response.8, 10 Therefore, in order to better characterize our new polymer system and gain 
insight into events mediating neuronal survival, neuroinflammatory and blood-brain 
barrier stability were monitored at three distinct time points during the inflammatory 
cascade.    
At 2 weeks after implantation, in comparison to neat PVA controls, curcumin-releasing 
implants were found to significantly reduce blood-brain barrier (BBB) permeability up to 
1000 µm from the implant interface (Figure 4-6). Interestingly, at the same time point, 
infiltration and activation of resident microglia/macrophages were statistically 
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insignificant between curcumin-loaded and neat PVA implants (Figures 4-8A, 4-9A). 
Additionally, animals receiving curcumin-loaded implants also exhibited a significantly 
more robust glial scar than animals implanted with neat PVA implants (Figure 4-7A). 
Many groups, including our own, have demonstrated the role of glial scar compaction 
and pro-inflammatory molecules on neuronal survival and BBB stability surrounding 
intracortical microelectrodes.7, 74, 75 In fact, it has been suggested that astrogliosis is 
critical in providing a physical barrier between neurotoxic cytokines and soluble factors 
released by activated microglia/macrophages and the neuronal environment.76 In 
addition, curcumin has been shown to up-regulate pathways responsible for the break-
down or down regulation of pro-inflammatory molecules in activated inflammatory 
cells.77 Therefore collectively, our results at 2 weeks further support the hypothesis that 
blood-brain barrier stability is associated with neuronal survival. Wherein, for our model, 
improvements in neuronal survival and BBB stability are due to a synergistic effect 
between glial scar compaction and/or a likely reduction of pro-inflammatory 
biomolecules accumulation from activated inflammatory cells. 
It is important to note, however, that within an inflammatory system a dichotomy 
between a pro- and anti-inflammatory state exists.78, 79 Therefore, therapeutic intervention 
within the system can bolster or deteriorate the surrounding tissue homeostasis depending 
on time of administration and therapeutic dosage. Specifically, Rennaker et al. 
demonstrated that short term dosing (5 days) with minocycline following intracortical 
microelectrode implantation was capable of sustaining a viable neuronal recording 
environment for up to 4 weeks after implantation.80 In addition, we recently demonstrated 
that dosing with resveratrol, a naturally derived anti-oxidant, the day before and after 
electrode implantation, could facilitate more viable neurons around intracortical 
microelectrodes for up to 4 weeks after implantation.10 Short-term therapeutic 
intervention in neurodegenerative disease models, such as traumatic brain injury and 
spinal cord injury, has also demonstrated similar neuroprotective effects.81, 82 Hence, it is 
not surprising that in our model, a short-term release of curcumin from polymer implants 
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resulted in conferred neuroprotection up to 4 weeks after surgical implantation (Figure 4-
5).  
However, neuronal populations surrounding intracortical microelectrodes have been 
shown to be multi-phasic, with lowest densities occurring at early (2 weeks) and late (>12 
weeks) time points.5, 7 Therefore, in order to fully determine if our polymer system was 
capable of providing long-term neuroprotection, we also investigated the 
neuroinflammatory response surrounding our PVA-based cortical implants at 12 weeks 
post-implantation. By 12 weeks, we found that both curcumin-loaded and neat PVA 
control implants had statistically similar neuronal populations at the interface, with 
statistical differences only noted at 100 to 200 µm away from the implant (Figure 4-5). 
Further, all other quantified neuroinflammatory markers were statistically comparable at 
the same time point between both polymer films. Together with the 2 and 4 week data, 
our data suggest that the short-term release of curcumin from the mechanically adaptive 
PVA system was unable to facilitate neuroprotection around the implant at late chronic 
time points. Specifically, in combination with our in vitro assessment, curcumin loaded 
polymer implants were only capable of releasing up to 4.5 µM for 48 hours after 
implantation. Due to this finding, we hypothesize that multiple exposures to an anti-
oxidant (localized or systemic) may be required to maintain neuroprotection around the 
device throughout the lifetime of the implant. Alternatively, the solubility of PVA may 
increase due to long-term exposure to harsh inflammatory cell laden environments, 
resulting in a delayed or secondary neuroinflammatory response. Consequently, we also 
propose that other mechanically adaptive polymer substrates be explored in combined 
anti-oxidant releasing systems. 
Further, we suggest that future design and use of mechanically adaptive polymer systems 
for neural interfaces must account for the degree of swelling demonstrated by the 
polymer systems. Here we found that our PVA polymer systems had a maximum 
swelling range of approximately 35% to 40%, but still had the ability to mediate the 
neuroinflammatory response occurring after cortical implantation. In addition, prior 
reports by our group and others have utilized polymer systems with similar or higher 
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degrees of swelling and also shown the ability of their various polymer systems in 
reducing the neuroinflammatory response to cortical implants.8, 83, 84 Thus, given the high 
potential our and similar polymer systems have had in stabilizing the neuroinflammatory 
response, we have previously reported on a manufacturing process to account for large 
degrees of swelling for mechanically adaptive polymer systems for the application of 
intracortical microelectrodes.26 Briefly, our previously described manufacturing 
processes would allow direct substitution of the silicon backbone for the mechanically 
adaptive polymer. Therefore, regardless of swelling, the electrical contacts along the 
device shank would still maintain functionality after implantation.     
Finally, curcumin has also been shown to impact wound healing.64, 85 Therefore, to 
examine the effects that curcumin-loaded implants had on wound healing in our 
intracortical microelectrode model, we investigated the expression of high mobility group 
box-1 (HMGB-1) around implanted polymer implants. Previous reports have shown 
HMGB-1 expression and release to be directly implicated in preventing collagen 
synthesis during wound healing.47 Notably, we found an increase of HMGB-1 expression 
around implanted curcumin-loaded PVA implants at 2 and 4 weeks in comparison to neat 
PVA controls (Figure 4-10). Interestingly, high levels of HMGB-1 expression were 
correlated with neuroprotection around the implants (Figure 4-5). Therefore, similar to 
our previous findings,10 a delayed wound healing response to intracortical implants may 
be beneficial in facilitating neuroprotection around the device. Further, given the 
similarities in neuronal populations between conditions at 12 weeks, our results suggest 
that initial delays in wound healing may not significantly affect the chronic response to 
the implanted device.  
4.6. CONCLUSIONS 
In summary, our results show that the incorporation of the anti-oxidant curcumin into the 
mechanically adaptive polymer poly(vinyl alcohol) provided significant improvements in 
neuronal densities surrounding cortical implants in comparison to neat polymer films up 
to 4 weeks after implantation. However, at 12 weeks post implantation, no significant 
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differences between curcumin-releasing and neat PVA reference implants were apparent 
for all investigated markers. Taken together, our results suggest that acute attenuation of 
inflammatory events using localized drug delivery mechanisms, such as release of 
curcumin, would not cause detrimental effects at more chronic time points. Further the 
results presented here provide exciting opportunities to better understand the importance 
and optimal timing of wound healing events around cortical implants such that neuronal 
degeneration is prevented. Building on our proof-of-concept study, we suggest that future 
studies should continue to investigate the use of mechanically adaptive polymer systems, 
in conjunction with anti-oxidant release to mediate acute and chronic neuroinflammatory 
events surrounding intracortical microelectrodes. In order to better understand if the 
effects of short-term local release of antioxidant therapies are sufficient for long-term 
neuroprotection surrounding intracortical microelectrodes, it is imperative that future 
studies investigate the use of additional anti-oxidants and alternative mechanically 
adaptive polymer systems with improved long-term in vivo stability.  
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4.8. APPENDIX 
Atomic Force Microscopy (AFM). Atomic force microscopy of CNCs was carried out 
on a NanoWizard II (JPK Instruments) microscope. 5 µL of the CNCs re-disperesed in 
DMSO (0.1 mg/ml, 30 min sonication) was placed on freshly cleaved mica (SPI Supplies 
Division of Structure Probe, Inc.) and allowed to dry. The scans were performed in 
tapping mode in air using silicon cantilevers (NANO WORLD, TESPA-50) with a scan 
rate of 1 line/sec. 
Transmission Electron Microscopy (TEM). The dimensions of the CNCs and the 
homogeneity of the CNC dispersion were examined by transmission electron microscopy 
(TEM) using a Hitachi H-1700 microscope operating at an accelerating voltage of 75 kV. 
To assess the CNCs dimensions, lyophilized CNCs were dispersed in deionized water at a 
concentration of 0.1 mg/mL by sonication. Subsequently, 3 µL of the aqueous CNC 
dispersions were deposited on carbon-coated grids (Electron Microscopy Sciences) and 
allowed to dry at 70 °C for 2 h. CNC dimensions were determined by analyzing 10 TEM 
images of CNCs with a total of more than 100 individual CNCs of which length and 
width were measured. The dimensions thus determined are reported as average values ± 
standard error. 
Differential scanning calorimetry Analysis. Differential scanning calorimetry (DSC, 
METTLER TOLEDO STAR) experiments were carried out under an N2 atmosphere. 
Heating and cooling cycles were conducted on a 10 mg film sample (-50 to 250 °C using 
a heating rate of 10 °C/min). The glass transition temperature (Tg) was defined as the 
temperature from the midpoint of the specific heat increment at the glass-rubber 
transition, while the melting temperature (Tm) was taken as the peak temperature of the 
melting endotherm. 
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Figure A4-1. (Left) AFM height image of CNCs derived from tunicates and deposited 
from DMSO re-dispersion (1 mg/mL) onto freshly cleaved mica surface. (Right) 
Representative transition electron microscopy (TEM) image of lyophilized CNCs, 
deposited from aqueous dispersions (0.1 mg/mL). 
 
Figure A4-2. Conductometric titration curve of lyophilized CNCs. Conductometric 
titrations were performed to quantify the density of surface charges of CNCs due to 
sulfate ester groups introduced during hydrolysis. 50 mg of the CNCs were suspended 
into 15 mL of aqueous 0.01 M hydrochloric acid (HCl). After 5 min of stirring and 30 
min of sonication, the suspensions were titrated with 0.01 M NaOH. The representative 
titration curve shows the presence of a strong acid, corresponding to the excess of HCl, 
and a weak acid corresponding to the sulfate ester surface groups (88 ± 3.0 mmol/kg). 
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Figure A4-3. Representative dynamic mechanical analysis (DMA) traces showing the 
tensile storage moduli of (A) dry and (B) wet curcumin-loaded PVA/CNCs polymers as a 
function of temperature. Average data of multiple experiments are compiled in Table A4-
2. 
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Figure A4-4. Cumulative in vitro release profile of curcumin-loaded materials in ACSF 
at 37 °C. Values represent mean ± S.D. (n = 4), and relative to the original nominal 
amount of curcumin in the materials. 
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Figure A4-5. (Top) Chemical structure of DPPH and its reaction with an anti-oxidant 
(AO-H). (Bottom) Representative photographs of solutions of DPPH in methanol (100 
μM, 3 mL) at 0, 9, 24 and 48 hours and after placing a film of the neat PVA control, or 
the curcumin-loaded PVA films into the DPPH solution. All samples were kept at 37 °C 
in the dark.  
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Figure A4-6. Representative photographs of solutions of DPPH in methanol (100 μM, 3 
mL) at 0, 9, 24 and 48 hours and after placing a film of the neat PVA/CNC control, or the 
curcumin-loaded PVA/CNC films into the DPPH solution. All samples were kept at 37 
°C in the dark.  
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Figure A4-7. (A) Plot showing the absorbance at 516 nm of a methanolic solution of 
DPPH (100 µM) as a function of time, and of the same solution in the presence of films 
consisting of the neat PVA/CNC nanocomposite, or the PVA/CNC nanocomposites with 
1 or 3% w/w curcumin, respectively, incubated at 37 °C in the dark for up to 48 hours. 
(B) DPPH scavenging activity calculated from the results shown in (A) according to 
equation 3. The results shown are means ± standard deviation of three independent 
experiments. 
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Table A4-1. Thermal properties of materials studied. 
Films Tg (°C) Tm (°C) ∆Hm (J/g) 𝜒! (%)a 
Neat PVA 68 218 46.5 28 
PVA/CNCs 80 215 44.6 31 
1% Cur/PVA 78 219 55.9 35 
3% Cur/PVA 78 220 50.2 32 
1% Cur/PVA/CNCs 82 216 47.2 33 
3% Cur/PVA/CNCs 88 219 44.9 32 
a The data obtained from the second heating scan of DSC measurements. aχc = (ΔHm)/(wΔH0), where w is 
the weight fraction of polymer matrix in the nanocomposites, ΔHm is the measured melting enthalpy and 
ΔH0 is the enthalpy of 100% crystalline PVA (161 J/g). 
 
 
 
 
 
Table A4-2. Tensile storage moduli (E’) of dry and ACSF-swollen films determined by 
dynamic mechanical analyzer.a 
Sample 
Drug 
Content 
(% w/w) 
E’ of dry materials E’ at 37 °C of ACSF-
swollen materials 
after 1 week in ACSF 
(MPa) 
at 25 °C (GPa) at 100 °C (GPa) 
Neat PVA  8.8 ± 0.7 1.0 ± 0.07 7.0 ± 5.0 
Cur/PVA 1 9.9 ± 0.9 1.2 ± 0.11 5.0 ± 4.0 
 3 9.3 ± 0.9 1.1 ± 0.19 13 ± 4.0 
PVA/CNCs  11.7 ± 0.5 3.3 ± 0.44 180 ± 80 
Cur/PVA/CNCs 1 11.6 ± 0.5 3.0 ± 0.14 130 ± 70 
 3 10.3 ± 0.6 2.4 ± 0.27 50 ± 15 
a Data represent averages (N = 3-5) ± s.d. 
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Chapter 5 – Physiologically Responsive Mechanically Adaptive 
Antioxidant-Releasing Nanocomposites for Cortical Implants with 
Improved Neural Integration   
 
5.1. ABSTRACT 
Building on previous findings that antioxidant treatment can prevent neurodegeneration 
and blood-brain barrier (BBB) breach around intracortical implants, and the hypothesis 
that the mechanical mismatch plays a dominant role in reactive gliosis at the 
implant/tissue interface, in-situ softening antioxidant-releasing polymeric materials were 
developed, which can serve to explore if the combination of two independently effective 
mechanisms – softening and antioxidant release – leads to synergistic effect in reducing 
the neuroinflammation at the intracortical microelectrode-tissue interface. A first series of 
curcumin-releasing mechanically adaptive implants based on poly(vinyl alcohol) (PVA) 
and optionally cellulose nanocrystals (CNCs) were reported in Chapter 4. An in-vivo 
study in rats showed that after 4 weeks, the new curcumin-releasing, mechanically 
adaptive implants promoted a higher neuron survival and a more stable BBB than the 
neat PVA controls, but the benefits of the curcumin release were lost after 12 weeks, 
where the antioxidant-releasing compliant materials caused no statistically significant 
differences in neuronal density distribution profiles viz the PVA reference. To explore to 
what extent the PVA matrix used in the study was responsible for this outcome, 
antioxidant-releasing, mechanically adaptive materials based on poly(vinyl acetate) 
(PVAc), CNCs, and the antioxidants curcumin or resveratrol were made and studied. 
Exposing the nanocomposites to (emulated) physiological conditions caused a drastic 
softening; the tensile storage modulus E’ was reduced form ca. ~6000 MPa (dry, 25 °C) 
to ~10 MPa. The ability of these physiologically responsive, mechanically adaptive 
nanocomposites to release the anti-oxidants was also studied. 
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5.2. INTRODUCTION 
Several types of medical devices are used within the central nervous system (CNS) with 
various levels of clinical success. In the case of intracortical microelectrodes, a decline in 
performance can be directly linked to the foreign body response to the implanted device.1, 
2 Previously, it was shown that the inflammatory response to intracortical microelectrodes 
has a biphasic response.3 Potter et al. reported that a single systemic administration of the 
antioxidant resveratrol can reduce the neuroinflammatory response at acute time points.4 
Additionally, our group has developed several generations of mechanically adaptive 
materials for use as substrates for intracortical microelectrodes.5-10 Such softening 
materials are useful in intracortical microelectrodes that initially require a stiff material 
for easy insertion, but benefit from subsequent softening upon exposure to physiological 
conditions so that the implant becomes mechanically more compatible with the 
surrounding soft brain tissue. Most of our reported materials are nanocomposites that are 
comprised of a polymeric matrix and reinforcing nanofillers, whose interactions are 
stimuli-responsive and regulate the mechanical properties of the bulk material. We have 
demonstrated that mechanically adaptive polymer implants are able to reduce the chronic 
neuroinflammatory response by reducing the mechanical mismatch between traditionally 
stiff microelectrode materials and neural tissue.11 Taken together, to date, it was shown 
that both antioxidative treatment and the use of mechanically compliant microelectrodes 
are strategies to temporally mitigate the neuroinflammatory response to intracortical 
microelectrodes.4, 11 
In order to explore if the combination of two independently effective mechanisms – 
softening and antioxidant release – leads to synergistic effect in reducing the 
neuroinflammation at the intracortical microelectrode-tissue interface, we recently 
developed a first series of curcumin-releasing mechanically adaptive implants based on 
poly(vinyl alcohol) (PVA) and optionally cellulose nanocrystals (CNCs) (Chapter 4).10 
An in-vivo study in rats showed that after 4 weeks, the new curcumin-releasing, 
mechanically adaptive implants promoted a higher neuron survival and a more stable 
BBB than the neat PVA controls, but the benefits of the curcumin release were lost after 
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12 weeks, where the antioxidant-releasing compliant materials caused no statistically 
significant differences in neuronal density distribution profiles viz the PVA reference. 
Thus, to date no approach has been able to provide continual neuroprotection, throughout 
the multiphasic tissue response that exists to implanted microelectrodes.3, 12 To explore to 
what extent the PVA matrix used in our study was responsible for this outcome, 
antioxidant-releasing, mechanically adaptive materials based on poly(vinyl acetate) 
(PVAc), CNCs, and the antioxidants curcumin or resveratrol were made and studied. The 
first in vivo evaluation of the neuro-inflammatory response to mechanically adaptable 
PVAc/CNC nanocomposites as substrate for penetrating microelectrodes was reported by 
Harris et al.11 Initial histological evaluations of these materials demonstrated that at four 
weeks post-implantation, compliant implants more rapidly stabilize neural cell 
populations within 200 µm of the implant than rigid, non-dynamic systems.11 
In addition to a wide range of therapeutic activities of curcumin, resveratrol is a natural 
polyphenol that found in red wine and grapes, which has several health benefits including 
anti-oxidant, anti-cancer, cardioprotective and anti-inflammatory effects.13 Recently, 
resveratrol has been shown to protect against various neurological disorders including 
brain ischemia, seizures, and neurodegenerative disease models,13 and to be capable of 
providing neuroprotection through its reactive oxygen species-scavenging properties 
towards activated microglia.14  
5.3. EXPERIMENTAL SECTION 
Materials. Pharmaceutical grade, 99% pure trans-resveratrol powder was purchased from 
Mega Resveratrol (Danbury, CT) and 99% pure curcumin was obtained from 
ChromaDex® (Figure 5-1). Poly(vinyl acetate) (PVAc, Mw = 100,000), 2,2-diphenyl-1-
picrylhydrazyl (DPPH), Triton-X 100, and all other reagents were purchased from Sigma 
Aldrich and were used without further purification. Cellulose nanocrystals (CNCs) in this 
study were isolated from tunicate (Styela clava) collected from floating docks in Point 
View Marina (Narragansett, RI), and prepared by sulfuric acid hydrolysis of the cellulose 
pulp, according to established protocols, as previously reported.9, 15 To simulate the ionic 
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composition of endogenous brain fluid, artificial cerebrospinal fluid (ACSF) was 
prepared following an established protocol16 by dissolving the following materials in one 
liter of deionized water: sodium chloride (NaCl) = 7.25 g, potassium chloride (KCl) = 
0.22 g, sodium bicarbonate (NaHCO3) = 2.18 g, calcium chloride dihydrate (CaCl2.2H2O) 
= 0.29 g, monopotassium phosphate (KH2PO4) = 0.17 g, magnesium sulfate heptahydrate 
(MgSO4.7H2O) = 0.25 g, and D-glucose = 1.80 g. 
 
Figure 5-1. Chemical structures of materials used in this study. 
Preparation of Antioxidant-Releasing Nanocomposites. A poly(vinyl acetate) (PVAc) 
stock solution was prepared by dissolving PVAc in dimethylformamide (DMF) at a 
concentration of 50 mg/mL by stirring for 3 hours at room temperature (RT). Similarly, 
stock solutions containing curcumin or resveratrol were made by separately dissolving 
the antioxidants in DMF (10 mg/mL) by stirring for 1 hour at RT. Lyophilized CNCs 
were dispersed in DMF at a concentration of 5 mg/mL by sonicating for 10 hours at room 
temperature using BANDELIN SONOREX TECHNIK RL 70 UH sonicator operating at 
40 kHz. Films containing either 0, 0.005, 0.01, 1.0 or 3.0% w/w of the antioxidant (i.e. 
curcumin or resveratrol) and 15% w/w CNCs were made by combining appropriate 
amounts of the above stock solutions, and CNC dispersion, and stirring the mixture for 30 
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minutes at RT. The mixtures were then cast into a Teflon® Petri dish, dried at 70 ºC for 5 
days and further dried at 120 ºC under high vacuum in an oven for an additional 24 hours 
to evaporate all of the solvent. After drying, nanocomposite films were compression-
molded between spacers in a Carver® laboratory press (1000 psi for 2 minutes, followed 
by an increase of pressure to 3000 psi for 10 minutes) at 90 ºC, to yield ~100 µm thin 
films. The drug-releasing films thus produced were stored in a desiccator at ambient 
temperature. 
Microscopy Studies. Atomic force microscopy (AFM) and transmission electron 
microscopy (TEM) were used to characterize the morphology and physical dimensions of 
the isolated CNCs. Atomic force microscopy of CNCs was carried out on a NanoWizard 
II (JPK Instruments) microscope. 5 µL of the CNCs re-dispersed in DMF (0.01 mg/mL, 
30 min sonication) was placed on freshly cleaved mica (SPI Supplies Division of 
Structure Probe, Inc.) and allowed to dry. The scans were performed in tapping mode in 
air using silicon cantilevers (NANO WORLD, TESPA-50) with a scan rate of 1 
line/second.  
A Hitachi H-1700 microscope operating at an accelerating voltage of 75 kV was used to 
examine the dimensions of the CNCs and the homogeneity of the CNC dispersion by 
TEM micrographs. To assess the CNCs dimensions, samples were prepared by dropping 
3 µL of the aqueous CNC dispersions (0.01 mg/mL) on carbon-coated grids (Electron 
Microscopy Sciences) and allowed to dry in an oven at 70 °C for 2 h. 
Swelling Behavior. The swelling behavior of the PVAc/CNC control nanocomposite and 
the antioxidant-loaded nanocomposite films was investigated by cutting the films into 
~30 mm × ~6 mm × ~100 µm rectangular strips and immersing the samples in artificial 
cerebrospinal fluid (ACSF) at the physiological temperature of 37 ºC for one week. After 
one week incubation in ACSF, the degree of swelling was calculated by comparing the 
weight of the films pre- and post-swelling: 
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Degree of swelling (%) =
(Ws - Wd)
Wd
 × 100                        (5− 1) 
where Wd is the weight of the dry film prior to swelling and Ws is the weight of the 
swollen film. After the swollen films were removed from the ACSF, the samples were 
briefly placed on a small piece of tissue paper to wick any excess ACSF from the surface, 
and the samples were immediately weighed. This experiment was repeated four times, 
and the results are expressed as mean ± standard deviation. 
Thermogravimetric Analysis. Thermogravimetric (TGA) analysis of the PVAc/CNC 
reference materials and the antioxidant releasing PVAc/CNC nanocomposites were 
performed with a thermogravimetric analyzer (Mettler Toledo STAR). Each sample (~10 
mg) was heated in an aluminum pan from 30 to 600 °C at a flow rate of 10 °C/min under 
nitrogen.  
Mechanical Characterization. The mechanical properties of the antioxidant-releasing 
nanocomposite films were characterized by dynamic mechanical analysis (DMA, TA 
Instruments, Model Q800). Tests were conducted in tensile mode, sweeping the 
temperature between 23-80 °C at a fixed frequency of 1 Hz, and using a strain amplitude 
of 15 µm, a heating rate of 5 °C/min. Samples for mechanical testing were prepared by 
cutting strips (~30 mm × ~6 mm × ~100 µm) from the films. To determine the 
mechanical properties of the films in the wet state, samples were first swelled in ACSF at 
37 °C for one week. After the degree of swelling had been measured, DMA experiments 
were conducted in submersion clamp using tensile mode, which allowed mechanical 
measurements while the nanocomposite films were immersed in ACSF. In submersion 
measurements, the temperature sweeps in the range of 25-50 °C with a heating rate of 1 
°C/min, a constant frequency of 1 Hz, and strain amplitude of 15 µm. These experiments 
were repeated five times, and the result was expressed as mean ± standard deviation. 
In vitro Drug Release. To determine the release rates of resveratrol or curcumin from the 
antioxidant-loaded nanocomposite films, samples (~30 mm × ~6 mm × ~100 µm) were 
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incubated at 37 °C in a mixture of 20 mL of 99.5% v/v ACSF and 0.5% v/v Tween-80, 
which was added to increase the solubility of the drug in the ACSF. In set time intervals 
(t=1, 2, 4, 6, 8, 10, 24, 29, 34, 48, 55, and 72 hours), 1 mL aliquots of the solutions were 
withdrawn, diluted with 1.5 mL of the neat solvent (99.5% v/v ACSF and 0.5% v/v 
Tween-80), and the amount of antioxidant released was detected spectrophotometrically 
(UV-vis 2401-PC spectrophotometer, Shimadzu). The concentration of antioxidant 
released was calculated using a calibration curve established by measuring the 
absorbance at 425 nm and 308 nm of solutions series of curcumin and resveratrol (5-30 
µg/mL) in ACSF/Tween 80, respectively. The amount of antioxidant released (relative to 
the amount of antioxidant originally present in the nanocomposites) was calculated using 
Equation 5-2, where [Antioxidant]UV is the concentration of the antioxidant measured by 
UV (mg/mL), VSample the volume of the sample in mL, WFilm the weight of the film in mg, 
and [Antioxidant]Film is the nominal concentration of the antioxidant in the film (mg/mg). 
This experiment was repeated four times, and the result was expressed as mean ± 
standard deviation. Antioxidant  Release   %   =    [Antioxidant]!"×  𝑉!"#$%&𝑊!"#$  ×[Antioxidant]!"#$     ×100                                    (5− 2) 
Measurement of Anti-Oxidative Activity of Antioxidant-Releasing Nanocomposites. 
The anti-oxidative activity of antioxidant-releasing nanocomposite films was assessed 
using 2,2-diphenyl-1-picrylhydrazyl (DPPH) following a previously reported method17 
with slight modifications. Here, the absorbance of DPPH, a stable free radical, at 516 nm 
was monitored to quantify the antioxidant activity of curcumin and resveratrol, which are 
known to reduce DPPH, and thereby decrease its absorbance at 516 nm. Briefly, the films 
were cut into rectangular pieces (~15 mm × ~6 mm × ~100 µm) and placed into a 20 mL 
methanolic solution of DPPH (100 µM). Samples were incubated at 37 ºC in the dark. 
The absorbance of the solution was measured spectrophotometrically at 516 nm in 
regular time intervals (t = 0, 1, 3, 5, 21, 25, 29, and 48 hours). The radical scavenging 
activity of curcumin-loaded films was expressed using Equation 5-3: 
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DPPH  Scavenging  Activity = 𝐴 − 𝐵𝐴                                            (5− 3) 
where A and B are the absorbance values at time t, of the neat DPPH solution (A) and the 
DPPH solution in the presence of the antioxidant loaded film (B), respectively. All 
samples were tested three times to ensure repeatability of measurements. 
5.4. RESULTS AND DISCUSSION 
5.4.1. Processing and Characterization of Materials 
The cellulose nanocrystals (CNCs) used in the present study were isolated form tunicates 
by sulfuric acid hydrolysis based on established protocols with a few modifications as 
previously reported.9 Atomic force microscopy (AFM) and transmission electron 
microscopy (TEM) were used to characterize the morphology and physical dimensions of 
the isolated CNCs (Figures 5-2 and A5-1). The dimensions of the CNCs, determined 
from TEM micrographs, were an average length and width of 2650 ± 1100 nm and 30 ± 
4, respectively (average aspect ratio ~88). The CNC dispersions, PVAc and stock 
solutions of the antioxidants resveratrol (Res) and curcumin (Cur) were combined, and 
after solution-casting, the resulting films were compression-molded to obtain 
nanocomposite films with 15% w/w CNCs and four different concentrations of 
antioxidant drug (0.005, 0.01, 1.0, and 3.0% w/w). Based on previous studies, PVAc 
nanocomposites with 16.5% v/v CNCs exhibited an adequate mechanical switching upon 
exposure to physiological conditions and upon implantation into cortical tissue (E' = 5.1 
GPa for a dry/pre-insertion and 12 MPa for ACSF-swollen nanocomposite).6, 7, 18 It was 
shown that dry implants of this nanocomposite can readily be inserted through the pia 
mater into the cerebral cortex of a rat without the need for assistive devices. Also, a range 
of antioxidant concentrations was used to test cytotoxicity at various resveratrol and 
curcumin concentrations to choose the optimal drug concentration for in vivo 
implantation. Figure 5-3 shows representative photographs of solution-cast antioxidant 
releasing nanocomposite films containing either 0.005% or 0.01% w/w of the 
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antioxidants. The morphology of the antioxidant-free reference nanocomposites was 
investigated by AFM imaging of ultrathin ﬁlms (~30 µm). Figure A5-2 shows the 
corresponding AFM images, in which individual CNCs can be clearly distinguished show 
a good homogeneous dispersion of CNCs in the PVAc matrix.  
 
Figure 5-2. Atomic force microscopy (AFM) image of lyophilized CNCs isolated from 
tunicates. The CNCs were deposited from aqueous dispersions (0.01 mg/mL) onto freshly 
cleaved mica surfaces.  
 
Figure 5-3. Photographs of solution-cast PVAc/CNC nanocomposite films (15% w/w 
CNCs) with either 0.005% or 0.01% w/w resveratrol (Res, A and B) or curcumin (Cur, C 
and D). 
 163 
The swelling behavior of the antioxidant-loaded (either with curcumin or resveratrol) and 
the PVAc/CNC control nanocomposites in (emulated) physiological conditions was 
investigated by immersing the materials into ACSF at 37 °C (Figure 5-4). As expected on 
the basis of previous studies on neat PVAc/CNC nanocomposites,7, 19 the water uptake 
was found to be ~75 - 85% w/w for all materials, and no dependence of the drug content 
or drug type is apparent. Additionally, the thermogravimetric properties of antioxidant-
loaded materials were determined using thermogravimetric analysis (TGA, Figure 5-5). 
The TGA curves show that the onset degradation for all nanocomposites was at 
approximately ~300 °C, confirmed that no solvent residues were present in the 
nanocomposite films after solution-casting and solvent evaporation. From the TGA 
analysis, it is clear that the processing technique for preparation of the antioxidant-loaded 
nanocomposite films presented in this study was reliable.  
 
 
Figure 5-4. Swelling behavior of PVAc/CNC nanocomposites (15% w/w CNCs) with 
different amounts of antioxidants after the films were immersed in ACSF at 37 °C for 1 
week. (N) neat PVAc/CNC nanocomposite; (C1) 0.005% w/w curcumin (Cur); (C2) 
0.01% w/w Cur; (C3) 1.0% w/w Cur; (C4) 3.0% w/w Cur; (R1) 0.005% w/w resveratrol 
(Res); (R2) 0.01% w/w Res; (R3) 1.0% w/w Res; and (R4) 3.0% w/w Res-loaded 
nanocomposites. Data represent averages of N = 3 measurements ± standard deviations.  
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Figure 5-5. Thermogravimetric analysis traces of (A) curcumin (Cur) and (B) resveratrol 
(Res) loaded PVAc/CNC nanocomposites (15% w/w CNCs) as a function of temperature.  
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5.4.2. Mechanically Adaptive Properties of Antioxidant-Loaded Materials 
The mechanical properties of both curcumin-loaded and resveratrol-loaded PVAc/CNC 
nanocomposite films were investigated using dynamic mechanical analysis (DMA). 
Figure 5-6 shows the tensile storage moduli (E’) of the antioxidant-loaded PVAc/CNC 
nanocomposites as well as the neat PVAc/CNC control nanocomposite film in the dry 
and ACSF-swollen state as a function of temperature. The curves reveal a nearly 
temperature-independent tensile storage modulus E’ of ~6000-6400 MPa below the glass 
transition temperature (Tg ~45 °C). E’ is reduced as the temperature is increased towards 
the Tg, and reaches a rubbery plateau above ~65 °C (Figure 5-6, Table 5-1).  
Table 5-1. Storage moduli (𝐸!) of dry and ACSF-swollen PVAc/CNC nanocomposites 
determined by DMA. Data represent averages (N = 5) and are shown for the neat 
PVAc/CNC reference nanocomposite as well as for curcumin (Cur) and resveratrol (Res) 
releasing nanocomposites loaded with different contents of these antioxidants. 
Nanocomposite 
Antioxidant 
Content 
(% w/w) 
Dry Nanocomposites Swollen Nanocomposites 𝐸! at 25 °C 
(MPa) 
𝐸! at 70 °C 
(MPa) 
𝐸! at 37 °C after 1 
week in ACSF (MPa) 
Neat PVAc/CNC  6300 ± 190 720 ± 180 13 ± 1.8 
Cur/PVAc/ CNC 0.005 6300 ± 270 930 ± 98 9.0 ± 2.5 
 0.01 6000 ± 300  810 ± 75 7.2 ± 3.2 
 1.0 6100 ± 27 680 ± 45 10 ± 1.0 
 3.0 6346 ± 100 740 ± 99 14 ± 1.4 
Res/PVAc/CNC 0.005 6100 ± 350 970 ± 72 7.0 ± 3.6 
 0.01 6050 ± 140 900 ± 85 6.0 ± 1.5 
 1.0 6100 ± 197 851 ± 67 13 ± 2.0 
 3.0 6340 ± 135 840 ± 205 14 ± 2.5 
All of the materials studied undergo a pronounced modulus reduction from ~6000 MPa to 
~10 MPa upon exposure to (emulated) physiological conditions, due to matrix 
plasticization and/or decoupling of CNCs on account of competitive hydrogen bonding 
with water. For example, the 3% w/w Cur/PVAc/CNC nanocomposite films display a 
reduction of E’ from 6346 MPa (dry, RT) to 14 MPa (ACSF-swollen, 37 °C), and the 3% 
w/w Res/PVA/CNC nanocomposite films exhibit a similar reduction of E’ from 6340 
MPa (dry, RT) to 14 MPa (ACSF-swollen, 37 °C) (Figure 5-6, and Table 5-1). Table 5-1 
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shows that in the compositional range studied, neither the amount nor the nature of the 
antioxidant had a significant influence on the mechanical properties. Thus, mechanical 
analysis confirm that all materials studied here are rigid when dry, but soften 
considerably upon swelling in (emulated) physiological conditions, as targeted for the 
intended penetrating intracortical microelectrode applications.  
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Figure 5-6. Representative dynamic mechanical analysis (DMA) traces showing the 
storage moduli E’ of (A) dry Cur/PVAc/CNC, (B) dry Res/PVAc/CNC, (C) ACSF-
swollen Cur/PVAc/CNC, and (D) ACSF-swollen Res/PVAc/CNC nanocomposites as a 
function of temperature and drug content (0.005, 0.01, 1.0 or 3.0% w/w). The neat 
PVAc/CNC nanocomposite was also studied for reference purposes and all PVAc/CNC 
nanocomposites contain 15% w/w CNCs. Average data of multiple experiments are 
compiled in Table 5-1.  
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5.4.3. Drug Release Studies 
In vitro antioxidant release studies were performed to establish the timeframe in which 
the antioxidants are released from the nanocomposites under (emulated) physiological 
conditions. The release studies were carried out by submersing antioxidant-loaded 
nanocomposite films in ACSF at 37 °C and monitoring the UV absorbance of curcumin 
and resveratrol in the supernatant solution as a function of time. The cumulative release 
percentage, relative to the total amount of antioxidants nominally included in the 
composition, is shown in Table 5-2. After the drug release experiments were carried out, 
the drug-loaded films were found to be colorless, indicating that almost all of the 
antioxidants loaded in PVAc/CNC nanocomposite films were released (100% release) 
into the medium within a timeframe of ~70 hours. While, only about ~45% w/w of the 
curcumin and ~60% w/w of the resveratrol comprised in the nanocomposites was 
detected by UV-vis after 72 hours (See Table 5-2).  
Table 5-2. Cumulative release (%) data of curcumin (Cur)-loaded PVAc/CNC 
nanocomposites and resveratrol (Res)-loaded PVAc/CNC nanocomposites in ACSF at 37 
°C determined by UV-vis. All PVAc/CNC nanocomposites contain 15% w/w CNCs and 
1 or 3% Cur or Res, as indicated in the Table. Values represent means ± standard 
deviations of N = 4 experiments, and relative to the original nominal amount of drug 
loaded in the nanocomposites. 
Time 
(hour) 
1% w/w 
Cur/PVAc/CNCs 
3% w/w 
Cur/PVAc/CNCs 
1% w/w 
Res/PVAc/CNCs 
3% w/w  
Res/PVAc/CNCs 
1 5.4 ± 1.6 3.0 ± 0.9 10.9 ± 2.2 6.7 ± 0.4 
2 7.5 ± 2.0 4.1 ± 0.9 13.3 ± 3.3 10.1 ± 0.7 
4 9.6 ± 2.6 8.4 ± 0.4 19.8 ± 0.8 15.1 ± 2.2 
6 16.5 ± 2.6 12.4 ± 0.6 24.0 ± 0.8 20.2 ± 1.8 
8 17.9 ± 1.5 14.9 ± 0.8 27.8 ± 1.6 23.2 ± 3.4 
10 19.9 ± 2.9 18.0 ± 0.3 30.7 ± 4.5 27.3 ± 4.4 
24 31.3 ± 2.4 32.5 ± 2.7 45.8 ± 5.5 44.0 ± 5.1 
29 32.4 ± 3.0 34.5 ± 2.8 47.0 ± 5.2 47.8 ± 2.4 
34 34.7 ± 3.5 37.5 ± 1.8 50.1 ± 3.5 50.0 ± 4.8 
48 43.4 ± 3.7 42.0 ± 2.0 59.1 ± 4.1 55.4 ± 4.6 
55 44.9 ± 4.2 43.8 ± 2.4 61.2 ± 4.2 56.8 ± 5.2 
72 48.7 ± 4.8 46.1 ± 1.9 64.3 ± 4.0 59.4 ± 4.6 
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The fact that the percentage of the weight of antioxidants released from the drug-loaded 
nanocomposite films was lower than 100% w/w could be due to a number of factors, e.g., 
decomposition of fractional amount of the antioxidants during processing conditions 
which can cause undesirable hydrolysis reactions in the active antioxidant compounds. 
Several factors have been reported in the literature regarding to the degradation of either 
curcumin or resveratrol such as light, solvents or pH conditions.20, 21 We found (data not 
shown) that antioxidants studied here are decomposed upon exposure the antioxidant 
solutions (dissolved in DMF) to oxygen at room temperature. Based on these results, the 
data presented in Table 5-2 were normalized as antioxidant released percentage versus 
time (Figure 5-7). Additionally, as expected, the absolute amount released from the films 
scaled with the drug content; the 3% curcumin-loaded nanocomposite films released ca. 
3.0 times more curcumin than the 1% curcumin-loaded PVAc/CNC films and the 3% 
resveratrol-loaded nanocomposite films released ca. 3.5 times more resveratrol than the 
1% resveratrol-loaded nanocomposite films after 72 hours incubation in ACSF at 37 °C. 
In comparison to our previous poly(vinyl alcohol) (PVA) drug-releasing generation, the 
antioxidant release from the PVAc-based nanocomposites studied here is slower and 
qualitatively higher than PVA-based nanocomposites after 50 hours incubation in 
physiological conditions. For example, 3% Cur/PVA/CNC nanocomposites released only 
about ~25% w/w of the curcumin comprised in the film even after 50 hours, while 3% 
Cur/PVAc/CNC nanocomposites released ~45% w/w of the curcumin relative to the total 
amount of curcumin nominally incorporated in the film. This is indeed attributed to the 
semicrystalline nature of the polymer matrix PVA, which hinders the diffusion of the 
drug molecules.22 Unfortunately, it was not possible to detect the release of the 
antioxidants photometrically in low dose nanocomposites (0.005 and 0.01% w/w) due to 
the limited sensitivity of the technique. Assuming the same drug release profile, the drug-
loaded nanocomposite films were tested further by DPPH scavenging assay to investigate 
the materials antioxidant activity in vitro.  
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Figure 5-7. Drug release percentage (normalized drug release) of (A) curcumin (Cur)-
loaded PVAc/CNC nanocomposites and (B) resveratrol (Res)-loaded PVAc/CNC 
nanocomposites in ACSF at 37 °C. All PVAc/CNC nanocomposites contain 15% w/w 
CNCs and 1 or 3% Cur or Res, as indicated in the figure. Values represent means ± 
standard deviations of N = 4 experiments. 
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5.4.4. Antioxidative Activity of Drug-Loaded Nanocomposites 
The DPPH scavenging assay was employed to test the antioxidant activity of the 
nanocomposites studied. DPPH is a stable free radical with an absorption band at 516 nm, 
which loses this adsorption in the presence of antioxidants.23 This results in a noticeable 
discoloration of DPPH from purple to yellow (Figure 5-8). The corresponding reaction 
can be readily monitored spectrophotometrically (Figure 5-9). It was found that the 
absorbance of DPPH alone decline over the period of the experiments in the absence of 
any antioxidant-loaded nanocomposite films, which is due to slow reaction with the 
hydrogen-donating solvent (i.e. methanol),24 and requires that the spectroscopic 
scavenging data are referenced to this baseline. The function did not change when films 
of the PVAc/CNC control nanocomposites were placed into the DPPH solution (Figure 5-
9). By contrast, the decrease was accelerated in the case of PVA/CNC loaded with either 
1% w/w curcumin or resveratrol, and even more so in the case of nanocomposite films 
comprising 3% w/w antioxidants (Figures 5-9A and B). The relative antioxidant activity 
of the curcumin-loaded PVAc/CNC nanocomposites containing 1% curcumin after 21 h 
incubation in methanol was ~0.7, while that of the resveratrol-loaded PVAc/CNC 
nanocomposites containing 3% resveratrol was ~0.6 (Figures 5-9C and D). Based on our 
previous studies,10 there is indeed no correlation between the drug release kinetic and the 
antioxidant activity of the drugs, however, there is a clear correlation between the 
antioxidant activity and the relative amount of the drug incorporated in the 
nanocomposite films (Figures 5-8 and 5-9). 
The results on the DPPH scavenging ability of the antioxidant-loaded materials confirm 
that the activity of the antioxidants was not affected during material processing. The 
percentage of DPPH free radical scavenging shows a linear increase with increasing 
concentration of antioxidants in the nanocomposite films. Of the eight tested antioxidant-
loaded materials, the 3% w/w antioxidant-containing PVAc/CNC nanocomposites were 
the most effective compositions in scavenging all the DPPH radicals within 5 hours of 
incubation. This is simply due to the antioxidant concentration released into the medium 
was significantly higher than the free DPPH radicals available in the medium. For 
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example, 3% Cur/PVAc/CNC scavenged all the free radicals (100%) of the DPPH within 
5 hours of incubation at 37 °C, while 0.005% Cur/PVAc/CNC scavenged ~4.3% of the 
DPPH after 48 hours. By contrast, resveratrol-loaded PVA/CNC nanocomposites with 
0.005% and 3% w/w resveratrol showed ~2.4% (after 48 hours) and 100% scavenging 
activity (after 5 hours), respectively. In addition to this, DPPH assay studies showed that 
curcumin has greater antioxidant activity than resveratrol, for example 3% 
Cur/PVAc/CNC scavenged ~78% of the DPPH radicals after 1 hour incubation at 37 °C, 
while 3% Res/PVAc/CNC scavenged ~73% of the DPPH radical. This is consistent with 
the literature which already has been reported that curcumin has potent antioxidant 
activity compared to other well-known antioxidants such as resveratrol and quercetin.25 
 
 
Figure 5-8. Representative photographs of solutions of DPPH in methanol (100 μM, 3 
mL) at time t = 0 (A) and 1 h (B) and after placing films of the neat PVAc/CNC control 
(C), or the PVAc/CNC nanocomposites with 3% w/w Res (D), or 3% w/w Cur (E) into 
the DPPH solution after 1 h. All samples were kept at 37 °C in the dark. All PVAc/CNC 
nanocomposites contain 15% w/w CNCs. 
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Figure 5-9. (A, B) Plots showing the absorbance at 516 nm of a methanolic solution of 
DPPH (100 μM) as function of time, and of the same solution in the presence of 
nanocomposite films consisting of the neat PVAc/CNC reference nanocomposite, or 
PVAc/CNC nanocomposites with different content of curcumin (Cur, A) or resveratrol 
(Res, B), respectively. (C, D) DPPH scavenging activity of curcumin-loaded (C) or 
resveratrol-loaded nanocomposites (D) calculated from the data shown in (A) and (B) 
according to equation 3. The results shown are means ± standard deviations of N = 3 
experiments. All PVAc/CNC nanocomposites contain 15% w/w CNCs. 
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5.5. CONCLUSIONS 
There are a variety of factors that contribute to the neuroinflammatory response to 
intracortical microelectrodes. Therefore, a synergistic approach addressing various 
aspects of the foreign body response is needed to improve material design and long-term 
performance for neural implants. Our system utilizes anti-oxidant therapy and material 
modulus to affect the inflammatory response at acute time points. In summary, 
biologically-inspired mechanically adaptive nanocomposites based on PVAc and CNCs 
with the capability to release natural anti-oxidant agents (i.e. curcumin or resveratrol) 
locally within 72 hours of incubation in emulated physiological conditions. The 
nanocomposites soften substantially upon immersion in artificial cerebrospinal fluid at 
body temperature; tensile modulus reduced form ~6000 MPa to ~10 MPa (~600-fold). 
Additionally, curcumin-releasing mechanically adaptive nanocomposite exhibited greater 
antioxidant activity in vitro than their counterparts. Ongoing in vivo histological studies 
tend to quantify the benefits of synergistic effects of mechanically adaptive materials 
combined with anti-oxidant releasing properties to mediate acute neuroinflammatory 
events surrounding intracrotical microelectrodes. 
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5.7. APPENDIX 
 
 
Figure A5-1. Representative transition electron microscopy (TEM) image of CNCs 
isolated from tunicates. For TEM imaging, lyophilized CNCs were re-dispersed in water 
at a concentration of 0.01 mg/mL and was deposited on carbon-coated grids. 
 
 
 
 
Figure A5-2. Atomic force microscopy (AFM) images of a PVAc/CNC nanocomposite 
film showing the dispersion of cellulose nanocrystals within the polymer matrix as made 
surface.
 
 
178 
Chapter 6 – Physiologically Responsive Mechanically Adaptive Polymer 
Optical Fibers for Optogenetics4 
 
6.1. ABSTRACT 
The capability to deliver light to specific locations within the brain using optogenetic 
tools has opened up new possibilities in the field of neural interfacing. In this context, 
optical fibers are commonly inserted into the brain to activate or mute neurons using 
photosensitive proteins. While chronic optogenetic stimulation studies are just beginning 
to emerge, knowledge gathered in connection with electrophysiological implants suggests 
that the mechanical mismatch of conventional optical fibers and the cortical tissue may 
be a significant contributor to neuroinflammatory response. We here present the design 
and fabrication of physiologically responsive mechanically adaptive optical fibers made 
of poly(vinyl alcohol) (PVA) that may mitigate this problem. Produced by a one-step dry-
jet wet-spinning process, the fibers display a tensile storage modulus, E’ of ~7000 MPa in 
the dry state at 25 °C and can thus readily be inserted into cortical tissue. Exposure to 
water causes a drastic reduction of E’ to ~35 MPa, on account of modest swelling with 
the water. The optical properties at 470 and 590 were comparable with losses of 0.7 ± 
0.04 dB/cm at 470 nm and 0.6 ± 0.1 dB/cm at 590 nm in the dry and 1.1 ± 0.1 dB/cm at 
470 nm and 0.9 ± 0.3 dB/cm at 590 nm in the wet state. The dry end of a partially 
switched fiber of a length of 10 cm was coupled with a light-emitting diode with an 
output of 10.1 mW to deliver light with a power density of  >500 mW/cm2 from the wet 
end, which is more than sufficient to stimulate neurons in vivo. Thus, even without a low-
refractive index cladding, the physiologically responsive mechanically adaptive optical 
fibers presented here appear to be a most useful new tool for future optogenetic studies. 
                                                
4This chapter is adopted from Jorfi, M.; Voirin, G.; Foster, E.J.; Weder, C. Opt. Lett. 2014, 39, 2872-2875.   
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6.2. INTRODUCTION 
Neural interfaces, which (re)connect the brain with the outside world, are enabling tools 
for studies of the brain function and also essential elements for a broad range of clinical 
applications.1 While intracortical microelectrodes, which can electrically record or 
stimulate the activity of individual or small populations of neurons, have been known for 
decades,2 the discovery that optical signals can be used to interface with neurons is a 
more recent development. In particular the possibility to activate or mute neurons using 
photosensitive proteins has opened up new possibilities in the field of neural interfacing.3 
Optogenetic technology is thus generating considerable excitement in neuroscience and 
biomedical engineering, and has quickly become a widely used toolbox to investigate the 
brain function and behavior in a broad variety of organisms that ranges from zebrafish to 
rodents to nonhuman primates.4-7 
The majority of optogenetics studies conducted in vivo use optical fibers, which are often 
guided through an implanted cannula and/or combined with a tungsten microelectrode.8, 9 
In a recent study, Zorzos et al. extended the design concept to three-dimensional micro-
waveguides, which are capable of delivering light to targets distributed in a 3D pattern 
throughout the brain.10 While such optical interfaces have successfully been used in many 
short-term animal experiments, long-term in vivo studies are only emerging.11, 12 The 
possibility to use optogenetic tools under chronic conditions, ideally in freely moving 
animals and with minimal neuroinflammatory response, is desirable for both fundamental 
studies and possible clinical applications, but reliable chronic interfaces have proved 
difficult to realize.13 A growing body of work gathered in connection with 
electrophysiological implants suggests that the mechanical mismatch of rigid neural 
implants and the much softer cortical tissue is a contributing factor to the cell-mediated 
inflammatory responses, neuronal dieback, and eventual encapsulation of cortical 
implants.13, 14 One can speculate that the mechanical mismatch of conventional optical 
fibers and the cortical tissue may cause similar effects in chronic optogenetic 
applications. One recent approach to alleviate the problems arising from such mechanical 
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mismatch between neural microelectrodes and the cortical tissue is the development of 
physiologically responsive mechanically adaptive materials, which are sufficiently rigid 
to permit insertion of small-diameter implants, but which soften considerably upon 
exposure to emulated physiological conditions.15-18 Such adaptive materials can be made 
by creating nanocomposites consisting of polymers and rigid nanofillers, in which the 
interactions between the nanofiller particles, and therewith the overall mechanical 
properties, can be influenced by exposure to water.19-22 For example, the tensile storage 
modulus (E’) of nanocomposites based on poly(vinyl alcohol) (PVA) and cellulose 
nanocrystals is reduced from ~14 GPa in the dry state at room temperature to ~10 MPa 
upon exposure to simulated physiological conditions.23 Since the introduction of 
nanocellulose into polymers is normally accompanied by increased light scattering, such 
nanocomposites are not well suited as basis for adaptive optical fibers and alternative 
design approaches are needed. 
Poly(vinyl alcohol) (PVA) has been used in a wide variety of biomedical applications 
including contact lenses24, 25 and FDA-approved nerve grafts.26 We have recently shown 
that heat-treated, water-insoluble PVA shows water-induced mechanical switching, on 
account of plasticization upon minimal swelling.23, 27 Here we report the fabrication and 
characteristics of physiologically responsive, mechanically adaptive optical fibers based 
on PVA, which were fabricated by dry-jet wet-spinning and subsequent annealing. 
6.3. EXPERIMENTAL SECTION 
Materials. Poly(vinyl alcohol) (PVA, 99% hydrolyzed, Mw = 85000−124000 g/mol) and 
all the chemical reagents were purchased from Sigma Aldrich and were used without 
further purifications.  
Fabrication of Optical Fibers. A dry-jet wet-spinning process was used to spin a 10 
mg/mL solution of PVA in a 4:1 v/v DMSO/water mixture into a coagulation bath of 
methanol cooled to -20 °C, using a spinneret with a diameter of 0.8 mm and a flow rate 
of 0.36 mL/min. The as-spun PVA fibers were kept immersed in the coagulation bath for 
 
 
181 
24 h at -20 °C and for another 24 h at room temperature. The methanol-swollen fibers 
were subsequently aligned and fixated on an aluminum sheet, dried for 24 h in an oven at 
50 °C, and finally heat-treated at 150 °C for 15 min. 
Microscopy Studies. To measure the morphology and dimensions of the PVA optical 
fibers, optical microscopy images were taken on Olympus BX51 microscope equipped 
with DP72 digital camera. 
Swelling Behavior. To evaluate the swelling behavior of the optical fibers in water at 37 
°C, the degree of swelling was calculated by measuring the weight of the fibers pre- and 
post-swelling:  
Degree of swelling  (%)  = (𝑊! - 𝑊!)𝑊!  ×  100                 6− 1  
Where Wd is the weight of the dry film before swelling, and Ws is the weight of the 
swollen film at a deﬁnite time interval. To minimize the error in measuring the degree of 
swelling, once the swollen films were taken out of the water, they were placed on paper 
tissue to wick any excess water from the surface; the samples were then immediately 
weighed.  
Dynamic Mechanical Analyses. DMA measurements of the commercial single mode 
optical fibers and the PVA fibers were performed using a TA Instruments Model Q800 
dynamic mechanical analyzer. All tests were carried out in tensile mode using a 
temperature sweep method from 0 ºC to 140 ºC and applying an oscillatory deformation 
with a frequency of 1 Hz and a strain with an amplitude of 15 µm. To determine the 
mechanical properties of the water-swollen optical fibers in the wet state, the fibers were 
first immersed in water at 37 °C for 1 day. Then, the mechanical tests were conducted in 
a submersion clamp, which allowed measurements while the fibers were immersed in 
water. In this method, the temperature sweeps were done in the range of 23-60 °C with a 
heating rate of 1 °C/min, and a strain amplitude of 15 µm using the tensile mode. 
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Optical Measurements. Blue (470 nm, M470F1, 10.1 mW, ThorLabs) and amber (590 
nm, M590F1, 3.2 mW, ThorLabs) fiber-coupled high-power LEDs were used to 
characterize the PVA fibers’ optical properties. The light transmission of the PVA fibers 
was quantified by determining the loss of light using a cutback method,28, 29 in which the 
optical fibers were truncated and the intensity of the transmitted light was measured using 
a photodiode (S120VC, ThorLabs) coupled with a photometer (PM100USB, ThorLabs). 
To characterize the optical properties in the wet state, the fiber was threaded through two 
ferrules embedded in opposite windows of a 1 cm x 1 cm x 5 cm polystyrene cuvette 
such that the two fiber extremities remained dry while the middle portion could be 
exposed to a fluid.  
6.4. RESULTS AND DISCUSSION 
The various steps of the fabrication process employed are schematically shown in Figure 
6-1. A dry-jet wet-spinning process was used to spin a 10 mg/mL solution of in a 4:1 v/v 
DMSO/water mixture into a coagulation bath of methanol cooled to -20 °C, using a 
spinneret with a diameter of 0.8 mm and a flow rate of 0.36 mL/min. The as-spun PVA 
fibers were kept immersed in the coagulation bath for 24 h at -20 °C and for another 24 h 
at room temperature. The methanol-swollen fibers were subsequently aligned and fixated 
on an aluminum sheet, dried for 24 h in an oven at 50 °C, and finally heat-treated at 150 
°C for 15 min. This method afforded fibers with a diameter of ~150 µm. Optical 
microscopy images show rather homogeneous cross-sections and smooth surfaces (Figure 
6-2a,b), while polarized optical microscopy images reveal a high degree of uniaxial 
orientation (Figure 6-2c,d). For this initial study no further cladding was used. 
The swelling behavior of the PVA fibers was investigated by immersing them in 
deionized water at physiological temperature of 37 °C for one day. After one day of 
incubation in water, the degree of swelling was determined by measuring the weight of 
the fibers pre- and post- swelling as reported before,23 yielding an equilibrium water 
uptake of 35 ± 4.5% w/w.  
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Figure 6-1. Schematic representation of the various processing steps used to fabricate 
physiologically-responsive, mechanically adaptive optical fibers based on PVA. 
Dynamic mechanical analysis (DMA) experiments were carried out to determine the 
tensile storage modulus (E’) of the fibers in the dry and wet state. The adaptive PVA 
fibers display an initial tensile storage modulus E’ of 7100 ± 230 MPa (dry state at 25 °C, 
Figure 6-3), which is reduced as the temperature is increased above the Tg (~68 °C) to 
reach a rubbery plateau with an E’ of 1630 ± 400 MPa at 100 °C (data not shown, N = 3). 
Upon immersion in deionized water for 1 day at 37 °C, the PVA fibers softened 
substantially to reach an E’ of ~35 MPa after equilibration.  
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Figure 6-2. Optical microscopic images of a PVA optical fiber (a, b). Cross-polarized 
optical micrographs of a PVA optical fiber arranged with its long axis oriented with 
angles of 45° (c) and 0° (d) relative to the analyzer; the orientation of the polarizers (solid 
arrows) and sample (dashed arrows) is also shown. 
Figure 6-3 shows time-dependent measurements of the tensile storage modulus E’ of a 
PVA fiber and a single mode optical fiber which is a silica core coated with dual acrylate 
(S405-XP, ThorLabs) as reference, starting in the dry state at room temperature and upon 
addition of water at 37 °C. In the case of the PVA fiber, a rapid (4 min) decrease of E’ is 
observed, while the mechanical properties of the conventional SM optical fiber remain 
unchanged. Thus, mechanical tests confirm unequivocally that the PVA fibers 
investigated here are rigid when dry, but soften considerably upon swelling in water. 
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Figure 6-3. Tensile storage modulus (E’) of an adaptive PVA fiber and a commercial 
single mode (SM) optical fiber (S405-XP, ThorLabs) as a function of immersion time in 
water at 37 °C. The water was added after 3.5 min, as indicated in the figure. 
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Figure 6-4. Optical losses of PVA optical fibers in the dry and wet state as function of 
fiber length. Data are shown for 470 (dry,  ; wet,  ) and 590 nm (dry,  ; wet,  ) incide-
nt light and represent of N=5 samples ± standard deviation. Solid (470 nm) and dashed 
(590 nm) lines are least square fits. The inset shows a photograph of a fiber transmitting 
590 nm light in the dry, rigid state. 
Blue (470 nm, M470F1, 10.1 mW, ThorLabs) and amber (590 nm, M590F1, 3.2 mW, 
ThorLabs) fiber-coupled high-power LEDs were used to demonstrate the PVA fibers’ 
ability to deliver light of different wavelengths as they are commonly used in optogenetic 
applications. The light transmission of the PVA fibers was quantified by determining the 
loss of light using a cutback method,28, 29 in which the optical fibers were truncated and 
the intensity of the transmitted light was measured using a photodiode (S120VC, 
ThorLabs) coupled with a photometer (PM100USB, ThorLabs). Figure 6-4 shows the 
light loss as function of fiber length, wavelength, and switching state. The propagation 
losses determined through linear regression of the data sets are 0.7 ± 0.04 dB/cm at 470 
nm and 0.6 ± 0.1 dB/cm at 590 nm (N = 5) in the dry state. 
 
Figure 6-5. (a) Schematic representation of the cell used to operate optical fibers in the 
dry and water-swollen state. (b, c) Photographs of a 5 cm long PVA fiber transmitting 
470 nm light in the dry state (b) and after adding water of a temperature of 25 °C (c). 
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The setup sketched in Figure 6-5a was used to measure the optical transmission through 
the fibers in the rigid dry and wet soft state. The fiber was threaded through two ferrules 
embedded in opposite windows of a 1 cm x 1 cm x 5 cm polystyrene cuvette such that the 
two fiber extremities remained dry while the middle portion could be exposed to a fluid. 
Light from a 470 nm LED with an output of 10.1 mW was coupled into one end of the 
fiber. Figures 6-5b and 6-5c, which show the setup in the dry and water-filled state, 
reveal no qualitative differences in light transmission and scattering. However, in the 
water-swollen state the PVA fiber can be readily bent (Figure 6-5c). Figure 6-6 shows 
how the transmitted power and power density change over time as the fiber is repeatedly 
softened by addition of deionized water, and rigidified upon drying. In a first 5 h dry 
phase, light transmission is stable as expected. Upon addition of water (refractive index n 
= 1.33) a brief increase of the transmitted power (density) of ~10% is observed, which is 
likely related to increased total internal reflection in the fiber (n = 1.46). Upon 
swelling/softening, the transmission is rapidly decreased by ~15%. We speculate that the 
reduction of the fibers’ refractive index on account of swelling with water (n = 1.33) and 
reduced total internal reflection as well increased scattering effects contribute to these 
relatively small losses; a similar trend was observed by Dupuis et al. for microstructured 
polymer optical fibers made form cellulose butyrate 30. Figure 6-6 shows that drying and 
another wetting and drying cycle permitted to reversibly switch the transmission 
characteristics of the PVA fibers and that under unchanged conditions the transmission 
stabilized quickly and was then stable for many hours.  The propagation loss of the PVA 
fibers in the water-swollen soft state, measured after immersion for 30 min in water at 
room temperature, was 1.1 ± 0.1 dB/cm at 470 nm and 0.9 ± 0.3 dB/cm at 590 nm 
(Figure 6-4, N = 5), i.e., slightly higher than in the dry state. The linear losses vs. 
distance functions confirm that the optical properties are homogeneous along the PVA 
fiber and that smooth bents introduce negligible losses. Due to significant scattering 
losses imparted by the slightly crystalline polymer, the optical losses of the current PVA 
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fibers are higher than in conventional optical fibers, but their optical properties are clearly 
sufficient (vide infra) for the targeted application. 
 
Figure 6-6. Changes of transmitted power ( ) and power density ( ) over time as a 10 
cm long PVA fiber transporting 470 nm light from a 10.1 mW fiber-coupled high-power 
LED is switched from the dry, rigid state to the water-swollen soft state (room 
temperature) and back.  
The illumination power density required for optogenetic applications is typically in the 
range of 10-1000 mW/cm2.31 The data in Figure 6-6 show that this level can be met with 
the current PVA fibers. For example, if a LED with an output of 10.1 mW is used, a 150 
µm thick, 10 cm long PVA fiber had an output power density of ~700 and ~500 mW/cm2 
in the dry and wet state, respectively. Thus, the illumination power achievable with the 
physiologically responsive, mechanically adaptive PVA fibers described here is adequate 
to activate neurons in the brain, which bodes well for future in vivo optogenetic 
applications.  
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6.5. CONCLUSIONS 
In summary, we have demonstrated the design and fabrication of physiologically-
responsive, mechanically adaptive optical fibers from poly(vinyl alcohol). These fibers 
offer an initial stiffness of ~7 GPa, which is slightly higher than those of commercial 
single mode optical fibers and permits facile insertion of small-diameter implants into the 
cortex. Upon exposure to water the fibers swell slightly and their stiffness is reduced 200-
fold, while the concomitant changes to the fiber’s optical properties are small. Clearly, 
the optical properties of the PVA fibers studied are not comparable to those of 
conventional optical fibers; the semicrystalline nature of the polymer, which causes 
scattering, and the absence of a cladding contribute to significant losses. However, the 
targeted application in optogenetics requires fibers that are only a few mm long. We have 
shown that the optical characteristics of the, at this point largely unoptimized, PVA fibers 
produced here are already sufficient to meet the demands of this application, and permit 
to deliver light of a range of wavelengths that is sufficiently intense to stimulate neurons 
in the brain. The hitherto unavailable mechanical morphing feature of the PVA optical 
fibers promises to be useful for chronic optogenetics technology and in vivo studies are 
planned that seek to quantify the potential benefits in terms of reduced 
neuroinflammatory response and improved neural integration. 
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Chapter 7 – Conclusions and Outlook 
 
7.1. CONCLUSIONS 
The present dissertation presents the design, preparation, and investigation of a new 
platform of physiologically responsive mechanically adaptive materials for neural 
interfacing applications, which alter their mechanical characteristics in response to 
physiological conditions. The materials are sufficiently rigid to facilitate implantation of 
the cortical devices into the cortex, but once in place, the materials will respond to the 
chemical environment of the cortex, soften substantially to closely match the mechanics 
of the surrounding tissue, and thus become “mechanically invisible” to minimize brain 
tissue response. The mechanical morphing of these materials relies on either 
plasticization of the polymer matrix upon absorption of water and/or on a nanocomposite 
architecture where physiologically benign rigid, rod-like cellulose nanocrystals are 
introduced into a polymer of interest. The high stiffness in the dry state and the ability to 
tailor the mechanical contrast via composition and processing renders these materials 
particularly useful for a wide variety of adaptive biomedical implants (patents 
pending5,6,7) such as intracortical microelectrodes. The chapters in this dissertation have 
been presented in a chronological fashion to illustrate the development of this new class 
of physiologically responsive biomaterials. 
Chapter 3 described chemo-responsive mechanically adaptive nanocomposites based on 
poly(vinyl alcohol) (PVA) and cellulose nanocrystals (CNCs), which offer an initial 
stiffness that is significantly higher than that of previous generations of such adaptive 
materials. The use of PVA as a matrix polymer into which CNCs are incorporated proved 
                                                
5Polymer Nanocomposites Having Switchable Mechanical Properties; European Patent Application 
61/701,000, Patent Filed 9/14/2012. 
6Medical Injection Device; European Patent Application 61/700,995, Patent Filed 9/14/2012. 
7Physiologically Responsive Mechanically Adaptive Polymer Optical Fibers, Production and Methods of 
Use; US Provisional Patent Application 61/939,893, Patent Filed 2/14/2014. 
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useful for several reasons. The tensile storage moduli of the nanocomposites were 
significantly higher than those of comparable nanocomposites in both the glassy and 
rubbery regime. It appears that in addition to CNC-CNC interactions, polymer-CNC 
interactions, which could be promoted by the strong propensity of PVA to form hydrogen 
bonds and provide a compatible polymer-filler interface, are a significant factor in this 
context. Another significant factor is the possibility of controlling the swelling 
characteristics of the PVA matrix, and therefore the properties of water- or artificial 
cerebrospinal fluid-swollen materials, via the processing conditions. Using this tool, the 
switching “contrast” of the materials upon exposure to physiological conditions could be 
varied between a 90-fold to a 200-fold modulus reduction depending on the source of 
cellulose nanocrystals. The results suggest that other ranges are accessible via the 
processing temperature, which (in relative terms) affects mainly the soft state. Although 
not as stiff initially in the dry state, materials fabricated from cotton cellulose 
nanocrystals exhibit a larger mechanical contrast (up to 900-fold), as they soften much 
more than the tunicate-based materials. This effect is related to the lower reinforcing 
power of cotton. Overall, we have demonstrated that varying the CNC type and 
concentration and the processing temperature allows one to tailor the mechanical 
properties of “hard” and “soft” state over a broad range. The hitherto unavailable 
contrasts accessible by these materials make them potentially useful as substrates for next 
generation of neural prosthetic devices.  
Chapters 4 and 5 dealt with the development of new class of drug-releasing mechanically 
adaptive materials. In Chapter 4, in situ softening antioxidant releasing polymeric 
materials were developed to explore if the combination of two independently effective 
mechanisms, softening vs. antioxidant release, leads to a synergistic effect in reducing the 
neuroinflammation at the intracortical microelectrode-tissue interface. Results showed 
that the incorporation of the antioxidant curcumin into the mechanically adaptive 
poly(vinyl alcohol) provided significant improvements in neuronal densities surrounding 
cortical implants in comparison to neat polymer films up to 4 weeks after implantation. 
However, at 12 weeks post-implantation, there were no significant differences between 
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curcumin-releasing and neat PVA reference implants for all investigated markers. Taken 
together, our results suggested that acute attenuation of inflammatory events using 
localized drug delivery mechanisms, such as release of curcumin, would not cause 
detrimental effects in the long-term. Further, the results presented here provide exciting 
opportunities to better understand the importance and optimal timing of wound healing 
events around cortical implants such that neuronal degeneration is prevented.  
Building on our proof-of-concept study in Chapter 4, we suggested that future studies 
should continue to investigate the use of mechanically adaptive polymer systems in 
conjunction with antioxidant release to mediate acute and chronic neuroinflammatory 
events surrounding intracortical microelectrodes. In order to better understand if the 
effects of short-term local release of antioxidant therapies are sufficient for long-term 
neuroprotection surrounding intracortical microelectrodes, it is imperative that future 
studies screen both additional antioxidants and alternative mechanically adaptive polymer 
systems with improved long-term in vivo stability. Therefore, in Chapter 5, mechanically 
adaptive materials based on poly(vinyl acetate) and CNCs with the ability to release two 
different natural antioxidant drugs (i.e. curcumin or resveratrol) locally within 72 hours 
of incubation in emulated physiological conditions were investigated. The 
nanocomposites softened substantially upon immersion in artificial cerebrospinal fluid at 
body temperature; tensile modulus decreased from ~6000 MPa to ~10 MPa (~600-fold). 
Additionally, curcumin-releasing mechanically adaptive nanocomposite exhibited greater 
antioxidant activity in vitro than their counterparts. Ongoing in vivo histological studies 
seek to quantify the benefits of synergistic effects of mechanically adaptive materials 
with antioxidant releasing properties to mediate acute and chronic neuroinflammatory 
events surrounding intracortical microelectrodes in comparison to commercial silicon-
based intracortical microelectrodes. 
Chapter 6 discussed expanding the idea of mechanically adaptive neural interfacing 
materials towards optogenetic applications. A different approach was taken to design and 
fabricate physiologically responsive, mechanically adaptive optical fibers from 
poly(vinyl alcohol). These fibers offer an initial stiffness of ~7000 MPa, which is slightly 
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higher than those of commercial optical fibers and permits facile insertion of small-
diameter implants into the cortex. Upon exposure to emulated physiological conditions 
the fibers swell slightly with water and their stiffness is reduced 200-fold, while the 
concomitant changes to the fiber’s optical properties are small. We have shown that the 
optical characteristics of the fibers produced here are already sufficient to meet the 
demands of this application, and permit the delivery of light in a range of wavelengths 
that is intense enough to stimulate neurons in the brain. The mechanical morphing feature 
of these optical fibers promises to be useful for chronic optogenetics technology and in 
vivo studies are planned that will quantify the potential benefits in terms of reduced 
neuroinflammatory response and improved neural integration. 
This dissertation derived fundamental insights into the structure-property relationships by 
controlling the adaptive nature of these materials through composition (i.e. different 
polymer matrices, types and amount of nanofiller, and therapeutic agents) and also 
processing conditions. While in vivo studies using the new materials presented here have 
only recently begun, it is already clear that the materials made and studied in this 
dissertation will be useful to advance the understanding of how stimuli-responsive 
polymeric materials can help to decrease the neuroinflammation effects associated with 
intracortical implants. 
7.2. OUTLOOK 
The hypothesis that the mechanical mismatch between current metallic- or silicon-based 
intracortical microelectrodes and brain tissue propagates neuroinflammation, an event 
leading to microelectrode failure, has led to the development of new family of in situ 
softening polymeric materials as presented in this dissertation. The application of 
mechanically adaptive materials in chronic neural interfaces is still in its infancy despite 
an impressive body of emerging research, partly because of the complexities associated 
with interacting with neural cells and the mammalian nervous system. Moreover, there 
are fundamental gaps of knowledge that need to be addressed. In addition to the areas 
investigated in the present dissertation, there are still many opportunities for in situ 
 196 
softening materials to enhance and improve current technologies in neural interfacing 
devices. While initial histological studies of implants based on mechanically adaptive 
polymers suggest that adaptive materials can better stabilize neural cell populations at the 
neural tissue/electrode interface than rigid electrodes (up to eight weeks), there are still 
several challenges that need to be addressed. First, the mechanical strain placed on 
cortical tissue by stiffer implants played a less important role soon after implantation than 
at more long-term times. Therefore, histological studies for such adaptive materials must 
be conducted for long-term implantation times to better understand the impact of 
mechanically adaptive materials in improving long-term performance of intracortical 
microelectrodes. It is also important to note that, at present, tissue histochemistry alone 
does not predict neural recording quality of intracortical electrodes. Future research 
activities in mechanically adaptive materials for intracortical microelectrode applications 
must focus, in parallel with histological studies, on investigating the transition of this 
platform technology to actual recording electrodes. Second, if such in vivo tissue 
response studies confirm that adaptive materials are indeed better than previously 
developed rigid electrodes, one must next determine how soft they need to be. In other 
words, could even softer materials (~kPa) further improve the tissue response? While the 
adaptive polymeric materials are several orders of magnitude softer than traditionally 
used materials, the materials are still two or three orders of magnitude stiffer than brain 
tissue. Answers to these questions are important to the development of this field. 
Additionally, limited studies on the mechanical properties of dynamic materials for the 
duration of implant lifetime suggest that further research is needed to assess the durability 
of softening polymeric-based intracortical microelectrodes in animal models. This will 
provide an insight into possible degradation of such adaptive polymer systems. 
The work presented in this dissertation also suggests the potential for synergistic effects 
of combinatorial approaches throughout the progressive inflammatory response. For 
example, one could envision the incorporation of bioactive molecules such as anti-
inflammatory, antioxidant therapies and/or proteins on or within the mechanically 
dynamic neural electrode devices to mitigate initial trauma, coupled with a chronically 
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compliant device to dictate scar mechanics and mediate chronic tissue strain. One 
limitation of drug-releasing implants is their limited effective duration. There are 
currently few if any viable options for locally delivering drugs for the extended periods of 
time that may be clinically relevant for intracortical microelectrode applications. 
Therefore, the field should also seek to develop sustained drug-releasing implants for 
long-term cortical applications.  
Finally, a proof of concept has been successfully established in Chapter 6 to expand the 
concept of mechanically adaptive polymeric materials towards other central nervous 
system applications; optogenetics. This developed platform technology can be tailored to 
a variety of biomedical applications, such as sensing, to create interesting polymeric 
optical fibers with mechanically dynamic properties. One could develop stimuli-
responsive adaptive polymeric fibers that could react to different stimuli such as pH. In 
the case of optogenetic applications, it is clear that long-term in vivo studies are necessary 
to better investigate the effect and behavior of such physiologically responsive 
mechanically adaptive optical fibers in the brain compared to commercial optical fibers.  
It is also important to note that despite the vast amount of research being developed 
recently on polymeric materials for neural interfacing applications; in most cases 
researchers have simply repurposed polymers developed for different applications for use 
in intracortical microelectrodes. Although the development of such materials-based 
intracortical microelectrodes has contributed significantly to our understanding of the 
technology, one should think of designing novel materials, strategies and concepts for the 
purposes of this field. Furthermore, due to the exciting advances in the fields of materials 
science, neural engineering and bioengineering, we should foster dynamic multi-
disciplinary teams, in order to accumulate the skills and knowledge to design, test, and 
integrate the next generation intracortical microelectrodes, capable of long-term clinical 
deployment for neuro-rehabilitative applications, and beyond.
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